Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:fenvalerate
go back to main search page
Accession:CHEBI:5014 term browser browse the term
Definition:A carboxylic ester obtained by formal condensation between 2-(4-chlorophenyl)-3-methylbutyric acid and cyano(3-phenoxyphenyl)methanol.
Synonyms:exact_synonym: cyano(3-phenoxyphenyl)methyl 2-(4-chlorophenyl)-3-methylbutanoate
 related_synonym: Formula=C25H22ClNO3;   InChI=1S/C25H22ClNO3/c1-17(2)24(18-11-13-20(26)14-12-18)25(28)30-23(16-27)19-7-6-10-22(15-19)29-21-8-4-3-5-9-21/h3-15,17,23-24H,1-2H3;   InChIKey=NYPJDWWKZLNGGM-UHFFFAOYSA-N;   Pydrin;   SMILES=CC(C)C(C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1)c1ccc(Cl)cc1;   alpha-cyano-(3-phenoxyphenyl)methyl-4-chloro-alpha-(1-methylethyl)benzeneacetate;   alpha-cyano-3-phenoxybenzyl 2-(4-chlorophenyl)-3-methylbutyrate;   alpha-cyano-m-phenoxybenzyl 2-(p-chlorophenyl)-3-methylbutyrate;   phenvalerate
 xref: Beilstein:2025982;   CAS:51630-58-1;   KEGG:C10988;   KEGG:D07952
 xref_mesh: MESH:C017690
 xref: PPDB:314;   Reaxys:2025982;   VSDB:314


show annotations for term's descendants           Sort by:
fenvalerate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein CTD PMID:34896426 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786 		JBrowse link
G A3galt2 alpha 1,3-galactosyltransferase 2 increases expression EXP fenvalerate results in increased expression of A3GALT2 mRNA CTD PMID:30307764 NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641 		JBrowse link
G Aak1 AP2 associated kinase 1 increases expression EXP fenvalerate results in increased expression of AAK1 mRNA CTD PMID:30307764 NCBI chr 4:119,300,128...119,451,834
Ensembl chr 4:119,295,257...119,450,969 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
decreases activity
decreases expression		 ISO
EXP		 fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]
fenvalerate results in decreased activity of ABCB1 protein
fenvalerate results in decreased expression of ABCB1A mRNA		 CTD PMID:21783720 PMID:30307764 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCB6 protein CTD PMID:34896426 NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 increases expression EXP fenvalerate results in increased expression of ABCG1 mRNA CTD PMID:30307764 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948 		JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 increases expression EXP fenvalerate results in increased expression of ABCG4 mRNA CTD PMID:30307764 NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCG5 protein CTD PMID:34896426 NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563 		JBrowse link
G Abhd11-as1 ABHD11 antisense RNA 1 (tail to tail) increases expression EXP fenvalerate results in increased expression of ABHD11-AS1 mRNA CTD PMID:30307764 NCBI chr12:21,681,118...21,682,106 JBrowse link
G Abhd8 abhydrolase domain containing 8 increases expression EXP fenvalerate results in increased expression of ABHD8 mRNA CTD PMID:30307764 NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667 		JBrowse link
G Abo3 histo-blood group ABO system transferase 3 increases expression EXP fenvalerate results in increased expression of ABO3 mRNA CTD PMID:30307764 NCBI chr 3:9,743,861...9,761,049
Ensembl chr 3:9,646,515...9,761,043 		JBrowse link
G Abr ABR activator of RhoGEF and GTPase increases expression EXP fenvalerate results in increased expression of ABR mRNA CTD PMID:30307764 NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression EXP fenvalerate results in decreased expression of ACAT2 protein CTD PMID:33656234 NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821 		JBrowse link
G Acbd4 acyl-CoA binding domain containing 4 increases expression EXP fenvalerate results in increased expression of ACBD4 mRNA CTD PMID:30307764 NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500 		JBrowse link
G Ace angiotensin I converting enzyme affects methylation ISO fenvalerate affects the methylation of ACE gene CTD PMID:23548413 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Ache acetylcholinesterase multiple interactions
affects activity
decreases activity
increases activity		 EXP [cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein
fenvalerate affects the activity of ACHE protein
fenvalerate results in decreased activity of ACHE protein
fenvalerate results in increased activity of ACHE protein		 CTD PMID:8385837 PMID:10355540 PMID:15186033 NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACKR3 protein CTD PMID:34896426 NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases activity EXP fenvalerate metabolite results in increased activity of ACOX1 protein CTD PMID:10630566 NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acsbg2 acyl-CoA synthetase bubblegum family member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACSBG2 protein CTD PMID:34896426 NCBI chr 9:1,683,846...1,715,517
Ensembl chr 9:1,683,847...1,714,518 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression EXP fenvalerate results in increased expression of ACSL1 mRNA CTD PMID:30307764 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACTN1 protein CTD PMID:34896426 NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251 		JBrowse link
G Acvr1c activin A receptor type 1C increases expression EXP fenvalerate results in increased expression of ACVR1C mRNA CTD PMID:30307764 NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327 		JBrowse link
G Adam2 ADAM metallopeptidase domain 2 increases expression EXP fenvalerate results in increased expression of ADAM2 mRNA CTD PMID:30307764 NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952 		JBrowse link
G Adam22 ADAM metallopeptidase domain 22 increases expression EXP fenvalerate results in increased expression of ADAM22 mRNA CTD PMID:30307764 NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962 		JBrowse link
G Adam23 ADAM metallopeptidase domain 23 increases expression EXP fenvalerate results in increased expression of ADAM23 mRNA CTD PMID:30307764 NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 increases expression EXP fenvalerate results in increased expression of ADAM7 mRNA CTD PMID:30307764 NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression EXP fenvalerate results in increased expression of ADAM8 mRNA CTD PMID:30307764 NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801 		JBrowse link
G Adamts7 ADAM metallopeptidase with thrombospondin type 1 motif, 7 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein CTD PMID:34896426 NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328 		JBrowse link
G Adarb1 adenosine deaminase, RNA-specific, B1 decreases expression EXP fenvalerate results in decreased expression of ADARB1 mRNA CTD PMID:30307764 NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852 		JBrowse link
G Adcy2 adenylate cyclase 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein CTD PMID:34896426 NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236 		JBrowse link
G Adcy4 adenylate cyclase 4 increases expression EXP fenvalerate results in increased expression of ADCY4 mRNA CTD PMID:30307764 NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I increases expression EXP fenvalerate results in increased expression of ADCYAP1R1 mRNA CTD PMID:30307764 NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700 		JBrowse link
G Add1 adducin 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of ADD1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182 		JBrowse link
G Adgrb3 adhesion G protein-coupled receptor B3 increases expression EXP fenvalerate results in increased expression of ADGRB3 mRNA CTD PMID:30307764 NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 increases expression EXP fenvalerate results in increased expression of ADGRG6 mRNA CTD PMID:30307764 NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123 		JBrowse link
G Adgrl3 adhesion G protein-coupled receptor L3 increases expression EXP fenvalerate results in increased expression of ADGRL3 mRNA CTD PMID:30307764 NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression EXP fenvalerate results in decreased expression of ADORA1 mRNA CTD PMID:30307764 NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801 		JBrowse link
G Adrb3 adrenoceptor beta 3 increases expression EXP fenvalerate results in increased expression of ADRB3 mRNA CTD PMID:30307764 NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552 		JBrowse link
G Adss2 adenylosuccinate synthase 2 increases expression EXP fenvalerate results in increased expression of ADSS2 mRNA CTD PMID:30307764 NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604 		JBrowse link
G Aebp1 AE binding protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AEBP1 protein CTD PMID:34896426 NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877 		JBrowse link
G Afdn afadin, adherens junction formation factor increases expression EXP fenvalerate results in increased expression of AFDN mRNA CTD PMID:30307764 NCBI chr 1:53,905,344...54,034,216
Ensembl chr 1:53,905,373...54,034,216 		JBrowse link
G Agl amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase increases expression EXP fenvalerate results in increased expression of AGL mRNA CTD PMID:30307764 NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828 		JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 increases expression EXP fenvalerate results in increased expression of AGPAT3 mRNA CTD PMID:30307764 NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358 		JBrowse link
G Agtpbp1 ATP/GTP binding carboxypeptidase 1 increases expression EXP fenvalerate results in increased expression of AGTPBP1 mRNA CTD PMID:30307764 NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869 		JBrowse link
G Agxt2 alanine-glyoxylate aminotransferase 2 increases expression EXP fenvalerate results in increased expression of AGXT2 mRNA CTD PMID:30307764 NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926 		JBrowse link
G Aif1l allograft inflammatory factor 1-like increases expression EXP fenvalerate results in increased expression of AIF1L mRNA CTD PMID:30307764 NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023 		JBrowse link
G Ajm1 apical junction component 1 homolog increases expression EXP fenvalerate results in increased expression of AJM1 mRNA CTD PMID:30307764 NCBI chr 3:8,394,942...8,401,323
Ensembl chr 3:8,392,889...8,401,321 		JBrowse link
G Ak2 adenylate kinase 2 decreases expression EXP fenvalerate results in decreased expression of AK2 protein CTD PMID:33656234 NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632 		JBrowse link
G Ak3 adenylate kinase 3 increases expression EXP fenvalerate results in increased expression of AK3 protein CTD PMID:33656234 NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625 		JBrowse link
G Ak5 adenylate kinase 5 increases expression EXP fenvalerate results in increased expression of AK5 mRNA CTD PMID:30307764 NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458 		JBrowse link
G Ak7 adenylate kinase 7 decreases expression EXP fenvalerate results in decreased expression of AK7 mRNA CTD PMID:30307764 NCBI chr 6:124,611,789...124,679,978
Ensembl chr 6:124,611,902...124,679,961 		JBrowse link
G Akap1 A-kinase anchoring protein 1 increases expression EXP fenvalerate results in increased expression of AKAP1 mRNA CTD PMID:30307764 NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896 		JBrowse link
G Akap13 A-kinase anchoring protein 13 increases expression EXP fenvalerate results in increased expression of AKAP13 mRNA CTD PMID:30307764 NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646 		JBrowse link
G Akap14 A-kinase anchoring protein 14 increases expression EXP fenvalerate results in increased expression of AKAP14 mRNA CTD PMID:30307764 NCBI chr  X:116,395,512...116,410,697
Ensembl chr  X:116,395,516...116,410,697 		JBrowse link
G Akap3 A-kinase anchoring protein 3 increases expression EXP fenvalerate results in increased expression of AKAP3 mRNA CTD PMID:30307764 NCBI chr 4:159,688,049...159,714,067
Ensembl chr 4:159,699,289...159,713,903 		JBrowse link
G Akap5 A-kinase anchoring protein 5 decreases expression EXP fenvalerate results in decreased expression of AKAP5 mRNA CTD PMID:30307764 NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578 		JBrowse link
G Akap7 A-kinase anchoring protein 7 increases expression EXP fenvalerate results in increased expression of AKAP7 mRNA CTD PMID:30307764 NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation		 ISO [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of AKT1 protein
fenvalerate results in increased phosphorylation of AKT1 protein		 CTD PMID:28949029 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 increases expression EXP fenvalerate results in increased expression of AKT3 mRNA CTD PMID:30307764 NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708 		JBrowse link
G Alb albumin decreases expression EXP fenvalerate results in decreased expression of ALB protein CTD PMID:33656234 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 increases expression EXP fenvalerate results in increased expression of ALDH6A1 mRNA CTD PMID:30307764 NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A decreases expression EXP fenvalerate results in decreased expression of ALDOA protein CTD PMID:33656234 NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ALOX15 protein CTD PMID:34896426 NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874 		JBrowse link
G Alpk3 alpha-kinase 3 increases expression EXP fenvalerate results in increased expression of ALPK3 mRNA CTD PMID:30307764 NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases activity		 ISO
EXP		 fenvalerate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein]
fenvalerate results in increased activity of ALPL protein		 CTD PMID:15696646 PMID:16326432 PMID:29149346 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Alx3 ALX homeobox 3 increases expression EXP fenvalerate results in increased expression of ALX3 mRNA CTD PMID:30307764 NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609 		JBrowse link
G Amelx amelogenin, X-linked increases expression EXP fenvalerate results in increased expression of AMELX mRNA CTD PMID:30307764 NCBI chr  X:25,076,362...25,087,660
Ensembl chr  X:25,076,362...25,087,660 		JBrowse link
G Amh anti-Mullerian hormone multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of AMH mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA CTD PMID:34896426 PMID:36053783 NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282 		JBrowse link
G Amn1 antagonist of mitotic exit network 1 homolog increases expression EXP fenvalerate results in increased expression of AMN1 mRNA CTD PMID:30307764 NCBI chr 4:182,155,140...182,182,085
Ensembl chr 4:182,155,142...182,182,016 		JBrowse link
G Andpro androgen regulated protein increases expression EXP fenvalerate results in increased expression of ANDPRO mRNA CTD PMID:30307764 NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966 		JBrowse link
G Ank2 ankyrin 2 increases expression EXP fenvalerate results in increased expression of ANK2 mRNA CTD PMID:30307764 NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923 		JBrowse link
G Ankef1 ankyrin repeat and EF-hand domain containing 1 increases expression EXP fenvalerate results in increased expression of ANKEF1 mRNA CTD PMID:30307764 NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059 		JBrowse link
G Ankh ANKH inorganic pyrophosphate transport regulator multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANKH protein CTD PMID:34896426 NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187 		JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 increases expression EXP fenvalerate results in increased expression of ANKIB1 mRNA CTD PMID:30307764 NCBI chr 4:30,333,678...30,457,781
Ensembl chr 4:30,333,677...30,457,781 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 increases expression EXP fenvalerate results in increased expression of ANKRD1 mRNA CTD PMID:30307764 NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919 		JBrowse link
G Ankrd52 ankyrin repeat domain 52 increases expression EXP fenvalerate results in increased expression of ANKRD52 mRNA CTD PMID:30307764 NCBI chr 7:806,829...820,481
Ensembl chr 7:806,767...820,481 		JBrowse link
G Ankrd6 ankyrin repeat domain 6 increases expression EXP fenvalerate results in increased expression of ANKRD6 mRNA CTD PMID:30307764 NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090 		JBrowse link
G Ankrd60 ankyrin repeat domain 60 increases expression EXP fenvalerate results in increased expression of ANKRD60 mRNA CTD PMID:30307764 NCBI chr 3:162,365,158...162,376,491
Ensembl chr 3:162,364,896...162,375,596 		JBrowse link
G Ankrd63 ankyrin repeat domain 63 increases expression EXP fenvalerate results in increased expression of ANKRD63 mRNA CTD PMID:30307764 NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404 		JBrowse link
G Ankrd9 ankyrin repeat domain 9 decreases expression EXP fenvalerate results in decreased expression of ANKRD9 mRNA CTD PMID:30307764 NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923 		JBrowse link
G Ano3 anoctamin 3 increases expression EXP fenvalerate results in increased expression of ANO3 mRNA CTD PMID:30307764 NCBI chr 3:97,235,671...97,550,090
Ensembl chr 3:97,238,354...97,550,154 		JBrowse link
G Ano8 anoctamin 8 increases expression EXP fenvalerate results in increased expression of ANO8 mRNA CTD PMID:30307764 NCBI chr16:18,163,853...18,173,248
Ensembl chr16:18,163,843...18,173,545 		JBrowse link
G Ano9 anoctamin 9 increases expression EXP fenvalerate results in increased expression of ANO9 mRNA CTD PMID:30307764 NCBI chr 1:196,208,863...196,230,381
Ensembl chr 1:196,197,341...196,229,900 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression EXP fenvalerate results in increased expression of ANTXR1 mRNA CTD PMID:30307764 NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232 		JBrowse link
G Anxa6 annexin A6 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein CTD PMID:34896426 NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433 		JBrowse link
G Apod apolipoprotein D increases expression EXP fenvalerate results in increased expression of APOD mRNA CTD PMID:30307764 NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305 		JBrowse link
G Apoe apolipoprotein E increases expression EXP fenvalerate results in increased expression of APOE mRNA CTD PMID:30307764 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Apol11a apolipoprotein L11a increases expression EXP fenvalerate results in increased expression of APOL11A mRNA CTD PMID:30307764 NCBI chr 7:109,248,260...109,262,266
Ensembl chr 7:109,248,942...109,253,716 		JBrowse link
G Ar androgen receptor multiple interactions
decreases activity
increases expression		 ISO
EXP		 [Dihydrotestosterone co-treated with fenvalerate] results in decreased expression of AR mRNA; Dihydrotestosterone inhibits the reaction [fenvalerate results in increased activity of AR protein]; fenvalerate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]
fenvalerate results in decreased activity of AR protein
fenvalerate results in increased expression of AR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA		 CTD PMID:15064155 PMID:16125883 PMID:16857237 PMID:20410157 PMID:21232584 More... NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Arf2 ADP-ribosylation factor 2 increases expression EXP fenvalerate results in increased expression of ARF2 mRNA CTD PMID:30307764 NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659 		JBrowse link
G Arg2 arginase 2 increases expression EXP fenvalerate results in increased expression of ARG2 mRNA CTD PMID:31524104 NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378 		JBrowse link
G Arhgap10 Rho GTPase activating protein 10 increases expression EXP fenvalerate results in increased expression of ARHGAP10 mRNA CTD PMID:30307764 NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313 		JBrowse link
G Arhgef28 Rho guanine nucleotide exchange factor 28 increases expression EXP fenvalerate results in increased expression of ARHGEF28 mRNA CTD PMID:30307764 NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672 		JBrowse link
G Arid3b AT-rich interaction domain 3B increases expression EXP fenvalerate results in increased expression of ARID3B mRNA CTD PMID:30307764 NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318 		JBrowse link
G Arih1 ariadne RBR E3 ubiquitin protein ligase 1 increases expression EXP fenvalerate results in increased expression of ARIH1 mRNA CTD PMID:30307764 NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245 		JBrowse link
G Ark2c arkadia C-terminal like ring finger ubiquitin ligase 2C increases expression EXP fenvalerate results in increased expression of ARK2C mRNA CTD PMID:30307764 NCBI chr18:70,984,566...71,100,836
Ensembl chr18:70,989,731...71,100,836 		JBrowse link
G Arl5c ADP-ribosylation factor like GTPase 5C increases expression EXP fenvalerate results in increased expression of ARL5C mRNA CTD PMID:30307764 NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002 		JBrowse link
G Arl8b ADP-ribosylation factor like GTPase 8B increases expression EXP fenvalerate results in increased expression of ARL8B mRNA CTD PMID:30307764 NCBI chr 4:141,748,634...141,792,605
Ensembl chr 4:141,748,587...141,792,596 		JBrowse link
G Arl9 ADP-ribosylation factor like GTPase 9 increases expression EXP fenvalerate results in increased expression of ARL9 mRNA CTD PMID:30307764 NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,157,586...31,166,699 		JBrowse link
G Armc5 armadillo repeat containing 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein CTD PMID:34896426 NCBI chr 1:182,820,141...182,826,913
Ensembl chr 1:182,820,141...182,826,907 		JBrowse link
G Armh4 armadillo-like helical domain containing 4 increases expression EXP fenvalerate results in increased expression of ARMH4 mRNA CTD PMID:30307764 NCBI chr15:22,975,895...23,076,986
Ensembl chr15:22,975,895...23,076,949 		JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 increases expression EXP fenvalerate results in increased expression of ARNT2 mRNA CTD PMID:30307764 NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of ARPC1B protein CTD PMID:34896426 NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747 		JBrowse link
G Arsg arylsulfatase G increases expression EXP fenvalerate results in increased expression of ARSG mRNA CTD PMID:30307764 NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941 		JBrowse link
G Art1 ADP-ribosyltransferase 1 increases expression EXP fenvalerate results in increased expression of ART1 mRNA CTD PMID:30307764 NCBI chr 1:156,478,096...156,487,172
Ensembl chr 1:156,482,621...156,487,172 		JBrowse link
G Arx aristaless related homeobox increases expression EXP fenvalerate results in increased expression of ARX mRNA CTD PMID:30307764 NCBI chr  X:58,016,233...58,028,149
Ensembl chr  X:58,016,233...58,028,142 		JBrowse link
G Asic2 acid sensing ion channel subunit 2 increases expression EXP fenvalerate results in increased expression of ASIC2 mRNA CTD PMID:30307764 NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424 		JBrowse link
G Asmt acetylserotonin O-methyltransferase increases expression EXP fenvalerate results in increased expression of ASMT mRNA CTD PMID:30307764 NCBI chr12:16,304,719...16,309,568
Ensembl chr12:16,304,719...16,309,568 		JBrowse link
G Asphd1 aspartate beta-hydroxylase domain containing 1 increases expression EXP fenvalerate results in increased expression of ASPHD1 mRNA CTD PMID:30307764 NCBI chr 1:181,552,968...181,556,902
Ensembl chr 1:181,552,884...181,556,090 		JBrowse link
G Aspscr1 ASPSCR1 tether for SLC2A4, UBX domain containing increases expression EXP fenvalerate results in increased expression of ASPSCR1 mRNA CTD PMID:30307764 NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904 		JBrowse link
G Atf3 activating transcription factor 3 increases expression EXP fenvalerate results in increased expression of ATF3 mRNA CTD PMID:30307764 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atn1 atrophin 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATN1 protein CTD PMID:34896426 NCBI chr 4:157,554,287...157,568,092
Ensembl chr 4:157,551,276...157,568,132 		JBrowse link
G Atosa atos homolog A increases expression EXP fenvalerate results in increased expression of ATOSA mRNA CTD PMID:30307764 NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549 		JBrowse link
G Atp1a4 ATPase Na+/K+ transporting subunit alpha 4 increases expression EXP fenvalerate results in increased expression of ATP1A4 mRNA CTD PMID:30307764 NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATP2A1 protein CTD PMID:34896426 NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838 		JBrowse link
G Atp2b3 ATPase plasma membrane Ca2+ transporting 3 increases expression EXP fenvalerate results in increased expression of ATP2B3 mRNA CTD PMID:30307764 NCBI chr  X:151,216,483...151,289,069
Ensembl chr  X:151,216,507...151,286,775 		JBrowse link
G Atp2b4 ATPase plasma membrane Ca2+ transporting 4 increases expression EXP fenvalerate results in increased expression of ATP2B4 mRNA CTD PMID:30307764 NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246 		JBrowse link
G Atp2c1 ATPase secretory pathway Ca2+ transporting 1 increases expression EXP fenvalerate results in increased expression of ATP2C1 mRNA CTD PMID:30307764 NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha decreases expression EXP fenvalerate results in decreased expression of ATP5F1A protein CTD PMID:33656234 NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794 		JBrowse link
G Atp6v0a4 ATPase H+ transporting V0 subunit a4 increases expression EXP fenvalerate results in increased expression of ATP6V0A4 mRNA CTD PMID:30307764 NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110 		JBrowse link
G Atp6v1c2 ATPase H+ transporting V1 subunit C2 increases expression EXP fenvalerate results in increased expression of ATP6V1C2 mRNA CTD PMID:30307764 NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028 		JBrowse link
G Atp6v1g3 ATPase H+ transporting V1 subunit G3 increases expression EXP fenvalerate results in increased expression of ATP6V1G3 mRNA CTD PMID:30307764 NCBI chr13:49,800,256...49,825,247
Ensembl chr13:49,794,222...49,825,247 		JBrowse link
G Atp8b2 ATPase phospholipid transporting 8B2 increases expression EXP fenvalerate results in increased expression of ATP8B2 mRNA CTD PMID:30307764 NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883 		JBrowse link
G Atxn1 ataxin 1 increases expression EXP fenvalerate results in increased expression of ATXN1 mRNA CTD PMID:30307764 NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360 		JBrowse link
G Aunip aurora kinase A and ninein interacting protein increases expression EXP fenvalerate results in increased expression of AUNIP mRNA CTD PMID:30307764 NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501 		JBrowse link
G Aurka aurora kinase A increases expression EXP fenvalerate results in increased expression of AURKA mRNA CTD PMID:30307764 NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390 		JBrowse link
G Aurkc aurora kinase C increases expression EXP fenvalerate results in increased expression of AURKC mRNA CTD PMID:30307764 NCBI chr 1:66,843,653...66,849,775
Ensembl chr 1:66,843,653...66,864,386 		JBrowse link
G Auts2 activator of transcription and developmental regulator AUTS2 increases expression EXP fenvalerate results in increased expression of AUTS2 mRNA CTD PMID:30307764 NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416 		JBrowse link
G Avil advillin increases expression
multiple interactions		 EXP fenvalerate results in increased expression of AVIL mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AVIL protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071 		JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 increases expression EXP fenvalerate results in increased expression of B3GNT5 mRNA CTD PMID:30307764 NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166 		JBrowse link
G Baalc BAALC binder of MAP3K1 and KLF4 increases expression EXP fenvalerate results in increased expression of BAALC mRNA CTD PMID:30307764 NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288 		JBrowse link
G Babam2 BRISC and BRCA1 A complex member 2 increases expression EXP fenvalerate results in increased expression of BABAM2 mRNA CTD PMID:30307764 NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression EXP fenvalerate results in increased expression of BASP1 mRNA CTD PMID:30307764 NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BAX mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of BAX mRNA CTD PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A increases expression EXP fenvalerate results in increased expression of BAZ1A mRNA CTD PMID:30307764 NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459 		JBrowse link
G Baz1b bromodomain adjacent to zinc finger domain, 1B increases expression EXP fenvalerate results in increased expression of BAZ1B mRNA CTD PMID:30307764 NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426 		JBrowse link
G Bbs7 Bardet-Biedl syndrome 7 increases expression EXP fenvalerate results in increased expression of BBS7 mRNA CTD PMID:30307764 NCBI chr 2:119,434,760...119,474,665
Ensembl chr 2:119,434,760...119,474,396 		JBrowse link
G Bcan brevican multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BCAN protein CTD PMID:34896426 NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460 		JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor increases expression EXP fenvalerate results in increased expression of BCAS3 mRNA CTD PMID:30307764 NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO
EXP		 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA		 CTD PMID:28949029 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions ISO [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein CTD PMID:28949029 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 		JBrowse link
G Bdkrb2 bradykinin receptor B2 increases expression EXP fenvalerate results in increased expression of BDKRB2 mRNA CTD PMID:30307764 NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497 		JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression
decreases expression		 EXP
ISO		 fenvalerate results in increased expression of BDNF mRNA
fenvalerate results in decreased expression of BDNF mRNA		 CTD PMID:16166269 PMID:34358930 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615 		JBrowse link
G Bend4 BEN domain containing 4 increases expression EXP fenvalerate results in increased expression of BEND4 mRNA CTD PMID:30307764 NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504 		JBrowse link
G Bex2 brain expressed X-linked 2 increases expression EXP fenvalerate results in increased expression of BEX1 mRNA CTD PMID:30307764 NCBI chr  X:99,019,847...99,021,375
Ensembl chr  X:99,019,000...99,021,503 		JBrowse link
G Bfsp1 beaded filament structural protein 1 increases expression EXP fenvalerate results in increased expression of BFSP1 mRNA CTD PMID:30307764 NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in decreased expression of BID protein CTD PMID:28949029 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720 		JBrowse link
G Bin2a beta-galactosidase-like protein increases expression EXP fenvalerate results in increased expression of BIN2A mRNA CTD PMID:30307764 NCBI chr 8:25,248,570...25,287,173
Ensembl chr 8:25,248,570...25,287,173 		JBrowse link
G Bmp6 bone morphogenetic protein 6 increases expression EXP fenvalerate results in increased expression of BMP6 mRNA CTD PMID:30307764 NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365 		JBrowse link
G Bpgm bisphosphoglycerate mutase decreases expression EXP fenvalerate results in decreased expression of BPGM protein CTD PMID:33656234 NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581 		JBrowse link
G Bpifb2 BPI fold containing family B, member 2 increases expression EXP fenvalerate results in increased expression of BPIFB2 mRNA CTD PMID:30307764 NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044 		JBrowse link
G Brca1 BRCA1, DNA repair associated affects binding
increases expression
multiple interactions		 ISO
EXP		 fenvalerate binds to BRCA1 protein
fenvalerate results in increased expression of BRCA1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein		 CTD PMID:30307764 PMID:32278787 PMID:34896426 NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304 		JBrowse link
G Brdt bromodomain testis associated multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT protein CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842 		JBrowse link
G Brf1 BRF1, RNA polymerase III transcription initiation factor subunit decreases expression EXP fenvalerate results in decreased expression of BRF1 mRNA CTD PMID:30307764 NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278 		JBrowse link
G Brinp2 BMP/retinoic acid inducible neural specific 2 increases expression EXP fenvalerate results in increased expression of BRINP2 mRNA CTD PMID:30307764 NCBI chr13:70,431,006...70,532,766
Ensembl chr13:70,431,010...70,531,810 		JBrowse link
G Brinp3 BMP/retinoic acid inducible neural specific 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRINP3 protein CTD PMID:34896426 NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770 		JBrowse link
G C19h1orf131 similar to human chromosome 1 open reading frame 131 increases expression EXP fenvalerate results in increased expression of C19H1ORF131 mRNA CTD PMID:30307764 NCBI chr19:52,807,932...52,822,259
Ensembl chr19:52,807,934...52,822,267 		JBrowse link
G C1qtnf4 C1q and TNF related 4 increases expression EXP fenvalerate results in increased expression of C1QTNF4 mRNA CTD PMID:30307764 NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139 		JBrowse link
G C2h1orf52 similar to human chromosome 1 open reading frame 52 decreases expression EXP fenvalerate results in decreased expression of C2H1ORF52 mRNA CTD PMID:30307764 NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040 		JBrowse link
G C3 complement C3 affects expression
multiple interactions		 ISO fenvalerate affects the expression of C3 protein
fenvalerate affects the expression of and results in increased activity of C3 protein		 CTD PMID:21557984 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429 		JBrowse link
G C3ar1 complement C3a receptor 1 increases expression EXP fenvalerate results in increased expression of C3AR1 mRNA CTD PMID:30307764 NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701 		JBrowse link
G Cabs1 calcium binding protein, spermatid associated 1 increases expression EXP fenvalerate results in increased expression of CABS1 mRNA CTD PMID:30307764 NCBI chr14:20,096,962...20,099,024
Ensembl chr14:20,096,899...20,099,181 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A increases expression EXP fenvalerate results in increased expression of CACNA1A mRNA CTD PMID:30307764 NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225 		JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B increases expression EXP fenvalerate results in increased expression of CACNA1B mRNA CTD PMID:30307764 NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C increases expression
multiple interactions		 EXP fenvalerate results in increased expression of CACNA1C mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S increases expression
multiple interactions		 EXP fenvalerate results in increased expression of CACNA1S mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1S protein		 CTD PMID:30307764 PMID:34896426 NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA2D1 protein CTD PMID:34896426 NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969 		JBrowse link
G Cacnb2 calcium voltage-gated channel auxiliary subunit beta 2 increases expression EXP fenvalerate results in increased expression of CACNB2 mRNA CTD PMID:30307764 NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106 		JBrowse link
G Cacnb4 calcium voltage-gated channel auxiliary subunit beta 4 increases expression EXP fenvalerate results in increased expression of CACNB4 mRNA CTD PMID:30307764 NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944 		JBrowse link
G Cacng5 calcium voltage-gated channel auxiliary subunit gamma 5 increases expression EXP fenvalerate results in increased expression of CACNG5 mRNA CTD PMID:30307764 NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614 		JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 increases expression EXP fenvalerate results in increased expression of CACNG7 mRNA CTD PMID:30307764 NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression EXP fenvalerate results in increased expression of CALCA mRNA CTD PMID:30307764 NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Calcr calcitonin receptor increases expression EXP fenvalerate results in increased expression of CALCR mRNA CTD PMID:30307764 NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392 		JBrowse link
G Calhm6 calcium homeostasis modulator family member 6 increases expression EXP fenvalerate results in increased expression of CALHM6 mRNA CTD PMID:30307764 NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278 		JBrowse link
G Calm1 calmodulin 1 increases expression ISO fenvalerate results in increased expression of CALM1 mRNA; fenvalerate results in increased expression of CALM1 protein CTD PMID:22437841 NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227 		JBrowse link
G Camk1g calcium/calmodulin-dependent protein kinase IG increases expression EXP fenvalerate results in increased expression of CAMK1G mRNA CTD PMID:30307764 NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556 		JBrowse link
G Camkk1 calcium/calmodulin-dependent protein kinase kinase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CAMKK1 protein CTD PMID:34896426 NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498 		JBrowse link
G Camkk2 calcium/calmodulin-dependent protein kinase kinase 2 increases expression EXP fenvalerate results in increased expression of CAMKK2 mRNA CTD PMID:30307764 NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279 		JBrowse link
G Camkv CaM kinase-like vesicle-associated increases expression EXP fenvalerate results in increased expression of CAMKV mRNA CTD PMID:30307764 NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169 		JBrowse link
G Camsap1 calmodulin regulated spectrin-associated protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CAMSAP1 protein CTD PMID:34896426 NCBI chr 3:8,746,176...8,806,067
Ensembl chr 3:8,746,176...8,806,072 		JBrowse link
G Capn10 calpain 10 increases expression EXP fenvalerate results in increased expression of CAPN10 mRNA CTD PMID:30307764 NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494 		JBrowse link
G Capn3 calpain 3 increases expression EXP fenvalerate results in increased expression of CAPN3 mRNA CTD PMID:30307764 NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858 		JBrowse link
G Capn8 calpain 8 increases expression EXP fenvalerate results in increased expression of CAPN8 mRNA CTD PMID:30307764 NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146 		JBrowse link
G Caprin1 cell cycle associated protein 1 increases expression EXP fenvalerate results in increased expression of CAPRIN1 mRNA CTD PMID:30307764 NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502 		JBrowse link
G Car2 carbonic anhydrase 2 decreases expression EXP fenvalerate results in decreased expression of CAR2 protein CTD PMID:33656234 NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818 		JBrowse link
G Car6 carbonic anhydrase 6 decreases expression EXP fenvalerate results in decreased expression of CA6 mRNA CTD PMID:30307764 NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644 		JBrowse link
G Carmil3 capping protein regulator and myosin 1 linker 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CARMIL3 protein CTD PMID:34896426 NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225 		JBrowse link
G Casc3 CASC3 exon junction complex subunit increases expression EXP fenvalerate results in increased expression of CASC3 mRNA CTD PMID:30307764 NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage		 ISO
EXP		 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; [U 0126 co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]
fenvalerate results in increased cleavage of CASP3 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP3 mRNA; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]		 CTD PMID:28949029 PMID:30307764 PMID:34896426 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of CASP9 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CASP9 mRNA		 CTD PMID:30307764 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Casz1 castor zinc finger 1 increases expression EXP fenvalerate results in increased expression of CASZ1 mRNA CTD PMID:30307764 NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400 		JBrowse link
G Cat catalase multiple interactions
decreases activity
increases activity		 EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein; [cypermethrin co-treated with fenvalerate] results in increased activity of CAT protein; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein]
fenvalerate metabolite results in decreased activity of CAT protein; fenvalerate results in decreased activity of CAT protein
fenvalerate results in increased activity of CAT protein		 CTD PMID:10355540 PMID:15892188 PMID:30307764 PMID:33396045 PMID:35678313 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cbfb core-binding factor subunit beta increases expression EXP fenvalerate results in increased expression of CBFB mRNA CTD PMID:30307764 NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751 		JBrowse link
G Cblif cobalamin binding intrinsic factor increases expression EXP fenvalerate results in increased expression of CBLIF mRNA CTD PMID:30307764 NCBI chr 1:208,605,983...208,620,231
Ensembl chr 1:208,605,983...208,620,344 		JBrowse link
G Cbln1 cerebellin 1 precursor increases expression EXP fenvalerate results in increased expression of CBLN1 mRNA CTD PMID:30307764 NCBI chr19:19,608,763...19,612,572
Ensembl chr19:19,608,716...19,612,572 		JBrowse link
G Cc2d1a coiled-coil and C2 domain containing 1A multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CC2D1A protein CTD PMID:34896426 NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936 		JBrowse link
G Cc2d2a coiled-coil and C2 domain containing 2A increases expression EXP fenvalerate results in increased expression of CC2D2A mRNA CTD PMID:30307764 NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949 		JBrowse link
G Ccdc127 coiled-coil domain containing 127 increases expression EXP fenvalerate results in increased expression of CCDC127 mRNA CTD PMID:30307764 NCBI chr 1:28,928,420...28,935,885
Ensembl chr 1:28,928,325...28,935,893 		JBrowse link
G Ccdc13 coiled-coil domain containing 13 increases expression EXP fenvalerate results in increased expression of CCDC13 mRNA CTD PMID:30307764 NCBI chr 8:121,455,202...121,507,487
Ensembl chr 8:121,457,697...121,502,337 		JBrowse link
G Ccdc25 coiled-coil domain containing 25 increases expression EXP fenvalerate results in increased expression of CCDC25 mRNA CTD PMID:30307764 NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758 		JBrowse link
G Ccdc30 coiled-coil domain containing 30 increases expression EXP fenvalerate results in increased expression of CCDC30 mRNA CTD PMID:30307764 NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659 		JBrowse link
G Ccdc65 coiled-coil domain containing 65 increases expression EXP fenvalerate results in increased expression of CCDC65 mRNA CTD PMID:30307764 NCBI chr 7:129,857,118...129,870,803
Ensembl chr 7:129,857,247...129,870,803 		JBrowse link
G Cckar cholecystokinin A receptor increases expression EXP fenvalerate results in increased expression of CCKAR mRNA CTD PMID:30307764 NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO fenvalerate results in decreased expression of CCL2 mRNA CTD PMID:23397585 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression EXP fenvalerate results in increased expression of CCL3 mRNA CTD PMID:30307764 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression EXP fenvalerate results in increased expression of CCL7 mRNA CTD PMID:30307764 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303 		JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CCN1 protein CTD PMID:34896426 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484 		JBrowse link
G Ccn4 cellular communication network factor 4 increases expression EXP fenvalerate results in increased expression of CCN4 mRNA CTD PMID:30307764 NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression EXP fenvalerate results in increased expression of CCN5 mRNA CTD PMID:30307764 NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636 		JBrowse link
G Ccna2 cyclin A2 increases expression EXP fenvalerate results in increased expression of CCNA2 mRNA CTD PMID:30307764 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccrl2 C-C motif chemokine receptor like 2 increases expression EXP fenvalerate results in increased expression of CCRL2 mRNA CTD PMID:30307764 NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664 		JBrowse link
G Ccser2 coiled-coil serine-rich protein 2 decreases expression EXP fenvalerate results in decreased expression of CCSER2 mRNA CTD PMID:30307764 NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738 		JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 decreases expression EXP fenvalerate results in decreased expression of CCT3 protein CTD PMID:33656234 NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757 		JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 increases expression EXP fenvalerate results in increased expression of CCT8 protein CTD PMID:33656234 NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079 		JBrowse link
G Cd24 CD24 molecule increases expression EXP fenvalerate results in increased expression of CD24 mRNA CTD PMID:31524104 NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662 		JBrowse link
G Cd28 Cd28 molecule increases expression EXP fenvalerate results in increased expression of CD28 mRNA CTD PMID:30307764 NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685 		JBrowse link
G Cd36 CD36 molecule decreases expression ISO fenvalerate results in decreased expression of CD36 mRNA CTD PMID:28369636 NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903 		JBrowse link
G Cd38 CD38 molecule increases expression EXP fenvalerate results in increased expression of CD38 mRNA CTD PMID:30307764 NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986 		JBrowse link
G Cd9 CD9 molecule multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222 		JBrowse link
G Cdc45 cell division cycle 45 increases expression EXP fenvalerate results in increased expression of CDC45 mRNA CTD PMID:30307764 NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619 		JBrowse link
G Cdh11 cadherin 11 increases expression EXP fenvalerate results in increased expression of CDH11 mRNA CTD PMID:30307764 NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272 		JBrowse link
G Cdh13 cadherin 13 increases expression EXP fenvalerate results in increased expression of CDH13 mRNA CTD PMID:30307764 NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459 		JBrowse link
G Cdh22 cadherin 22 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDH22 protein CTD PMID:34896426 NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588 		JBrowse link
G Cdh23 cadherin-related 23 increases expression EXP fenvalerate results in increased expression of CDH23 mRNA CTD PMID:30307764 NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419 		JBrowse link
G Cdk13 cyclin-dependent kinase 13 increases expression EXP fenvalerate results in increased expression of CDK13 mRNA CTD PMID:30307764 NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721 		JBrowse link
G Cdk2 cyclin dependent kinase 2 increases expression
multiple interactions
affects binding		 ISO fenvalerate results in increased expression of CDK2 mRNA
CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate binds to CDK2 protein		 CTD PMID:22850687 PMID:32278787 NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403 		JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDK5RAP2 protein CTD PMID:34896426 NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 increases expression EXP fenvalerate results in increased expression of CDK6 mRNA CTD PMID:30307764 NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 increases expression EXP fenvalerate results in increased expression of CDK9 mRNA CTD PMID:30307764 NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP fenvalerate results in increased expression of CDKN1A mRNA CTD PMID:30307764 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
decreases expression
decreases response to substance		 ISO CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate results in decreased expression of CDKN1B mRNA; fenvalerate results in decreased expression of CDKN1B protein
CDKN1B protein results in decreased susceptibility to fenvalerate		 CTD PMID:22850687 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon increases expression EXP fenvalerate results in increased expression of CEBPE mRNA CTD PMID:30307764 NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814 		JBrowse link
G Cela1 chymotrypsin like elastase 1 decreases expression EXP fenvalerate results in decreased expression of CELA1 mRNA CTD PMID:30307764 NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 increases expression EXP fenvalerate results in increased expression of CELF5 mRNA CTD PMID:30307764 NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322 		JBrowse link
G Cenpf centromere protein F decreases expression EXP fenvalerate results in decreased expression of CENPF protein CTD PMID:33656234 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669 		JBrowse link
G Cenpt centromere protein T increases expression EXP fenvalerate results in increased expression of CENPT mRNA CTD PMID:30307764 NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142 		JBrowse link
G Cenpx centromere protein X decreases expression EXP fenvalerate results in decreased expression of CENPX mRNA CTD PMID:30307764 NCBI chr10:105,991,469...105,994,310 JBrowse link
G Cep126 centrosomal protein 126 increases expression EXP fenvalerate results in increased expression of CEP126 mRNA CTD PMID:30307764 NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467 		JBrowse link
G Cep350 centrosomal protein 350 increases expression EXP fenvalerate results in increased expression of CEP350 mRNA CTD PMID:30307764 NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214 		JBrowse link
G Cep68 centrosomal protein 68 increases expression EXP fenvalerate results in increased expression of CEP68 mRNA CTD PMID:30307764 NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517 		JBrowse link
G Cep76 centrosomal protein 76 increases expression EXP fenvalerate results in increased expression of CEP76 mRNA CTD PMID:30307764 NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504 		JBrowse link
G Cerkl ceramide kinase-like increases expression EXP fenvalerate results in increased expression of CERKL mRNA CTD PMID:30307764 NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675 		JBrowse link
G Ces1d carboxylesterase 1D increases metabolic processing ISO CES1 protein results in increased metabolism of fenvalerate CTD PMID:19249324 NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035 		JBrowse link
G Ces2e carboxylesterase 2E affects metabolic processing ISO CES2E protein affects the metabolism of fenvalerate CTD PMID:15123619 NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856 		JBrowse link
G Cfap100 cilia and flagella associated protein 100 increases expression EXP fenvalerate results in increased expression of CFAP100 mRNA CTD PMID:30307764 NCBI chr 4:122,914,693...122,938,994
Ensembl chr 4:122,914,698...122,938,580 		JBrowse link
G Cfap144 cilia and flagella associated protein 144 increases expression EXP fenvalerate results in increased expression of CFAP144 mRNA CTD PMID:30307764 NCBI chr10:43,509,823...43,519,693
Ensembl chr10:43,509,826...43,520,086 		JBrowse link
G Cfap161 cilia and flagella associated protein 161 decreases expression EXP fenvalerate results in decreased expression of CFAP161 protein CTD PMID:33656234 NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730 		JBrowse link
G Cfap300 cilia and flagella associated protein 300 decreases expression EXP fenvalerate results in decreased expression of CFAP300 protein CTD PMID:33656234 NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807 		JBrowse link
G Cfb complement factor B decreases expression EXP fenvalerate results in decreased expression of CFB protein CTD PMID:33656234 NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505 		JBrowse link
G Cfdp1 craniofacial development protein 1 increases expression EXP fenvalerate results in increased expression of CFDP1 mRNA CTD PMID:30307764 NCBI chr19:39,718,313...39,823,824
Ensembl chr19:39,718,347...39,823,824 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CFTR protein CTD PMID:34896426 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B increases expression EXP fenvalerate results in increased expression of CHAF1B mRNA CTD PMID:30307764 NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 increases expression EXP fenvalerate results in increased expression of CHD7 mRNA CTD PMID:30307764 NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358 		JBrowse link
G Chek2 checkpoint kinase 2 increases expression EXP fenvalerate results in increased expression of CHEK2 mRNA CTD PMID:30307764 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286 		JBrowse link
G Chm CHM Rab escort protein increases expression EXP fenvalerate results in increased expression of CHM mRNA CTD PMID:30307764 NCBI chr  X:78,203,200...78,361,996
Ensembl chr  X:78,203,204...78,361,943 		JBrowse link
G Chrna3 cholinergic receptor nicotinic alpha 3 subunit increases expression EXP fenvalerate results in increased expression of CHRNA3 mRNA CTD PMID:30307764 NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165 		JBrowse link
G Chrna9 cholinergic receptor nicotinic alpha 9 subunit increases expression EXP fenvalerate results in increased expression of CHRNA9 mRNA CTD PMID:30307764 NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192 		JBrowse link
G Chrnb1 cholinergic receptor nicotinic beta 1 subunit increases expression EXP fenvalerate results in increased expression of CHRNB1 mRNA CTD PMID:30307764 NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345 		JBrowse link
G Chrne cholinergic receptor nicotinic epsilon subunit increases expression EXP fenvalerate results in increased expression of CHRNE mRNA CTD PMID:30307764 NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530 		JBrowse link
G Ciita class II, major histocompatibility complex, transactivator multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CIITA mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440 		JBrowse link
G Cimap3 ciliary microtubule associated protein 3 increases expression EXP fenvalerate results in increased expression of CIMAP3 mRNA CTD PMID:30307764 NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139 		JBrowse link
G Cirbp cold inducible RNA binding protein decreases expression EXP fenvalerate results in decreased expression of CIRBP mRNA CTD PMID:30307764 NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818 		JBrowse link
G Cish cytokine inducible SH2-containing protein increases expression EXP fenvalerate results in increased expression of CISH mRNA CTD PMID:30307764 NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 increases expression EXP fenvalerate results in increased expression of CKAP4 mRNA CTD PMID:30307764 NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914 		JBrowse link
G Clasrp CLK4-associating serine/arginine rich protein increases expression EXP fenvalerate results in increased expression of CLASRP mRNA CTD PMID:30307764 NCBI chr 1:79,232,260...79,256,462
Ensembl chr 1:79,232,261...79,256,354 		JBrowse link
G Cldn10 claudin 10 increases expression EXP fenvalerate results in increased expression of CLDN10 mRNA CTD PMID:30307764 NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526 		JBrowse link
G Clec16a C-type lectin domain containing 16A decreases expression EXP fenvalerate results in decreased expression of CLEC16A mRNA CTD PMID:30307764 NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578 		JBrowse link
G Clic4 chloride intracellular channel 4 increases expression EXP fenvalerate results in increased expression of CLIC4 mRNA CTD PMID:30307764 NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452 		JBrowse link
G Cltc clathrin heavy chain increases expression EXP fenvalerate results in increased expression of CLTC mRNA CTD PMID:30307764 NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737 		JBrowse link
G Clu clusterin multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA CTD PMID:33051911 NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315 		JBrowse link
G Cma1 chymase 1 increases expression EXP fenvalerate results in increased expression of CMA1 mRNA CTD PMID:30307764 NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233 		JBrowse link
G Cmklr1 chemerin chemokine-like receptor 1 increases expression EXP fenvalerate results in increased expression of CMKLR1 mRNA CTD PMID:30307764 NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129 		JBrowse link
G Cmtm4 CKLF-like MARVEL transmembrane domain containing 4 increases expression EXP fenvalerate results in increased expression of CMTM4 mRNA CTD PMID:30307764 NCBI chr19:576,203...616,109
Ensembl chr19:576,203...616,109 		JBrowse link
G Cnbd2 cyclic nucleotide binding domain containing 2 increases expression EXP fenvalerate results in increased expression of CNBD2 mRNA CTD PMID:30307764 NCBI chr 3:144,819,166...144,884,825
Ensembl chr 3:144,819,195...144,901,583 		JBrowse link
G Cngb1 cyclic nucleotide gated channel subunit beta 1 increases expression EXP fenvalerate results in increased expression of CNGB1 mRNA CTD PMID:30307764 NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173 		JBrowse link
G Cnmd chondromodulin increases expression EXP fenvalerate results in increased expression of CNMD mRNA CTD PMID:30307764 NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297 		JBrowse link
G Cnot6 CCR4-NOT transcription complex, subunit 6 increases expression EXP fenvalerate results in increased expression of CNOT6 mRNA CTD PMID:30307764 NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025 		JBrowse link
G Cnst consortin, connexin sorting protein increases expression ISO
EXP		 fenvalerate results in increased expression of CNST mRNA CTD PMID:23397585 PMID:30307764 NCBI chr13:91,296,740...91,373,531
Ensembl chr13:91,296,142...91,373,531 		JBrowse link
G Cntfr ciliary neurotrophic factor receptor increases expression EXP fenvalerate results in increased expression of CNTFR mRNA CTD PMID:30307764 NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392 		JBrowse link
G Cntn3 contactin 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CNTN3 protein CTD PMID:34896426 NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613 		JBrowse link
G Col10a1 collagen type X alpha 1 chain decreases expression EXP fenvalerate results in decreased expression of COL10A1 mRNA CTD PMID:30307764 NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO fenvalerate results in increased expression of COL1A1 mRNA CTD PMID:20230880 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col23a1 collagen type XXIII alpha 1 chain increases expression EXP fenvalerate results in increased expression of COL23A1 mRNA CTD PMID:30307764 NCBI chr10:35,549,090...35,839,152
Ensembl chr10:35,549,113...35,836,314 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COL27A1 protein CTD PMID:34896426 NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174 		JBrowse link
G Col2a1 collagen type II alpha 1 chain increases expression EXP fenvalerate results in increased expression of COL2A1 mRNA CTD PMID:30307764 NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546 		JBrowse link
G Col5a3 collagen type V alpha 3 chain increases expression EXP fenvalerate results in increased expression of COL5A3 mRNA CTD PMID:30307764 NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853 		JBrowse link
G Colec12 collectin sub-family member 12 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COLEC12 protein CTD PMID:34896426 NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618 		JBrowse link
G Cop1 COP1, E3 ubiquitin ligase increases expression EXP fenvalerate results in increased expression of COP1 mRNA CTD PMID:30307764 NCBI chr13:71,467,164...71,561,826
Ensembl chr13:71,429,961...71,538,890 		JBrowse link
G Cops2 COP9 signalosome subunit 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COPS2 protein CTD PMID:34896426 NCBI chr 3:113,084,174...113,110,090
Ensembl chr 3:113,084,176...113,109,947 		JBrowse link
G Cops7b COP9 signalosome subunit 7B increases expression EXP fenvalerate results in increased expression of COPS7B mRNA CTD PMID:30307764 NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A increases expression EXP fenvalerate results in increased expression of COX5A protein CTD PMID:33656234 NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781 		JBrowse link
G Cox6b2 cytochrome c oxidase subunit 6B2 increases expression EXP fenvalerate results in increased expression of COX6B2 mRNA CTD PMID:30307764 NCBI chr 1:69,094,009...69,095,312 JBrowse link
G Cpa1 carboxypeptidase A1 increases expression EXP fenvalerate results in increased expression of CPA1 mRNA CTD PMID:30307764 NCBI chr 4:59,257,417...59,263,544
Ensembl chr 4:59,257,417...59,263,544 		JBrowse link
G Cpa3 carboxypeptidase A3 increases expression EXP fenvalerate results in increased expression of CPA3 mRNA CTD PMID:30307764 NCBI chr 2:102,712,483...102,744,219
Ensembl chr 2:102,712,589...102,744,203 		JBrowse link
G Cpeb1 cytoplasmic polyadenylation element binding protein 1 increases expression EXP fenvalerate results in increased expression of CPEB1 mRNA CTD PMID:30307764 NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760 		JBrowse link
G Cplane1 ciliogenesis and planar polarity effector complex subunit 1 increases expression EXP fenvalerate results in increased expression of CPLANE1 mRNA CTD PMID:30307764 NCBI chr 2:57,269,195...57,369,580
Ensembl chr 2:57,268,884...57,369,500 		JBrowse link
G Cplx3 complexin 3 increases expression EXP fenvalerate results in increased expression of CPLX3 mRNA CTD PMID:30307764 NCBI chr 8:58,003,535...58,010,297
Ensembl chr 8:58,003,535...58,010,297 		JBrowse link
G Cracdl CRACD like increases expression EXP fenvalerate results in increased expression of CRACDL mRNA CTD PMID:30307764 NCBI chr 9:39,834,321...39,950,763
Ensembl chr 9:39,834,833...39,951,086 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 increases expression EXP fenvalerate results in increased expression of CREB3L4 mRNA CTD PMID:30307764 NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932 		JBrowse link
G Crebbp CREB binding protein multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Crebrf CREB3 regulatory factor increases expression EXP fenvalerate results in increased expression of CREBRF mRNA CTD PMID:30307764 NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999 		JBrowse link
G Crem cAMP responsive element modulator multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CREM mRNA CTD PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989 		JBrowse link
G Crtac1 cartilage acidic protein 1 increases expression EXP fenvalerate results in increased expression of CRTAC1 mRNA CTD PMID:30307764 NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421 		JBrowse link
G Cryba1 crystallin, beta A1 decreases expression EXP fenvalerate results in decreased expression of CRYBA1 mRNA CTD PMID:30307764 NCBI chr10:62,608,373...62,614,726
Ensembl chr10:62,608,383...62,614,726 		JBrowse link
G Csdc2 cold shock domain containing C2 decreases expression EXP fenvalerate results in decreased expression of CSDC2 mRNA CTD PMID:30307764 NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463 		JBrowse link
G Csf1 colony stimulating factor 1 increases expression EXP fenvalerate results in increased expression of CSF1 mRNA CTD PMID:30307764 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Csnk1e casein kinase 1, epsilon increases expression EXP fenvalerate results in increased expression of CSNK1E mRNA CTD PMID:30307764 NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794 		JBrowse link
G Csnk1g3 casein kinase 1, gamma 3 increases expression EXP fenvalerate results in increased expression of CSNK1G3 mRNA CTD PMID:30307764 NCBI chr18:47,299,547...47,386,538
Ensembl chr18:47,299,579...47,386,535 		JBrowse link
G Cst5 cystatin D increases expression EXP fenvalerate results in increased expression of CST5 mRNA CTD PMID:30307764 NCBI chr 3:137,573,194...137,577,754
Ensembl chr 3:137,573,194...137,577,754 		JBrowse link
G Cst6 cystatin E/M increases expression EXP fenvalerate results in increased expression of CST6 mRNA CTD PMID:30307764 NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030 		JBrowse link
G Ctdspl CTD small phosphatase like increases expression EXP fenvalerate results in increased expression of CTDSPL mRNA CTD PMID:30307764 NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117 		JBrowse link
G Ctnnd2 catenin delta 2 increases expression EXP fenvalerate results in increased expression of CTNND2 mRNA CTD PMID:30307764 NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764 		JBrowse link
G Ctns cystinosin, lysosomal cystine transporter increases expression EXP fenvalerate results in increased expression of CTNS mRNA CTD PMID:30307764 NCBI chr10:57,801,551...57,817,213
Ensembl chr10:57,801,456...57,817,120 		JBrowse link
G Cul9 cullin 9 increases expression EXP fenvalerate results in increased expression of CUL9 mRNA CTD PMID:30307764 NCBI chr 9:14,435,948...14,479,552
Ensembl chr 9:14,436,111...14,479,548 		JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression EXP fenvalerate results in increased expression of CUZD1 mRNA CTD PMID:30307764 NCBI chr 1:186,089,422...186,130,536
Ensembl chr 1:186,089,423...186,102,546 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 decreases expression EXP fenvalerate results in decreased expression of CX3CL1 mRNA CTD PMID:30307764 NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 decreases expression EXP fenvalerate results in decreased expression of CXCL14 mRNA CTD PMID:30307764 NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839 		JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 increases expression EXP fenvalerate results in increased expression of CXCR2 mRNA CTD PMID:30307764 NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 NCBI chr  X:13,358,101...13,392,570
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases activity
increases expression
decreases expression
multiple interactions		 ISO
EXP		 fenvalerate results in decreased activity of CYP11A1 protein
fenvalerate results in increased expression of CYP11A1 mRNA
fenvalerate results in decreased expression of CYP11A1 mRNA; fenvalerate results in decreased expression of CYP11A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP11A1 mRNA		 CTD PMID:15907653 PMID:16001830 PMID:18053657 PMID:19683566 PMID:19892000 More... NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression
multiple interactions		 ISO
EXP		 fenvalerate results in decreased expression of CYP17A1 mRNA; fenvalerate results in decreased expression of CYP17A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP17A1 mRNA		 CTD PMID:20063364 PMID:20138952 PMID:33051911 PMID:33396045 PMID:34896426 More... NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity ISO fenvalerate results in increased activity of CYP1A2 protein CTD PMID:22310298 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression EXP fenvalerate results in increased expression of CYP2B1 mRNA CTD PMID:11377398 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052 		JBrowse link
G Cyp2b12 cytochrome P450, family 2, subfamily b, polypeptide 12 increases expression EXP fenvalerate results in increased expression of CYP2B12 mRNA CTD PMID:30307764 NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases activity
increases expression
multiple interactions
decreases activity		 ISO fenvalerate results in increased activity of CYP2B6 protein
fenvalerate results in increased expression of CYP2B6 mRNA; fenvalerate results in increased expression of CYP2B6 protein
fenvalerate inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion]
fenvalerate results in decreased activity of CYP2B6 protein		 CTD PMID:15548381 PMID:22310298 PMID:22634058 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases expression ISO fenvalerate results in increased expression of CYP2C19 mRNA CTD PMID:22310298 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 increases expression ISO fenvalerate results in increased expression of CYP2C8 mRNA CTD PMID:22310298
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases activity ISO fenvalerate results in decreased activity of CYP2D6 protein CTD PMID:20183062 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
decreases activity		 ISO fenvalerate inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone]
fenvalerate results in decreased activity of CYP2E1 protein		 CTD PMID:22634058 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases activity
decreases activity
multiple interactions
increases expression		 ISO fenvalerate results in increased activity of CYP3A4 protein
fenvalerate results in decreased activity of CYP3A4 protein
Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A4 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A4 mRNA]
fenvalerate results in increased expression of CYP3A4 mRNA; fenvalerate results in increased expression of CYP3A4 protein		 CTD PMID:15548381 PMID:19249324 PMID:20599767 PMID:22310298 PMID:22634058 NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions
increases expression		 EXP Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A23-3A1 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:20599767 NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 increases activity
increases expression		 EXP fenvalerate metabolite results in increased activity of CYP4A22 protein
fenvalerate metabolite results in increased expression of CYP4A22 protein		 CTD PMID:10630566 NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464 		JBrowse link
G Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP4F4 protein CTD PMID:34896426 NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506 		JBrowse link
G Cyp4v3 cytochrome P450, family 4, subfamily v, polypeptide 3 increases expression EXP fenvalerate results in increased expression of CYP4V3 mRNA CTD PMID:30307764 NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP fenvalerate results in decreased expression of CYP7A1 mRNA CTD PMID:30307764 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Cysltr1 cysteinyl leukotriene receptor 1 increases expression EXP fenvalerate results in increased expression of CYSLTR1 mRNA CTD PMID:30307764 NCBI chr  X:71,661,421...71,690,012
Ensembl chr  X:71,663,821...71,690,121 		JBrowse link
G Cysltr2 cysteinyl leukotriene receptor 2 increases expression EXP fenvalerate results in increased expression of CYSLTR2 mRNA CTD PMID:30307764 NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136 		JBrowse link
G Cyss cystatin S increases expression EXP fenvalerate results in increased expression of CYSS mRNA CTD PMID:30307764 NCBI chr 3:137,432,049...137,436,654
Ensembl chr 3:137,432,049...137,436,610 		JBrowse link
G Cyth1 cytohesin 1 decreases expression EXP fenvalerate results in decreased expression of CYTH1 mRNA CTD PMID:30307764 NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760 		JBrowse link
G Cyth3 cytohesin 3 increases expression EXP fenvalerate results in increased expression of CYTH3 mRNA CTD PMID:30307764 NCBI chr12:10,840,137...10,933,792
Ensembl chr12:10,840,157...10,933,812 		JBrowse link
G Czib CXXC motif containing zinc binding protein increases expression EXP fenvalerate results in increased expression of CZIB protein CTD PMID:33656234 NCBI chr 5:122,648,333...122,657,767
Ensembl chr 5:122,648,411...122,656,910 		JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 increases expression EXP fenvalerate results in increased expression of DACT1 mRNA CTD PMID:30307764 NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906 		JBrowse link
G Dag1 dystroglycan 1 increases expression EXP fenvalerate results in increased expression of DAG1 mRNA CTD PMID:30307764 NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325 		JBrowse link
G Dazap1 DAZ associated protein 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor decreases expression EXP fenvalerate results in decreased expression of DBP mRNA CTD PMID:30307764 NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 increases expression EXP fenvalerate results in increased expression of DBT mRNA CTD PMID:30307764 NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609 		JBrowse link
G Dcaf6 DDB1 and CUL4 associated factor 6 increases expression EXP fenvalerate results in increased expression of DCAF6 mRNA CTD PMID:30307764 NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512 		JBrowse link
G Dclre1b DNA cross-link repair 1B increases expression EXP fenvalerate results in increased expression of DCLRE1B mRNA CTD PMID:30307764 NCBI chr 2:191,309,909...191,318,399
Ensembl chr 2:191,309,913...191,318,423 		JBrowse link
G Dctn2 dynactin subunit 2 increases expression EXP fenvalerate results in increased expression of DCTN2 protein CTD PMID:33656234 NCBI chr 7:63,092,061...63,107,560
Ensembl chr 7:63,092,057...63,108,543 		JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of DDR1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDR1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468 		JBrowse link
G Ddx11 DEAD/H-box helicase 11 increases expression EXP fenvalerate results in increased expression of DDX11 mRNA CTD PMID:30307764 NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550 		JBrowse link
G Ddx17 DEAD-box helicase 17 increases expression EXP fenvalerate results in increased expression of DDX17 mRNA CTD PMID:30307764 NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193 		JBrowse link
G Ddx25 DEAD-box helicase 25 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of DDX25 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked increases expression EXP fenvalerate results in increased expression of DDX3X mRNA CTD PMID:30307764 NCBI chr  X:9,479,532...9,493,169
Ensembl chr  X:9,479,532...9,493,168 		JBrowse link
G Ddx3y DEAD box helicase 3, Y-linked multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr  Y:1,115,095...1,135,754
Ensembl chr  Y:1,116,309...1,135,706 		JBrowse link
G Ddx46 DEAD-box helicase 46 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX46 protein CTD PMID:34896426 NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439 		JBrowse link
G Ddx50 DExD-box helicase 50 increases expression EXP fenvalerate results in increased expression of DDX50 mRNA CTD PMID:30307764 NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152 		JBrowse link
G Defb1 defensin beta 1 increases expression EXP fenvalerate results in increased expression of DEFB1 mRNA CTD PMID:30307764 NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604 		JBrowse link
G Deup1 deuterosome assembly protein 1 increases expression EXP fenvalerate results in increased expression of DEUP1 mRNA CTD PMID:30307764 NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199 		JBrowse link
G Dffb DNA fragmentation factor subunit beta increases expression EXP fenvalerate results in increased expression of DFFB mRNA CTD PMID:30307764 NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628 		JBrowse link
G Dgkb diacylglycerol kinase, beta increases expression EXP fenvalerate results in increased expression of DGKB mRNA CTD PMID:30307764 NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043 		JBrowse link
G Dgkd diacylglycerol kinase, delta increases expression EXP fenvalerate results in increased expression of DGKD mRNA CTD PMID:30307764 NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345 		JBrowse link
G Dgke diacylglycerol kinase epsilon increases expression EXP fenvalerate results in increased expression of DGKE mRNA CTD PMID:30307764 NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100 		JBrowse link
G Dguok deoxyguanosine kinase increases expression EXP fenvalerate results in increased expression of DGUOK mRNA CTD PMID:30307764 NCBI chr 4:115,987,101...116,014,733
Ensembl chr 4:115,979,094...116,014,733 		JBrowse link
G Dhh desert hedgehog signaling molecule increases expression EXP fenvalerate results in increased expression of DHH mRNA CTD PMID:30307764 NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406 		JBrowse link
G Dhrs7c dehydrogenase/reductase 7C increases expression EXP fenvalerate results in increased expression of DHRS7C mRNA CTD PMID:30307764 NCBI chr10:52,495,262...52,513,338
Ensembl chr10:52,495,262...52,513,338 		JBrowse link
G Dhx30 DExH-box helicase 30 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DHX30 protein CTD PMID:34896426 NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381 		JBrowse link
G Dhx34 DExH-box helicase 34 increases expression EXP fenvalerate results in increased expression of DHX34 mRNA CTD PMID:30307764 NCBI chr 1:76,880,867...76,905,148
Ensembl chr 1:76,880,867...76,905,113 		JBrowse link
G Diaph3 diaphanous-related formin 3 increases expression EXP fenvalerate results in increased expression of DIAPH3 mRNA CTD PMID:30307764 NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression EXP fenvalerate results in increased expression of DIO3 mRNA CTD PMID:30307764 NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660 		JBrowse link
G Dipk2a divergent protein kinase domain 2A increases expression EXP fenvalerate results in increased expression of DIPK2A mRNA CTD PMID:30307764 NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815 		JBrowse link
G Dld dihydrolipoamide dehydrogenase decreases expression EXP fenvalerate results in decreased expression of DLD protein CTD PMID:33656234 NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795 		JBrowse link
G Dlg2 discs large MAGUK scaffold protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLG2 protein CTD PMID:34896426 NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475 		JBrowse link
G Dlg3 discs large MAGUK scaffold protein 3 increases expression EXP fenvalerate results in increased expression of DLG3 mRNA CTD PMID:30307764 NCBI chr  X:65,859,653...65,911,887
Ensembl chr  X:65,860,172...65,910,322 		JBrowse link
G Dlgap1 DLG associated protein 1 increases expression EXP fenvalerate results in increased expression of DLGAP1 mRNA CTD PMID:30307764 NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817 		JBrowse link
G Dlst dihydrolipoamide S-succinyltransferase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLST protein CTD PMID:34896426 NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296 		JBrowse link
G Dlx3 distal-less homeobox 3 increases expression EXP fenvalerate results in increased expression of DLX3 mRNA CTD PMID:30307764 NCBI chr10:80,064,489...80,069,891
Ensembl chr10:80,064,489...80,069,872 		JBrowse link
G Dlx5 distal-less homeobox 5 increases expression EXP fenvalerate results in increased expression of DLX5 mRNA CTD PMID:30307764 NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407 		JBrowse link
G Dmac2l distal membrane arm assembly component 2 like decreases expression EXP fenvalerate results in decreased expression of DMAC2L protein CTD PMID:33656234 NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933 		JBrowse link
G Dmrt2 doublesex and mab-3 related transcription factor 2 increases expression EXP fenvalerate results in increased expression of DMRT2 mRNA CTD PMID:30307764 NCBI chr 1:223,317,543...223,324,131
Ensembl chr 1:223,317,642...223,324,131 		JBrowse link
G Dmrtc1c1 DMRT-like family C1c1 increases expression EXP fenvalerate results in increased expression of DMRTC1C1 mRNA CTD PMID:30307764 NCBI chr  X:67,896,973...67,904,182
Ensembl chr  X:67,896,974...67,904,182 		JBrowse link
G Dnah1 dynein, axonemal, heavy chain 1 increases expression EXP fenvalerate results in increased expression of DNAH1 mRNA CTD PMID:30307764 NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350 		JBrowse link
G Dnah17 dynein, axonemal, heavy chain 17 increases expression EXP fenvalerate results in increased expression of DNAH17 mRNA CTD PMID:30307764 NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901 		JBrowse link
G Dnai7 dynein axonemal intermediate chain 7 increases expression EXP fenvalerate results in increased expression of DNAI7 mRNA CTD PMID:30307764 NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980 		JBrowse link
G Dnajb13 DnaJ heat shock protein family (Hsp40) member B13 increases expression EXP fenvalerate results in increased expression of DNAJB13 mRNA CTD PMID:30307764 NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963 		JBrowse link
G Dnajb2 DnaJ heat shock protein family (Hsp40) member B2 increases expression EXP fenvalerate results in increased expression of DNAJB2 mRNA CTD PMID:30307764 NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277 		JBrowse link
G Dnajb3 DnaJ heat shock protein family (Hsp40) member B3 increases expression EXP fenvalerate results in increased expression of DNAJB3 mRNA CTD PMID:30307764 NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560 		JBrowse link
G Dnajc17 DnaJ heat shock protein family (Hsp40) member C17 increases expression EXP fenvalerate results in increased expression of DNAJC17 mRNA CTD PMID:30307764 NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751 		JBrowse link
G Dnajc30 DnaJ heat shock protein family (Hsp40) member C30 increases expression EXP fenvalerate results in increased expression of DNAJC30 mRNA CTD PMID:30307764 NCBI chr12:21,628,319...21,629,398
Ensembl chr12:21,626,450...21,629,408 		JBrowse link
G Dnm1l dynamin 1-like increases expression EXP fenvalerate results in increased expression of DNM1L mRNA CTD PMID:30307764 NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA CTD PMID:33051911 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124 		JBrowse link
G Dnpep aspartyl aminopeptidase decreases expression EXP fenvalerate results in decreased expression of DNPEP protein CTD PMID:33656234 NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716 		JBrowse link
G Dop1a DOP1 leucine zipper like protein A decreases expression EXP fenvalerate results in decreased expression of DOP1A mRNA CTD PMID:30307764 NCBI chr 8:87,415,266...87,517,935
Ensembl chr 8:87,414,593...87,518,353 		JBrowse link
G Dph7 diphthamide biosynthesis 7 decreases expression EXP fenvalerate results in decreased expression of DPH7 mRNA CTD PMID:30307764 NCBI chr 3:7,770,368...7,778,994
Ensembl chr 3:7,770,379...7,778,982 		JBrowse link
G Dpm1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic increases expression EXP fenvalerate results in increased expression of DPM1 mRNA CTD PMID:30307764 NCBI chr 3:156,919,979...156,939,522
Ensembl chr 3:156,919,979...156,939,536 		JBrowse link
G Drc12 dynein regulatory complex subunit 12 homolog increases expression EXP fenvalerate results in increased expression of CCDC153 mRNA CTD PMID:30307764 NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338 		JBrowse link
G Drc3 dynein regulatory complex subunit 3 increases expression EXP fenvalerate results in increased expression of DRC3 mRNA CTD PMID:30307764 NCBI chr10:45,149,094...45,200,659
Ensembl chr10:45,157,354...45,199,369 		JBrowse link
G Drd3 dopamine receptor D3 increases expression EXP fenvalerate results in increased expression of DRD3 mRNA CTD PMID:30307764 NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596 		JBrowse link
G Drd4 dopamine receptor D4 increases expression EXP fenvalerate results in increased expression of DRD4 mRNA CTD PMID:30307764 NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553 		JBrowse link
G Drp2 dystrophin related protein 2 increases expression EXP fenvalerate results in increased expression of DRP2 mRNA CTD PMID:30307764 NCBI chr  X:97,607,577...97,658,117
Ensembl chr  X:97,607,719...97,655,684 		JBrowse link
G Dscam DS cell adhesion molecule increases expression EXP fenvalerate results in increased expression of DSCAM mRNA CTD PMID:30307764 NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415 		JBrowse link
G Dsg1 desmoglein 1 increases expression EXP fenvalerate results in increased expression of DSG1 mRNA CTD PMID:30307764 NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443 		JBrowse link
G Dst dystonin increases expression EXP fenvalerate results in increased expression of DST mRNA CTD PMID:30307764 NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615 		JBrowse link
G Dstn destrin, actin depolymerizing factor decreases expression EXP fenvalerate results in decreased expression of DSTN protein CTD PMID:33656234 NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379 		JBrowse link
G Duox2 dual oxidase 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DUOX2 protein CTD PMID:34896426 NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902 		JBrowse link
G Dus4l dihydrouridine synthase 4-like increases expression EXP fenvalerate results in increased expression of DUS4L mRNA CTD PMID:30307764 NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression EXP fenvalerate results in increased expression of DUSP1 mRNA CTD PMID:30307764 NCBI chr10:16,680,478...16,683,275 JBrowse link
G Dusp9 dual specificity phosphatase 9 increases expression EXP fenvalerate results in increased expression of DUSP9 mRNA CTD PMID:30307764 NCBI chr  X:151,351,897...151,355,822
Ensembl chr  X:151,351,897...151,355,821 		JBrowse link
G Dvl2 dishevelled segment polarity protein 2 increases expression EXP fenvalerate results in increased expression of DVL2 mRNA CTD PMID:30307764 NCBI chr10:54,723,356...54,732,823
Ensembl chr10:54,723,411...54,732,820 		JBrowse link
G Dync2h1 dynein cytoplasmic 2 heavy chain 1 increases expression EXP fenvalerate results in increased expression of DYNC2H1 mRNA CTD PMID:30307764 NCBI chr 8:4,189,067...4,412,183
Ensembl chr 8:4,189,257...4,412,183 		JBrowse link
G Dzip3 DAZ interacting zinc finger protein 3 increases expression EXP fenvalerate results in increased expression of DZIP3 mRNA CTD PMID:30307764 NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353 		JBrowse link
G E2f8 E2F transcription factor 8 increases expression EXP fenvalerate results in increased expression of E2F8 mRNA CTD PMID:30307764 NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098 		JBrowse link
G Ebf2 EBF transcription factor 2 increases expression EXP fenvalerate results in increased expression of EBF2 mRNA CTD PMID:30307764 NCBI chr15:41,435,509...41,634,403
Ensembl chr15:41,435,509...41,634,403 		JBrowse link
G Ecel1 endothelin converting enzyme-like 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ECEL1 protein CTD PMID:34896426 NCBI chr 9:87,819,516...87,829,154
Ensembl chr 9:87,816,718...87,826,675 		JBrowse link
G Ech1 enoyl-CoA hydratase 1 decreases expression EXP fenvalerate results in decreased expression of ECH1 protein CTD PMID:33656234 NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795 		JBrowse link
G Edc3 enhancer of mRNA decapping 3 decreases expression EXP fenvalerate results in decreased expression of EDC3 mRNA CTD PMID:30307764 NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671 		JBrowse link
G Edn2 endothelin 2 increases expression EXP fenvalerate results in increased expression of EDN2 mRNA CTD PMID:30307764 NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814 		JBrowse link
G Ednra endothelin receptor type A decreases expression EXP fenvalerate results in decreased expression of EDNRA mRNA CTD PMID:30307764 NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase increases expression EXP fenvalerate results in increased expression of EEF2K mRNA CTD PMID:30307764 NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164 		JBrowse link
G Eeig2 EEIG family member 2 increases expression EXP fenvalerate results in increased expression of EEIG2 mRNA CTD PMID:30307764 NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371 		JBrowse link
G Efcab2 EF-hand calcium binding domain 2 increases expression EXP fenvalerate results in increased expression of EFCAB2 mRNA CTD PMID:30307764 NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218 		JBrowse link
G Efhc2 EF-hand domain containing 2 increases expression EXP fenvalerate results in increased expression of EFHC2 mRNA CTD PMID:30307764 NCBI chr  X:5,360,499...5,564,004
Ensembl chr  X:5,360,617...5,560,970 		JBrowse link
G Efr3a EFR3 homolog A increases expression EXP fenvalerate results in increased expression of EFR3A mRNA CTD PMID:30307764 NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369 		JBrowse link
G Egr3 early growth response 3 increases expression EXP fenvalerate results in increased expression of EGR3 mRNA CTD PMID:30307764 NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627 		JBrowse link
G Egr4 early growth response 4 increases expression EXP fenvalerate results in increased expression of EGR4 mRNA CTD PMID:30307764 NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328 		JBrowse link
G Eif4a3 eukaryotic translation initiation factor 4A3 decreases expression EXP fenvalerate results in decreased expression of EIF4A3 protein CTD PMID:33656234 NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057 		JBrowse link
G Elac2 elaC ribonuclease Z 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ELAC2 protein CTD PMID:34896426 NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614 		JBrowse link
G Elavl2 ELAV like RNA binding protein 2 increases expression EXP fenvalerate results in increased expression of ELAVL2 mRNA CTD PMID:30307764 NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097 		JBrowse link
G Elavl4 ELAV like RNA binding protein 4 increases expression EXP fenvalerate results in increased expression of ELAVL4 mRNA CTD PMID:30307764 NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446 		JBrowse link
G Elf2 E74 like ETS transcription factor 2 increases expression EXP fenvalerate results in increased expression of ELF2 mRNA CTD PMID:30307764 NCBI chr 2:135,292,291...135,385,942
Ensembl chr 2:135,294,906...135,385,947 		JBrowse link
G Elfn2 extracellular leucine-rich repeat and fibronectin type III domain containing 2 increases expression EXP fenvalerate results in increased expression of ELFN2 mRNA CTD PMID:30307764 NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433 		JBrowse link
G Elmo2 engulfment and cell motility 2 decreases expression EXP fenvalerate results in decreased expression of ELMO2 mRNA CTD PMID:30307764 NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185 		JBrowse link
G Elovl4 ELOVL fatty acid elongase 4 increases expression EXP fenvalerate results in increased expression of ELOVL4 mRNA CTD PMID:30307764 NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 decreases expression EXP fenvalerate results in decreased expression of ELOVL6 mRNA CTD PMID:30307764 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186 		JBrowse link
G Enah ENAH, actin regulator increases expression EXP fenvalerate results in increased expression of ENAH mRNA CTD PMID:30307764 NCBI chr13:93,617,747...93,738,119
Ensembl chr13:93,626,944...93,740,955 		JBrowse link
G Endod1 endonuclease domain containing 1 increases expression EXP fenvalerate results in increased expression of ENDOD1 mRNA CTD PMID:30307764 NCBI chr 8:11,209,113...11,238,507
Ensembl chr 8:11,211,110...11,238,892 		JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 increases expression EXP fenvalerate results in increased expression of ENTPD4 mRNA CTD PMID:30307764 NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of EP300 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Epcip exosomal polycystin 1 interacting protein increases expression EXP fenvalerate results in increased expression of EPCIP mRNA CTD PMID:30307764 NCBI chr11:30,307,842...30,325,829
Ensembl chr11:30,310,350...30,325,439 		JBrowse link
G Epha3 Eph receptor A3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA3 protein CTD PMID:34896426 NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900 		JBrowse link
G Epha4 Eph receptor A4 increases expression EXP fenvalerate results in increased expression of EPHA4 mRNA CTD PMID:30307764 NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139 		JBrowse link
G Epha6 Eph receptor A6 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein CTD PMID:34896426 NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311 		JBrowse link
G Epha7 Eph receptor A7 increases expression EXP fenvalerate results in increased expression of EPHA7 mRNA CTD PMID:30307764 NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases activity EXP fenvalerate metabolite results in increased activity of EPHX1 protein CTD PMID:10630566 NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235 		JBrowse link
G Ephx2 epoxide hydrolase 2 increases activity EXP fenvalerate metabolite results in increased activity of EPHX2 protein CTD PMID:10630566 NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615 		JBrowse link
G Ephx4 epoxide hydrolase 4 increases expression EXP fenvalerate results in increased expression of EPHX4 mRNA CTD PMID:30307764 NCBI chr14:2,343,376...2,372,680
Ensembl chr14:2,340,248...2,373,022 		JBrowse link
G Epn2 epsin 2 increases expression EXP fenvalerate results in increased expression of EPN2 mRNA CTD PMID:30307764 NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642 		JBrowse link
G Erap1 endoplasmic reticulum aminopeptidase 1 increases expression EXP fenvalerate results in increased expression of ERAP1 mRNA CTD PMID:30307764 NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ERBB3 protein CTD PMID:34896426 NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525 		JBrowse link
G Erc2 ELKS/RAB6-interacting/CAST family member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERC2 protein CTD PMID:34896426 NCBI chr16:2,812,712...3,673,624
Ensembl chr16:2,848,620...3,670,776 		JBrowse link
G Ercc3 ERCC excision repair 3, TFIIH core complex helicase subunit multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERCC3 protein CTD PMID:34896426 NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329 		JBrowse link
G Ercc8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit increases expression EXP fenvalerate results in increased expression of ERCC8 mRNA CTD PMID:30307764 NCBI chr 2:39,647,393...39,686,229
Ensembl chr 2:39,647,452...39,684,859 		JBrowse link
G Erhl1 ERH, mRNA splicing and mitosis factor like 1 increases expression EXP fenvalerate results in increased expression of ERHL1 mRNA CTD PMID:30307764 NCBI chr 2:132,570,276...132,573,582
Ensembl chr 2:132,570,285...132,573,604 		JBrowse link
G Ermn ermin increases expression EXP fenvalerate results in increased expression of ERMN mRNA CTD PMID:30307764 NCBI chr 3:42,628,160...42,633,816
Ensembl chr 3:42,626,309...42,633,744 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ESM1 protein CTD PMID:34896426 NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804 		JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions
affects binding
increases expression		 ISO
EXP		 fenvalerate results in increased activity of ESR1 protein
fenvalerate binds to and results in increased activity of ESR1 protein
fenvalerate binds to ESR1 protein
fenvalerate results in increased expression of ESR1 mRNA		 CTD PMID:12396874 PMID:15064155 PMID:16626760 PMID:20410157 PMID:24388911 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO fenvalerate binds to and results in increased activity of ESR2 protein CTD PMID:16626760 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Etfa electron transfer flavoprotein subunit alpha increases expression EXP fenvalerate results in increased expression of ETFA protein CTD PMID:33656234 NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969 		JBrowse link
G Exoc3 exocyst complex component 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EXOC3 protein CTD PMID:34896426 NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045 		JBrowse link
G Eya2 EYA transcriptional coactivator and phosphatase 2 increases expression EXP fenvalerate results in increased expression of EYA2 mRNA CTD PMID:30307764 NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 increases expression EXP fenvalerate results in increased expression of F2RL1 mRNA CTD PMID:30307764 NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226 		JBrowse link
G F8 coagulation factor VIII increases expression EXP fenvalerate results in increased expression of F8 mRNA CTD PMID:30307764 NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857 		JBrowse link
G Fabp9 fatty acid binding protein 9 affects expression EXP fenvalerate affects the expression of FABP9 protein CTD PMID:33656234 NCBI chr 2:91,591,842...91,595,873
Ensembl chr 2:91,592,298...91,595,873 		JBrowse link
G Fads3 fatty acid desaturase 3 decreases expression EXP fenvalerate results in decreased expression of FADS3 mRNA CTD PMID:30307764 NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769 		JBrowse link
G Fam110c family with sequence similarity 110, member C increases expression EXP fenvalerate results in increased expression of FAM110C mRNA CTD PMID:30307764 NCBI chr 6:47,638,466...47,644,723
Ensembl chr 6:47,638,276...47,644,634 		JBrowse link
G Fam168a family with sequence similarity 168, member A increases expression EXP fenvalerate results in increased expression of FAM168A mRNA CTD PMID:30307764 NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220 		JBrowse link
G Fam171a1 family with sequence similarity 171, member A1 increases expression EXP fenvalerate results in increased expression of FAM171A1 mRNA CTD PMID:30307764 NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255 		JBrowse link
G Fam181b family with sequence similarity 181, member B increases expression EXP fenvalerate results in increased expression of FAM181B mRNA CTD PMID:30307764 NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298
Ensembl chr 1:147,124,740...147,168,298 		JBrowse link
G Fam193a family with sequence similarity 193, member A increases expression EXP fenvalerate results in increased expression of FAM193A mRNA CTD PMID:30307764 NCBI chr14:76,250,103...76,382,525
Ensembl chr14:76,256,161...76,382,514 		JBrowse link
G Fam209 family with sequence similarity 209 increases expression EXP fenvalerate results in increased expression of FAM209 mRNA CTD PMID:30307764 NCBI chr 3:161,240,062...161,241,747
Ensembl chr 3:161,240,034...161,241,755 		JBrowse link
G Fam20b FAM20B, glycosaminoglycan xylosylkinase increases expression EXP fenvalerate results in increased expression of FAM20B mRNA CTD PMID:30307764 NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915 		JBrowse link
G Fam219a family with sequence similarity 219, member A increases expression EXP fenvalerate results in increased expression of FAM219A mRNA CTD PMID:30307764 NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924 		JBrowse link
G Fam221a family with sequence similarity 221, member A increases expression EXP fenvalerate results in increased expression of FAM221A mRNA CTD PMID:30307764 NCBI chr 4:78,337,296...78,358,918
Ensembl chr 4:78,337,296...78,358,909 		JBrowse link
G Fam241a family with sequence similarity 241 member A increases expression EXP fenvalerate results in increased expression of FAM241A mRNA CTD PMID:30307764 NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242 		JBrowse link
G Fam78b family with sequence similarity 78, member B increases expression EXP fenvalerate results in increased expression of FAM78B mRNA CTD PMID:30307764 NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500 		JBrowse link
G Fam81a family with sequence similarity 81, member A increases expression EXP fenvalerate results in increased expression of FAM81A mRNA CTD PMID:30307764 NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875 		JBrowse link
G Fam83f family with sequence similarity 83, member F increases expression EXP fenvalerate results in increased expression of FAM83F mRNA CTD PMID:30307764 NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452 		JBrowse link
G Fanca FA complementation group A increases expression EXP fenvalerate results in increased expression of FANCA mRNA CTD PMID:30307764 NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527 		JBrowse link
G Fancb FA complementation group B increases expression EXP fenvalerate results in increased expression of FANCB mRNA CTD PMID:30307764 NCBI chr  X:29,403,771...29,420,484
Ensembl chr  X:29,403,771...29,420,192 		JBrowse link
G Far1 fatty acyl CoA reductase 1 increases expression EXP fenvalerate results in increased expression of FAR1 mRNA CTD PMID:30307764 NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730 		JBrowse link
G Farp1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein CTD PMID:34896426 NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299 		JBrowse link
G Faslg Fas ligand increases expression EXP fenvalerate results in increased expression of FASLG mRNA CTD PMID:30307764 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fbln5 fibulin 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FBLN5 protein CTD PMID:34896426 NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755 		JBrowse link
G Fbrsl1 fibrosin-like 1 increases expression EXP fenvalerate results in increased expression of FBRSL1 mRNA CTD PMID:30307764 NCBI chr12:46,231,466...46,320,607
Ensembl chr12:46,231,495...46,320,357 		JBrowse link
G Fbxl22 F-box and leucine-rich repeat protein 22 increases expression EXP fenvalerate results in increased expression of FBXL22 mRNA CTD PMID:30307764 NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685 		JBrowse link
G Fbxl6 F-box and leucine-rich repeat protein 6 decreases expression EXP fenvalerate results in decreased expression of FBXL6 mRNA CTD PMID:30307764 NCBI chr 7:108,259,097...108,262,528
Ensembl chr 7:108,257,160...108,262,513 		JBrowse link
G Fbxo10 F-box protein 10 increases expression EXP fenvalerate results in increased expression of FBXO10 mRNA CTD PMID:30307764 NCBI chr 5:59,297,016...59,343,429
Ensembl chr 5:59,297,045...59,343,348 		JBrowse link
G Fbxo28 F-box protein 28 increases expression EXP fenvalerate results in increased expression of FBXO28 mRNA CTD PMID:30307764 NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464 		JBrowse link
G Fbxw2 F-box and WD repeat domain containing 2 increases expression EXP fenvalerate results in increased expression of FBXW2 mRNA CTD PMID:30307764 NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381 		JBrowse link
G Fbxw8 F-box and WD repeat domain containing 8 decreases expression EXP fenvalerate results in decreased expression of FBXW8 mRNA CTD PMID:30307764 NCBI chr12:38,426,466...38,517,076
Ensembl chr12:38,426,444...38,516,424 		JBrowse link
G Fcho1 FCH and mu domain containing endocytic adaptor 1 increases expression EXP fenvalerate results in increased expression of FCHO1 mRNA CTD PMID:30307764 NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104 		JBrowse link
G Fcnb ficolin B increases expression EXP fenvalerate results in increased expression of FCNB mRNA CTD PMID:30307764 NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151 		JBrowse link
G Fcrl6 Fc receptor-like 6 increases expression EXP fenvalerate results in increased expression of FCRL6 mRNA CTD PMID:30307764 NCBI chr13:85,062,709...85,072,308
Ensembl chr13:85,066,694...85,072,600 		JBrowse link
G Fem1b fem-1 homolog B multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein CTD PMID:34896426 NCBI chr 8:63,265,301...63,278,577
Ensembl chr 8:63,265,301...63,278,577 		JBrowse link
G Fes FES proto-oncogene, tyrosine kinase increases expression EXP fenvalerate results in increased expression of FES mRNA CTD PMID:30307764 NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934 		JBrowse link
G Fez1 fasciculation and elongation protein zeta 1 increases expression EXP fenvalerate results in increased expression of FEZ1 mRNA CTD PMID:30307764 NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683 		JBrowse link
G Fezf2 Fez family zinc finger 2 increases expression EXP fenvalerate results in increased expression of FEZF2 mRNA CTD PMID:30307764 NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554 		JBrowse link
G Fgb fibrinogen beta chain increases expression EXP fenvalerate results in increased expression of FGB mRNA CTD PMID:30307764 NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979 		JBrowse link
G Fgd4 FYVE, RhoGEF and PH domain containing 4 increases expression EXP fenvalerate results in increased expression of FGD4 mRNA CTD PMID:30307764 NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972 		JBrowse link
G Fgf12 fibroblast growth factor 12 increases expression EXP fenvalerate results in increased expression of FGF12 mRNA CTD PMID:30307764 NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607 		JBrowse link
G Fgf13 fibroblast growth factor 13 increases expression EXP fenvalerate results in increased expression of FGF13 mRNA CTD PMID:30307764 NCBI chr  X:137,276,498...137,800,056
Ensembl chr  X:137,276,511...137,800,391 		JBrowse link
G Fgf14 fibroblast growth factor 14 increases expression EXP fenvalerate results in increased expression of FGF14 mRNA CTD PMID:30307764 NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900 		JBrowse link
G Fgf3 fibroblast growth factor 3 increases expression EXP fenvalerate results in increased expression of FGF3 mRNA CTD PMID:30307764 NCBI chr 1:200,001,162...200,005,539
Ensembl chr 1:200,001,261...200,005,187 		JBrowse link
G Fgf9 fibroblast growth factor 9 increases expression EXP fenvalerate results in increased expression of FGF9 mRNA CTD PMID:30307764 NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309 		JBrowse link
G Fgl2 fibrinogen-like 2 increases expression EXP fenvalerate results in increased expression of FGL2 mRNA CTD PMID:30307764 NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207 		JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression EXP fenvalerate results in increased expression of FHL2 mRNA CTD PMID:30307764 NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192 		JBrowse link
G Fhl5 four and a half LIM domains 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FHL5 protein CTD PMID:34896426 NCBI chr 5:38,907,941...38,956,759
Ensembl chr 5:38,907,946...38,956,552 		JBrowse link
G Fibin fin bud initiation factor homolog increases expression EXP fenvalerate results in increased expression of FIBIN mRNA CTD PMID:30307764 NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676 		JBrowse link
G Filip1 filamin A interacting protein 1 increases expression EXP fenvalerate results in increased expression of FILIP1 mRNA CTD PMID:30307764 NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549 		JBrowse link
G Flnc filamin C increases expression EXP fenvalerate results in increased expression of FLNC mRNA CTD PMID:30307764 NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of FLT1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Flt4 Fms related receptor tyrosine kinase 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT4 protein CTD PMID:34896426 NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770 		JBrowse link
G Flywch2 FLYWCH family member 2 increases expression EXP fenvalerate results in increased expression of FLYWCH2 mRNA CTD PMID:30307764 NCBI chr10:12,798,757...12,807,082
Ensembl chr10:12,798,762...12,806,439 		JBrowse link
G Fmo4 flavin containing dimethylaniline monoxygenase 4 increases expression EXP fenvalerate results in increased expression of FMO4 mRNA CTD PMID:30307764 NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874 		JBrowse link
G Fmo5 flavin containing dimethylaniline monoxygenase 5 increases expression EXP fenvalerate results in increased expression of FMO5 mRNA CTD PMID:30307764 NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693 		JBrowse link
G Fnbp1 formin binding protein 1 increases expression EXP fenvalerate results in increased expression of FNBP1 mRNA CTD PMID:30307764 NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881 		JBrowse link
G Foxc1 forkhead box C1 increases expression EXP fenvalerate results in increased expression of FOXC1 mRNA CTD PMID:30307764 NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803 		JBrowse link
G Foxo3 forkhead box O3 affects methylation ISO fenvalerate affects the methylation of FOXO3 gene CTD PMID:23548413 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561 		JBrowse link
G Frs2 fibroblast growth factor receptor substrate 2 increases expression EXP fenvalerate results in increased expression of FRS2 mRNA CTD PMID:30307764 NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743 		JBrowse link
G Fryl FRY like transcription coactivator increases expression EXP fenvalerate results in increased expression of FRYL mRNA CTD PMID:30307764 NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222 		JBrowse link
G Fscn1 fascin actin-bundling protein 1 increases expression EXP fenvalerate results in increased expression of FSCN1 mRNA CTD PMID:30307764 NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211 		JBrowse link
G Fscn2 fascin actin-bundling protein 2, retinal increases expression EXP fenvalerate results in increased expression of FSCN2 mRNA CTD PMID:30307764 NCBI chr10:105,634,783...105,641,322
Ensembl chr10:105,634,783...105,641,322 		JBrowse link
G Fshb follicle stimulating hormone subunit beta increases expression
multiple interactions		 EXP fenvalerate results in increased expression of FSHB mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of FSHB protein		 CTD PMID:30307764 PMID:34896426 PMID:36053783 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Fshr follicle stimulating hormone receptor multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of FSHR mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785 		JBrowse link
G Fstl4 follistatin-like 4 increases expression EXP fenvalerate results in increased expression of FSTL4 mRNA CTD PMID:30307764 NCBI chr10:36,911,422...37,344,545
Ensembl chr10:36,911,420...37,338,588 		JBrowse link
G Fyttd1 forty-two-three domain containing 1 increases expression EXP fenvalerate results in increased expression of FYTTD1 mRNA CTD PMID:30307764 NCBI chr11:67,877,967...67,907,500
Ensembl chr11:67,877,967...67,907,511 		JBrowse link
G Fzr1 fizzy and cell division cycle 20 related 1 increases expression EXP fenvalerate results in increased expression of FZR1 mRNA CTD PMID:30307764 NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase decreases activity EXP fenvalerate results in decreased activity of G6PDX protein CTD PMID:12507254 NCBI chr  X:152,201,081...152,220,863
Ensembl chr  X:152,201,098...152,220,801 		JBrowse link
G Gabarap GABA type A receptor-associated protein increases expression EXP fenvalerate results in increased expression of GABARAP mRNA CTD PMID:30307764 NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765 		JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 increases expression EXP fenvalerate results in increased expression of GABBR1 mRNA CTD PMID:30307764 NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994 		JBrowse link
G Gabrg1 gamma-aminobutyric acid type A receptor subunit gamma 1 increases expression EXP fenvalerate results in increased expression of GABRG1 mRNA CTD PMID:30307764 NCBI chr14:37,396,217...37,469,606
Ensembl chr14:37,396,294...37,635,956 		JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 increases expression EXP fenvalerate results in increased expression of GABRG2 mRNA CTD PMID:30307764 NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346 		JBrowse link
G Gabrg3 gamma-aminobutyric acid type A receptor subunit gamma 3 increases expression EXP fenvalerate results in increased expression of GABRG3 mRNA CTD PMID:30307764 NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763 		JBrowse link
G Gal3st1 galactose-3-O-sulfotransferase 1 increases expression EXP fenvalerate results in increased expression of GAL3ST1 mRNA CTD PMID:30307764 NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388 		JBrowse link
G Galk1 galactokinase 1 increases expression EXP fenvalerate results in increased expression of GALK1 protein CTD PMID:33656234 NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337 		JBrowse link
G Galm galactose mutarotase decreases expression EXP fenvalerate results in decreased expression of GALM protein CTD PMID:33656234 NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310 		JBrowse link
G Galnt14 polypeptide N-acetylgalactosaminyltransferase 14 increases expression EXP fenvalerate results in increased expression of GALNT14 mRNA CTD PMID:30307764 NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 increases expression EXP fenvalerate results in increased expression of GALNT16 mRNA CTD PMID:30307764 NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705 		JBrowse link
G Gap43 growth associated protein 43 increases expression EXP fenvalerate results in increased expression of GAP43 mRNA CTD PMID:30307764 NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045 		JBrowse link
G Gapdhs glyceraldehyde-3-phosphate dehydrogenase, spermatogenic decreases expression EXP fenvalerate results in decreased expression of GAPDHS protein CTD PMID:33656234 NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640 		JBrowse link
G Garin4 golgi associated RAB2 interactor family member 4 increases expression EXP fenvalerate results in increased expression of GARIN4 mRNA CTD PMID:30307764 NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GARS1 protein CTD PMID:34896426 NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609 		JBrowse link
G Gast gastrin increases expression EXP fenvalerate results in increased expression of GAST mRNA CTD PMID:30307764 NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496 		JBrowse link
G Gata1 GATA binding protein 1 increases expression EXP fenvalerate results in increased expression of GATA1 mRNA CTD PMID:30307764 NCBI chr  X:14,529,706...14,537,530
Ensembl chr  X:14,529,702...14,537,530 		JBrowse link
G Gata4 GATA binding protein 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GATA4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of GATA4 mRNA CTD PMID:33051911 PMID:34896426 PMID:36053783 NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636 		JBrowse link
G Gc GC, vitamin D binding protein multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GC protein CTD PMID:34896426 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein CTD PMID:34896426 NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gdf10 growth differentiation factor 10 increases expression EXP fenvalerate results in increased expression of GDF10 mRNA CTD PMID:30307764 NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209 		JBrowse link
G Gfra1 GDNF family receptor alpha 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 affects expression
increases expression		 EXP fenvalerate affects the expression of GGT1
fenvalerate results in increased expression of GGT1 mRNA		 CTD PMID:12479040 PMID:30307764 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442 		JBrowse link
G Gh1 growth hormone 1 increases expression EXP fenvalerate results in increased expression of GH1 mRNA CTD PMID:30307764 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078 		JBrowse link
G Gimap8 GTPase, IMAP family member 8 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GIMAP8 protein CTD PMID:34896426 NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590 		JBrowse link
G Git2 GIT ArfGAP 2 increases expression EXP fenvalerate results in increased expression of GIT2 mRNA CTD PMID:30307764 NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097 		JBrowse link
G Gja3 gap junction protein, alpha 3 increases expression EXP fenvalerate results in increased expression of GJA3 mRNA CTD PMID:30307764 NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810 		JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression EXP fenvalerate results in decreased expression of GJA4 mRNA CTD PMID:30307764 NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925 		JBrowse link
G Gja5 gap junction protein, alpha 5 increases expression EXP fenvalerate results in increased expression of GJA5 mRNA CTD PMID:30307764 NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952 		JBrowse link
G Gjb3 gap junction protein, beta 3 increases expression EXP fenvalerate results in increased expression of GJB3 mRNA CTD PMID:30307764 NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980 		JBrowse link
G Glal gliadoralin-A like increases expression EXP fenvalerate results in increased expression of GLAL mRNA CTD PMID:30307764 NCBI chr 4:165,928,441...165,931,317
Ensembl chr 4:165,922,843...165,989,527 		JBrowse link
G Glod4 glyoxalase domain containing 4 increases expression EXP fenvalerate results in increased expression of GLOD4 protein CTD PMID:33656234 NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898 		JBrowse link
G Gls glutaminase increases expression EXP fenvalerate results in increased expression of GLS mRNA CTD PMID:30307764 NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900 		JBrowse link
G Glul glutamate-ammonia ligase increases expression EXP fenvalerate results in increased expression of GLUL protein CTD PMID:33656234 NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108 		JBrowse link
G Gmfb glia maturation factor, beta increases expression EXP fenvalerate results in increased expression of GMFB protein CTD PMID:33656234 NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331 		JBrowse link
G Gmps guanine monophosphate synthase decreases expression EXP fenvalerate results in decreased expression of GMPS protein CTD PMID:33656234 NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875 		JBrowse link
G Gna14 G protein subunit alpha 14 decreases expression EXP fenvalerate results in decreased expression of GNA14 mRNA CTD PMID:30307764 NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423 		JBrowse link
G Gnai1 G protein subunit alpha i1 increases expression EXP fenvalerate results in increased expression of GNAI1 mRNA CTD PMID:30307764 NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417 		JBrowse link
G Gnao1 G protein subunit alpha o1 increases expression EXP fenvalerate results in increased expression of GNAO1 mRNA CTD PMID:30307764 NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493 		JBrowse link
G Gnb2 G protein subunit beta 2 increases expression EXP fenvalerate results in increased expression of GNB2 protein CTD PMID:33656234 NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019 		JBrowse link
G Gng13 G protein subunit gamma 13 increases expression EXP fenvalerate results in increased expression of GNG13 mRNA CTD PMID:30307764 NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083 		JBrowse link
G Gnl1 G protein nucleolar 1 decreases expression
multiple interactions		 EXP fenvalerate results in decreased expression of GNL1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr20:2,783,130...2,792,115
Ensembl chr20:2,778,985...2,792,115 		JBrowse link
G Gnrh1 gonadotropin releasing hormone 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GNRH1 protein CTD PMID:34896426 NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581
Ensembl chr15:41,972,905...41,973,581 		JBrowse link
G Gns glucosamine (N-acetyl)-6-sulfatase increases expression EXP fenvalerate results in increased expression of GNS mRNA CTD PMID:30307764 NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151 		JBrowse link
G Golim4 golgi integral membrane protein 4 increases expression EXP fenvalerate results in increased expression of GOLIM4 mRNA CTD PMID:30307764 NCBI chr 2:160,640,837...160,733,475
Ensembl chr 2:160,640,938...160,733,253 		JBrowse link
G Gon4l gon-4 like increases expression EXP fenvalerate results in increased expression of GON4L mRNA CTD PMID:30307764 NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases activity EXP fenvalerate results in increased activity of GOT1 protein CTD PMID:15186033 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Gpc3 glypican 3 increases expression EXP fenvalerate results in increased expression of GPC3 mRNA CTD PMID:30307764 NCBI chr  X:131,868,986...132,236,824
Ensembl chr  X:131,868,990...132,236,798 		JBrowse link
G Gphn gephyrin multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GPHN protein CTD PMID:34896426 NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612 		JBrowse link
G Gpm6a glycoprotein m6a increases expression EXP fenvalerate results in increased expression of GPM6A mRNA CTD PMID:30307764 NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475 		JBrowse link
G Gpr153 G protein-coupled receptor 153 decreases expression EXP fenvalerate results in decreased expression of GPR153 mRNA CTD PMID:30307764 NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971 		JBrowse link
G Gpr162 G protein-coupled receptor 162 increases expression EXP fenvalerate results in increased expression of GPR162 mRNA CTD PMID:30307764 NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121 		JBrowse link
G Gpr176 G protein-coupled receptor 176 increases expression EXP fenvalerate results in increased expression of GPR176 mRNA CTD PMID:30307764 NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226 		JBrowse link
G Gpr20 G protein-coupled receptor 20 increases expression EXP fenvalerate results in increased expression of GPR20 mRNA CTD PMID:30307764 NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430 		JBrowse link
G Gpr83 G protein-coupled receptor 83 increases expression EXP fenvalerate results in increased expression of GPR83 mRNA CTD PMID:30307764 NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028 		JBrowse link
G Gpr85 G protein-coupled receptor 85 increases expression EXP fenvalerate results in increased expression of GPR85 mRNA CTD PMID:30307764 NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566 		JBrowse link
G Gprasp2 G protein-coupled receptor associated sorting protein 2 increases expression EXP fenvalerate results in increased expression of GPRASP2 mRNA CTD PMID:30307764 NCBI chr  X:98,817,668...98,823,814
Ensembl chr  X:98,817,593...98,824,402 		JBrowse link
G Gpt glutamic--pyruvic transaminase increases activity
multiple interactions		 EXP fenvalerate results in increased activity of GPT protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein		 CTD PMID:15186033 PMID:33396045 PMID:35678313 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Gpx4 glutathione peroxidase 4 affects expression EXP fenvalerate affects the expression of GPX4 protein CTD PMID:33656234 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Grap2 GRB2-related adaptor protein 2 increases expression EXP fenvalerate results in increased expression of GRAP2 mRNA CTD PMID:30307764 NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression EXP fenvalerate results in increased expression of GREB1 mRNA CTD PMID:30307764 NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression EXP fenvalerate results in increased expression of GREM1 mRNA CTD PMID:30307764 NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082 		JBrowse link
G Grhl1 grainyhead-like transcription factor 1 increases expression EXP fenvalerate results in increased expression of GRHL1 mRNA CTD PMID:30307764 NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 decreases expression
increases expression		 EXP fenvalerate results in decreased expression of GRIA2 protein
fenvalerate results in increased expression of GRIA2 mRNA		 CTD PMID:26961610 PMID:30307764 NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIA3 protein CTD PMID:34896426 NCBI chr  X:120,238,515...120,504,106
Ensembl chr  X:120,238,534...120,504,096 		JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 increases expression EXP fenvalerate results in increased expression of GRIA4 mRNA CTD PMID:30307764 NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979 		JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 increases expression EXP fenvalerate results in increased expression of GRIK2 mRNA CTD PMID:30307764 NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375 		JBrowse link
G Grik5 glutamate ionotropic receptor kainate type subunit 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein CTD PMID:34896426 NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 increases expression
decreases expression		 EXP
ISO		 fenvalerate results in increased expression of GRIN1 mRNA
fenvalerate results in decreased expression of GRIN1 mRNA		 CTD PMID:30307764 PMID:34748853 NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603 		JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D increases expression EXP fenvalerate results in increased expression of GRIN2D mRNA CTD PMID:30307764 NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793 		JBrowse link
G Grin3a glutamate ionotropic receptor NMDA type subunit 3A increases expression EXP fenvalerate results in increased expression of GRIN3A mRNA CTD PMID:30307764 NCBI chr 5:64,006,847...64,206,408
Ensembl chr 5:64,009,980...64,206,085 		JBrowse link
G Grin3b glutamate ionotropic receptor NMDA type subunit 3B increases expression EXP fenvalerate results in increased expression of GRIN3B mRNA CTD PMID:30307764 NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183 		JBrowse link
G Grip2 glutamate receptor interacting protein 2 increases expression EXP fenvalerate results in increased expression of GRIP2 mRNA CTD PMID:30307764 NCBI chr 4:124,271,456...124,356,538
Ensembl chr 4:124,271,456...124,321,268 		JBrowse link
G Grm1 glutamate metabotropic receptor 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of GRM1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170 		JBrowse link
G Grm5 glutamate metabotropic receptor 5 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of GRM5 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM5 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274 		JBrowse link
G Grm8 glutamate metabotropic receptor 8 increases expression EXP fenvalerate results in increased expression of GRM8 mRNA CTD PMID:30307764 NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831 		JBrowse link
G Grn granulin precursor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRN protein CTD PMID:34896426 NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775 		JBrowse link
G Gspt2 G1 to S phase transition 2 increases expression EXP fenvalerate results in increased expression of GSPT2 mRNA CTD PMID:30307764 NCBI chr  X:59,587,237...59,589,758
Ensembl chr  X:59,587,276...59,594,162 		JBrowse link
G Gsr glutathione-disulfide reductase decreases activity EXP fenvalerate metabolite results in decreased activity of GSR protein; fenvalerate results in decreased activity of GSR protein CTD PMID:15892188 NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 decreases expression EXP fenvalerate results in decreased expression of GSTO1 protein CTD PMID:33656234 NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases expression EXP fenvalerate results in decreased expression of GSTP1 protein CTD PMID:33656234 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Gtf2i general transcription factor II I multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GTF2I protein CTD PMID:34896426 NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243 		JBrowse link
G Gtsf1l gametocyte specific factor 1-like increases expression EXP fenvalerate results in increased expression of GTSF1L mRNA CTD PMID:30307764 NCBI chr 3:151,736,020...151,738,715
Ensembl chr 3:151,735,997...151,736,863 		JBrowse link
G Gucy1a1 guanylate cyclase 1 soluble subunit alpha 1 increases expression EXP fenvalerate results in increased expression of GUCY1A1 mRNA CTD PMID:30307764 NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671 		JBrowse link
G Gucy1a2 guanylate cyclase 1 soluble subunit alpha 2 increases expression EXP fenvalerate results in increased expression of GUCY1A2 mRNA CTD PMID:30307764 NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203 		JBrowse link
G Gucy1b2 guanylate cyclase 1 soluble subunit beta 2 decreases expression EXP fenvalerate results in decreased expression of GUCY1B2 mRNA CTD PMID:30307764 NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441 		JBrowse link
G Gucy2c guanylate cyclase 2C increases expression EXP fenvalerate results in increased expression of GUCY2C mRNA CTD PMID:30307764 NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092 		JBrowse link
G Gucy2e guanylate cyclase 2E multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GUCY2E protein CTD PMID:34896426 NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 decreases expression ISO fenvalerate results in decreased expression of GULP1 mRNA CTD PMID:23397585 NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005 		JBrowse link
G Gusb glucuronidase, beta increases activity ISO fenvalerate results in increased activity of GUSB protein CTD PMID:7175102 NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905 		JBrowse link
G H2ap H2A.P histone increases expression EXP fenvalerate results in increased expression of H2AP mRNA CTD PMID:30307764 NCBI chr  X:12,907,962...12,908,516 JBrowse link
G Hacd4 3-hydroxyacyl-CoA dehydratase 4 increases expression EXP fenvalerate results in increased expression of HACD4 mRNA CTD PMID:30307764 NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase increases expression EXP fenvalerate results in increased expression of HADH mRNA CTD PMID:30307764 NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353 		JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha increases expression
multiple interactions		 EXP fenvalerate results in increased expression of HADHA mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HADHA protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869 		JBrowse link
G Hagh hydroxyacyl glutathione hydrolase decreases expression EXP fenvalerate results in decreased expression of HAGH protein CTD PMID:33656234 NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504 		JBrowse link
G Haghl hydroxyacylglutathione hydrolase-like increases expression EXP fenvalerate results in increased expression of HAGHL mRNA CTD PMID:30307764 NCBI chr10:14,804,957...14,809,495
Ensembl chr10:14,804,997...14,807,665 		JBrowse link
G Hap1 huntingtin-associated protein 1 affects methylation ISO fenvalerate affects the methylation of HAP1 gene CTD PMID:23548413 NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 increases expression EXP fenvalerate results in increased expression of HAPLN1 mRNA CTD PMID:30307764 NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777 		JBrowse link
G Hapstr1 HUWE1 associated protein modifying stress responses increases expression EXP fenvalerate results in increased expression of HAPSTR1 mRNA CTD PMID:30307764 NCBI chr10:6,746,037...6,774,992
Ensembl chr10:6,746,048...6,774,992 		JBrowse link
G Hbb hemoglobin subunit beta decreases expression EXP fenvalerate results in decreased expression of HBB protein CTD PMID:33656234 NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012 		JBrowse link
G Hbe1 hemoglobin subunit epsilon 1 increases expression EXP fenvalerate results in increased expression of HBE1 mRNA CTD PMID:30307764 NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression EXP fenvalerate results in increased expression of HBEGF mRNA CTD PMID:30307764 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441 		JBrowse link
G Hcn3 hyperpolarization-activated cyclic nucleotide-gated potassium channel 3 increases expression EXP fenvalerate results in increased expression of HCN3 mRNA CTD PMID:30307764 NCBI chr 2:174,551,861...174,567,459
Ensembl chr 2:174,551,680...174,565,966 		JBrowse link
G Hcrtr1 hypocretin receptor 1 increases expression EXP fenvalerate results in increased expression of HCRTR1 mRNA CTD PMID:30307764 NCBI chr 5:142,477,214...142,486,674
Ensembl chr 5:142,477,214...142,486,674 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HDAC1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111 		JBrowse link
G Hdac10 histone deacetylase 10 decreases expression
multiple interactions		 EXP fenvalerate results in decreased expression of HDAC10 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228 		JBrowse link
G Hdac4 histone deacetylase 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164 		JBrowse link
G Hdc histidine decarboxylase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDC mRNA CTD PMID:34896426 NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341 		JBrowse link
G Hdgfl3 HDGF like 3 increases expression EXP fenvalerate results in increased expression of HDGFL3 mRNA CTD PMID:30307764 NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719 		JBrowse link
G Helt helt bHLH transcription factor increases expression EXP fenvalerate results in increased expression of HELT mRNA CTD PMID:30307764 NCBI chr16:45,991,227...45,993,045
Ensembl chr16:45,991,227...45,992,960 		JBrowse link
G Helz helicase with zinc finger decreases expression EXP fenvalerate results in decreased expression of HELZ mRNA CTD PMID:30307764 NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HIF1A mRNA CTD PMID:33396045 PMID:34896426 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hif3a hypoxia inducible factor 3 subunit alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF3A protein CTD PMID:34896426 NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758 		JBrowse link
G Hk2 hexokinase 2 increases expression EXP fenvalerate results in increased expression of HK2 mRNA CTD PMID:30307764 NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100 		JBrowse link
G Hmgxb4 HMG-box containing 4 increases expression EXP fenvalerate results in increased expression of HMGXB4 mRNA CTD PMID:30307764 NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMOX1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA CTD PMID:33396045 PMID:34896426 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 affects expression EXP fenvalerate affects the expression of HNRNPA2B1 protein CTD PMID:33656234 NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D decreases expression EXP fenvalerate results in decreased expression of HNRNPD protein CTD PMID:33656234 NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K increases expression EXP fenvalerate results in increased expression of HNRNPK protein CTD PMID:33656234 NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997 		JBrowse link
G Homez homeobox and leucine zipper encoding increases expression EXP fenvalerate results in increased expression of HOMEZ mRNA CTD PMID:30307764 NCBI chr15:28,321,633...28,339,486
Ensembl chr15:28,320,819...28,339,745 		JBrowse link
G Hoxb6 homeo box B6 increases expression EXP fenvalerate results in increased expression of HOXB6 mRNA CTD PMID:30307764 NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449 		JBrowse link
G Hoxd8 homeobox D8 increases expression EXP fenvalerate results in increased expression of HOXD8 mRNA CTD PMID:30307764 NCBI chr 3:59,607,793...59,610,359
Ensembl chr 3:59,607,996...59,610,361 		JBrowse link
G Hp1bp3 heterochromatin protein 1, binding protein 3 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000 		JBrowse link
G Hpca hippocalcin increases expression EXP fenvalerate results in increased expression of HPCA mRNA CTD PMID:30307764 NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841 		JBrowse link
G Hpcal4 hippocalcin-like 4 increases expression EXP fenvalerate results in increased expression of HPCAL4 mRNA CTD PMID:30307764 NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase increases expression EXP fenvalerate results in increased expression of HPGD mRNA CTD PMID:30307764 NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228 		JBrowse link
G Hps1 HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 increases expression EXP fenvalerate results in increased expression of HPS1 mRNA CTD PMID:30307764 NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268 		JBrowse link
G Hpx hemopexin decreases expression EXP fenvalerate results in decreased expression of HPX protein CTD PMID:33656234 NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328 		JBrowse link
G Hrh2 histamine receptor H 2 increases expression EXP fenvalerate results in increased expression of HRH2 mRNA CTD PMID:30307764 NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631 		JBrowse link
G Hrh4 histamine receptor H4 increases expression EXP fenvalerate results in increased expression of HRH4 mRNA CTD PMID:30307764 NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345 		JBrowse link
G Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 decreases expression
affects expression
increases expression		 EXP
ISO		 fenvalerate results in decreased expression of HSD17B1 mRNA
fenvalerate affects the expression of HSD17B1 protein
fenvalerate results in increased expression of HSD17B1 mRNA		 CTD PMID:16001830 PMID:21232584 PMID:30307764 NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927 		JBrowse link
G Hsd17b14 hydroxysteroid (17-beta) dehydrogenase 14 increases expression EXP fenvalerate results in increased expression of HSD17B14 mRNA CTD PMID:30307764 NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression EXP fenvalerate results in decreased expression of HSD17B2 mRNA CTD PMID:30307764 NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202 		JBrowse link
G Hsd17b3 hydroxysteroid (17-beta) dehydrogenase 3 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of HSD17B3 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999 		JBrowse link
G Hsf2 heat shock transcription factor 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174 		JBrowse link
G Hsf2bp heat shock transcription factor 2 binding protein increases expression EXP fenvalerate results in increased expression of HSF2BP mRNA CTD PMID:30307764 NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 decreases expression EXP fenvalerate results in decreased expression of HSP90AA1 protein CTD PMID:33656234 NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 decreases expression EXP fenvalerate results in decreased expression of HSP90B1 protein CTD PMID:33656234 NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788 		JBrowse link
G Hspa12b heat shock protein family A (Hsp70) member 12B increases expression EXP fenvalerate results in increased expression of HSPA12B mRNA CTD PMID:30307764 NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737 		JBrowse link
G Hspa2 heat shock protein family A (Hsp70) member 2 increases expression EXP fenvalerate results in increased expression of HSPA2 mRNA CTD PMID:30307764 NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like decreases expression EXP fenvalerate results in decreased expression of HSPA4L protein CTD PMID:33656234 NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 affects expression EXP fenvalerate affects the expression of HSPA5 protein CTD PMID:33656234 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 affects expression EXP fenvalerate affects the expression of HSPA8 protein CTD PMID:33656234 NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259 		JBrowse link
G Hspb7 heat shock protein family B (small) member 7 increases expression EXP fenvalerate results in increased expression of HSPB7 mRNA CTD PMID:30307764 NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266 		JBrowse link
G Htr1f 5-hydroxytryptamine receptor 1F increases expression EXP fenvalerate results in increased expression of HTR1F mRNA CTD PMID:30307764 NCBI chr11:2,642,751...2,644,150
Ensembl chr11:2,642,751...2,644,150 		JBrowse link
G Htr2c 5-hydroxytryptamine receptor 2C increases expression EXP fenvalerate results in increased expression of HTR2C mRNA CTD PMID:30307764 NCBI chr  X:110,640,777...110,870,288
Ensembl chr  X:110,641,153...110,870,287 		JBrowse link
G Htr6 5-hydroxytryptamine receptor 6 increases expression EXP fenvalerate results in increased expression of HTR6 mRNA CTD PMID:30307764 NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912 		JBrowse link
G Htra4 HtrA serine peptidase 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HTRA4 protein CTD PMID:34896426 NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074 		JBrowse link
G Hycc2 hyccin PI4KA lipid kinase complex subunit 2 increases expression EXP fenvalerate results in increased expression of HYCC2 mRNA CTD PMID:30307764 NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007 		JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression EXP fenvalerate results in increased expression of HYOU1 mRNA CTD PMID:30307764 NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186 		JBrowse link
G Iapp islet amyloid polypeptide increases expression EXP fenvalerate results in increased expression of IAPP mRNA CTD PMID:30307764 NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920 		JBrowse link
G Ica1l islet cell autoantigen 1-like increases expression EXP fenvalerate results in increased expression of ICA1L mRNA CTD PMID:30307764 NCBI chr 9:61,410,959...61,469,884
Ensembl chr 9:61,412,091...61,470,134 		JBrowse link
G Icam2 intercellular adhesion molecule 2 increases expression EXP fenvalerate results in increased expression of ICAM2 mRNA CTD PMID:30307764 NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293 		JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression ISO fenvalerate results in increased expression of ID2 mRNA CTD PMID:23397585 NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha increases expression EXP fenvalerate results in increased expression of IDH3A protein CTD PMID:33656234 NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084 		JBrowse link
G Idh3b isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta increases expression EXP fenvalerate results in increased expression of IDH3B protein CTD PMID:33656234 NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982 		JBrowse link
G Ift81 intraflagellar transport 81 increases expression EXP fenvalerate results in increased expression of IFT81 mRNA CTD PMID:30307764 NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression
decreases secretion		 ISO fenvalerate results in decreased expression of IGF1 mRNA
fenvalerate results in decreased secretion of IGF1 protein		 CTD PMID:22210404 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor increases expression EXP fenvalerate results in increased expression of IGF1R mRNA CTD PMID:30307764 NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777 		JBrowse link
G Igf2 insulin-like growth factor 2 decreases expression
increases expression		 ISO
EXP		 fenvalerate results in decreased expression of IGF2 mRNA
fenvalerate results in increased expression of IGF2 mRNA		 CTD PMID:28369636 PMID:30307764 NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018 		JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 increases expression EXP fenvalerate results in increased expression of IGF2BP1 mRNA CTD PMID:30307764 NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129 		JBrowse link
G Igfbpl1 insulin-like growth factor binding protein-like 1 increases expression EXP fenvalerate results in increased expression of IGFBPL1 mRNA CTD PMID:30307764 NCBI chr 5:60,076,428...60,091,833
Ensembl chr 5:60,076,429...60,091,833 		JBrowse link
G Igsf9 immunoglobulin superfamily, member 9 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein CTD PMID:34896426 NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607 		JBrowse link
G Ikbip IKBKB interacting protein decreases expression EXP fenvalerate results in decreased expression of IKBIP mRNA CTD PMID:30307764 NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162 		JBrowse link
G Il12b interleukin 12B increases expression EXP fenvalerate results in increased expression of IL12B mRNA CTD PMID:30307764 NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 increases expression EXP fenvalerate results in increased expression of IL1R1 mRNA CTD PMID:30307764 NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937 		JBrowse link
G Il22ra2 interleukin 22 receptor subunit alpha 2 increases expression EXP fenvalerate results in increased expression of IL22RA2 mRNA CTD PMID:30307764 NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844 		JBrowse link
G Il31ra interleukin 31 receptor A decreases expression EXP fenvalerate results in decreased expression of IL31RA protein CTD PMID:33656234 NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767 		JBrowse link
G Il5 interleukin 5 increases expression EXP fenvalerate results in increased expression of IL5 mRNA CTD PMID:30307764 NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213 		JBrowse link
G Il6 interleukin 6 increases expression EXP fenvalerate results in increased expression of IL6 mRNA CTD PMID:30307764 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ildr1 immunoglobulin-like domain containing receptor 1 increases expression EXP fenvalerate results in increased expression of ILDR1 mRNA CTD PMID:30307764 NCBI chr11:64,085,774...64,118,760
Ensembl chr11:64,008,566...64,118,760 		JBrowse link
G Immt inner membrane mitochondrial protein increases expression EXP fenvalerate results in increased expression of IMMT mRNA CTD PMID:30307764 NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109 		JBrowse link
G Impg1 interphotoreceptor matrix proteoglycan 1 increases expression EXP fenvalerate results in increased expression of IMPG1 mRNA CTD PMID:30307764 NCBI chr 8:81,243,624...81,389,722
Ensembl chr 8:81,243,624...81,389,722 		JBrowse link
G Inafm1 InaF-motif containing 1 increases expression EXP fenvalerate results in increased expression of INAFM1 mRNA CTD PMID:30307764 NCBI chr 1:76,976,808...76,978,292 JBrowse link
G Incenp inner centromere protein increases expression EXP fenvalerate results in increased expression of INCENP mRNA CTD PMID:30307764 NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265 		JBrowse link
G Inhba inhibin subunit beta A multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of INHBA protein CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982 		JBrowse link
G Inka1 inka box actin regulator 1 increases expression EXP fenvalerate results in increased expression of INKA1 mRNA CTD PMID:30307764 NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953 		JBrowse link
G Inmt indolethylamine N-methyltransferase decreases expression EXP fenvalerate results in decreased expression of INMT mRNA CTD PMID:30307764 NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493 		JBrowse link
G Ino80e INO80 complex subunit E increases expression EXP fenvalerate results in increased expression of INO80E mRNA CTD PMID:30307764 NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:181,461,408...181,472,469 		JBrowse link
G Insm2 INSM transcriptional repressor 2 increases expression EXP fenvalerate results in increased expression of INSM2 mRNA CTD PMID:30307764 NCBI chr 6:72,973,861...72,976,453 JBrowse link
G Insr insulin receptor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSR protein CTD PMID:34896426 NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883 		JBrowse link
G Insrr insulin receptor-related receptor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSRR protein CTD PMID:34896426 NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800 		JBrowse link
G Ints14 integrator complex subunit 14 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INTS14 protein CTD PMID:34896426 NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804 		JBrowse link
G Ints6l integrator complex subunit 6 like increases expression EXP fenvalerate results in increased expression of INTS6L mRNA CTD PMID:30307764 NCBI chr  X:134,258,117...134,325,706
Ensembl chr  X:134,258,125...134,309,617 		JBrowse link
G Ints7 integrator complex subunit 7 increases expression EXP fenvalerate results in increased expression of INTS7 mRNA CTD PMID:30307764 NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592 		JBrowse link
G Ipo5 importin 5 increases expression EXP fenvalerate results in increased expression of IPO5 mRNA CTD PMID:30307764 NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126 		JBrowse link
G Iqca1 IQ motif containing with AAA domain 1 increases expression EXP fenvalerate results in increased expression of IQCA1 mRNA CTD PMID:30307764 NCBI chr 9:90,626,735...90,742,563
Ensembl chr 9:90,626,744...90,742,618 		JBrowse link
G Iqsec2 IQ motif and Sec7 domain ArfGEF 2 increases expression EXP fenvalerate results in increased expression of IQSEC2 mRNA CTD PMID:30307764 NCBI chr  X:21,254,799...21,337,179
Ensembl chr  X:21,254,914...21,336,584 		JBrowse link
G Iqsec3 IQ motif and Sec7 domain ArfGEF 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IQSEC3 protein CTD PMID:34896426 NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310 		JBrowse link
G Irf5 interferon regulatory factor 5 decreases expression EXP fenvalerate results in decreased expression of IRF5 mRNA CTD PMID:30307764 NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267 		JBrowse link
G Irx4 iroquois homeobox 4 increases expression EXP fenvalerate results in increased expression of IRX4 mRNA CTD PMID:30307764 NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:30,030,561...30,039,549 		JBrowse link
G Isyna1 inositol-3-phosphate synthase 1 decreases expression EXP fenvalerate results in decreased expression of ISYNA1 protein CTD PMID:33656234 NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979 		JBrowse link
G Itga11 integrin subunit alpha 11 increases expression EXP fenvalerate results in increased expression of ITGA11 mRNA CTD PMID:30307764 NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:63,146,001...63,254,407 		JBrowse link
G Itga9 integrin subunit alpha 9 increases expression EXP fenvalerate results in increased expression of ITGA9 mRNA CTD PMID:30307764 NCBI chr 8:118,307,424...118,615,527
Ensembl chr 8:118,307,381...118,613,754 		JBrowse link
G Itgam integrin subunit alpha M increases expression EXP fenvalerate results in increased expression of ITGAM mRNA CTD PMID:30307764 NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Itgb5 integrin subunit beta 5 decreases expression ISO fenvalerate results in decreased expression of ITGB5 mRNA CTD PMID:23397585 NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472 		JBrowse link
G Itpkc inositol-trisphosphate 3-kinase C multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITPKC protein CTD PMID:34896426 NCBI chr 1:82,500,957...82,522,533
Ensembl chr 1:82,500,957...82,522,779 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 increases expression ISO fenvalerate results in increased expression of ITPR1 mRNA CTD PMID:19428952 NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491 		JBrowse link
G Itpr3 inositol 1,4,5-trisphosphate receptor, type 3 increases expression ISO
EXP		 fenvalerate results in increased expression of ITPR3 mRNA CTD PMID:19428952 PMID:30307764 NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337 		JBrowse link
G Itsn1 intersectin 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITSN1 protein CTD PMID:34896426 NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645 		JBrowse link
G Jdp2 Jun dimerization protein 2 increases expression EXP fenvalerate results in increased expression of JDP2 mRNA CTD PMID:30307764 NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485 		JBrowse link
G Jkampl JNK1/MAPK8 associated membrane protein like increases expression EXP fenvalerate results in increased expression of JKAMPL mRNA CTD PMID:30307764 NCBI chr 4:105,520,442...105,521,542
Ensembl chr 4:105,520,442...105,521,542 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit decreases expression EXP fenvalerate results in decreased expression of JUND mRNA CTD PMID:30307764 NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799 		JBrowse link
G Kank2 KN motif and ankyrin repeat domains 2 increases expression EXP fenvalerate results in increased expression of KANK2 mRNA CTD PMID:30307764 NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900 		JBrowse link
G Katnal1 katanin catalytic subunit A1 like 1 increases expression EXP fenvalerate results in increased expression of KATNAL1 mRNA CTD PMID:30307764 NCBI chr12:6,094,663...6,156,114
Ensembl chr12:6,102,836...6,157,553 		JBrowse link
G Katnbl1 katanin regulatory subunit B1 like 1 increases expression EXP fenvalerate results in increased expression of KATNBL1 mRNA CTD PMID:30307764 NCBI chr 3:99,183,748...99,225,789
Ensembl chr 3:99,183,716...99,225,786 		JBrowse link
G Kbtbd6 kelch repeat and BTB domain containing 6 increases expression EXP fenvalerate results in increased expression of KBTBD6 mRNA CTD PMID:30307764 NCBI chr15:54,848,285...54,850,042
Ensembl chr15:54,848,446...54,850,453 		JBrowse link
G Kbtbd8 kelch repeat and BTB domain containing 8 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KBTBD8 protein CTD PMID:34896426 NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697 		JBrowse link
G Kcna5 potassium voltage-gated channel subfamily A member 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein CTD PMID:34896426 NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697 		JBrowse link
G Kcna6 potassium voltage-gated channel subfamily A member 6 increases expression EXP fenvalerate results in increased expression of KCNA6 mRNA CTD PMID:30307764 NCBI chr 4:159,542,941...159,576,189
Ensembl chr 4:159,542,615...159,576,189 		JBrowse link
G Kcnab1 potassium voltage-gated channel subfamily A regulatory beta subunit 1 increases expression EXP fenvalerate results in increased expression of KCNAB1 mRNA CTD PMID:30307764 NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534 		JBrowse link
G Kcnb2 potassium voltage-gated channel subfamily B member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNB2 protein CTD PMID:34896426 NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599 		JBrowse link
G Kcnc2 potassium voltage-gated channel subfamily C member 2 increases expression EXP fenvalerate results in increased expression of KCNC2 mRNA CTD PMID:30307764 NCBI chr 7:47,700,035...47,883,979
Ensembl chr 7:47,700,288...47,883,968 		JBrowse link
G Kcnc3 potassium voltage-gated channel subfamily C member 3 increases expression EXP fenvalerate results in increased expression of KCNC3 mRNA CTD PMID:30307764 NCBI chr 1:95,080,960...95,095,165
Ensembl chr 1:95,080,960...95,095,160 		JBrowse link
G Kcnd3 potassium voltage-gated channel subfamily D member 3 increases expression EXP fenvalerate results in increased expression of KCND3 mRNA CTD PMID:30307764 NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345 		JBrowse link
G Kcng2 potassium voltage-gated channel modifier subfamily G member 2 increases expression EXP fenvalerate results in increased expression of KCNG2 mRNA CTD PMID:30307764 NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723 		JBrowse link
G Kcng3 potassium voltage-gated channel modifier subfamily G member 3 increases expression EXP fenvalerate results in increased expression of KCNG3 mRNA CTD PMID:30307764 NCBI chr 6:11,051,311...11,099,264
Ensembl chr 6:11,051,134...11,099,264 		JBrowse link
G Kcnh3 potassium voltage-gated channel subfamily H member 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNH3 protein CTD PMID:34896426 NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855 		JBrowse link
G Kcnh5 potassium voltage-gated channel subfamily H member 5 increases expression EXP fenvalerate results in increased expression of KCNH5 mRNA CTD PMID:30307764 NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107 		JBrowse link
G Kcnip1 potassium voltage-gated channel interacting protein 1 increases expression EXP fenvalerate results in increased expression of KCNIP1 mRNA CTD PMID:30307764 NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045 		JBrowse link
G Kcnj11 potassium inwardly-rectifying channel, subfamily J, member 11 increases expression EXP fenvalerate results in increased expression of KCNJ11 mRNA CTD PMID:30307764 NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082 		JBrowse link
G Kcnj14 potassium inwardly-rectifying channel, subfamily J, member 14 increases expression EXP fenvalerate results in increased expression of KCNJ14 mRNA CTD PMID:30307764 NCBI chr 1:96,293,159...96,300,810
Ensembl chr 1:96,293,435...96,495,459 		JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 increases expression EXP fenvalerate results in increased expression of KCNJ5 mRNA CTD PMID:30307764 NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518 		JBrowse link
G Kcnk10 potassium two pore domain channel subfamily K member 10 increases expression EXP fenvalerate results in increased expression of KCNK10 mRNA CTD PMID:30307764 NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695 		JBrowse link
G Kcnk4 potassium two pore domain channel subfamily K member 4 increases expression EXP fenvalerate results in increased expression of KCNK4 mRNA CTD PMID:30307764 NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925 		JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 increases expression EXP fenvalerate results in increased expression of KCNN2 mRNA CTD PMID:30307764 NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347 		JBrowse link
G Kcns3 potassium voltage-gated channel, modifier subfamily S, member 3 increases expression EXP fenvalerate results in increased expression of KCNS3 mRNA CTD PMID:30307764 NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125 		JBrowse link
G Kcnt1 potassium sodium-activated channel subfamily T member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNT1 protein CTD PMID:34896426 NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667 		JBrowse link
G Kcnv1 potassium voltage-gated channel modifier subfamily V member 1 increases expression EXP fenvalerate results in increased expression of KCNV1 mRNA CTD PMID:30307764 NCBI chr 7:76,260,695...76,269,170
Ensembl chr 7:76,260,695...76,269,170 		JBrowse link
G Kcnv2 potassium voltage-gated channel modifier subfamily V member 2 increases expression EXP fenvalerate results in increased expression of KCNV2 mRNA CTD PMID:30307764 NCBI chr 1:224,999,552...225,014,062
Ensembl chr 1:224,999,552...225,014,062 		JBrowse link
G Kctd1 potassium channel tetramerization domain containing 1 increases expression EXP fenvalerate results in increased expression of KCTD1 mRNA CTD PMID:30307764 NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393 		JBrowse link
G Kdm3a lysine demethylase 3A multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KDM3A protein CTD PMID:34896426 NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073 		JBrowse link
G Kiaa0408L Kiaa0408-like increases expression EXP fenvalerate results in increased expression of KIAA0408L mRNA CTD PMID:30307764 NCBI chr 1:28,615,600...28,630,309
Ensembl chr 1:28,615,606...28,630,309 		JBrowse link
G Kif13a kinesin family member 13A increases expression EXP fenvalerate results in increased expression of KIF13A mRNA CTD PMID:30307764 NCBI chr17:17,766,597...17,948,517
Ensembl chr17:17,766,597...17,943,615 		JBrowse link
G Kif15 kinesin family member 15 increases expression EXP fenvalerate results in increased expression of KIF15 mRNA CTD PMID:30307764 NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750 		JBrowse link
G Kif1b kinesin family member 1B increases expression EXP fenvalerate results in increased expression of KIF1B mRNA CTD PMID:30307764 NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778 		JBrowse link
G Kif2c kinesin family member 2C increases expression EXP fenvalerate results in increased expression of KIF2C mRNA CTD PMID:30307764 NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637 		JBrowse link
G Kif3a kinesin family member 3a increases expression EXP fenvalerate results in increased expression of KIF3A mRNA CTD PMID:30307764 NCBI chr10:37,725,930...37,761,183
Ensembl chr10:37,725,970...37,759,191 		JBrowse link
G Kif5a kinesin family member 5A increases expression EXP fenvalerate results in increased expression of KIF5A mRNA CTD PMID:30307764 NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858 		JBrowse link
G Kif7 kinesin family member 7 increases expression EXP fenvalerate results in increased expression of KIF7 mRNA CTD PMID:30307764 NCBI chr 1:133,639,487...133,658,539
Ensembl chr 1:133,640,065...133,658,576 		JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KISS1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of KISS1 protein CTD PMID:34896426 PMID:36053783 NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase increases expression EXP fenvalerate results in increased expression of KIT mRNA CTD PMID:30307764 NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652 		JBrowse link
G Kitlg KIT ligand increases expression
multiple interactions		 EXP fenvalerate results in increased expression of KITLG mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214 		JBrowse link
G Klc2 kinesin light chain 2 decreases expression EXP fenvalerate results in decreased expression of KLC2 protein CTD PMID:33656234 NCBI chr 1:202,414,555...202,424,787
Ensembl chr 1:202,414,557...202,424,672 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602 		JBrowse link
G Klhl31 kelch-like family member 31 increases expression EXP fenvalerate results in increased expression of KLHL31 mRNA CTD PMID:30307764 NCBI chr 8:78,515,514...78,538,873
Ensembl chr 8:78,515,514...78,538,873 		JBrowse link
G Klhl4 kelch-like family member 4 decreases expression EXP fenvalerate results in decreased expression of KLHL4 mRNA CTD PMID:30307764 NCBI chr  X:79,429,193...79,719,482
Ensembl chr  X:79,622,113...79,719,480 		JBrowse link
G Klhl41 kelch-like family member 41 increases expression EXP fenvalerate results in increased expression of KLHL41 mRNA CTD PMID:30307764 NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222 		JBrowse link
G Klk1c4 kallikrein 1-related peptidase C4 increases expression EXP fenvalerate results in increased expression of KLK1C4 mRNA CTD PMID:30307764 NCBI chr 1:94,434,574...94,438,678
Ensembl chr 1:94,434,534...94,438,709 		JBrowse link
G Klk1c9 kallikrein 1-related peptidase C9 increases expression EXP fenvalerate results in increased expression of KLK1C9 mRNA CTD PMID:30307764 NCBI chr 1:94,597,359...94,601,245
Ensembl chr 1:94,597,359...94,601,245 		JBrowse link
G Klk8 kallikrein related-peptidase 8 increases expression EXP fenvalerate results in increased expression of KLK8 mRNA CTD PMID:30307764 NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646 		JBrowse link
G Klrk1 killer cell lectin like receptor K1 increases expression EXP fenvalerate results in increased expression of KLRK1 mRNA CTD PMID:30307764 NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459 		JBrowse link
G Knstrn kinetochore-localized astrin/SPAG5 binding protein increases expression EXP fenvalerate results in increased expression of KNSTRN mRNA CTD PMID:30307764 NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715 		JBrowse link
G Kremen1 kringle containing transmembrane protein 1 increases expression EXP fenvalerate results in increased expression of KREMEN1 mRNA CTD PMID:30307764 NCBI chr14:80,081,870...80,147,489
Ensembl chr14:80,084,403...80,147,516 		JBrowse link
G Krt15 keratin 15 increases expression EXP fenvalerate results in increased expression of KRT15 mRNA CTD PMID:30307764 NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799 		JBrowse link
G Krt4 keratin 4 decreases expression EXP fenvalerate results in decreased expression of KRT4 mRNA CTD PMID:30307764 NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019 		JBrowse link
G Krt8 keratin 8 increases expression EXP fenvalerate results in increased expression of KRT8 mRNA CTD PMID:31524104 NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728 		JBrowse link
G Krt86 keratin 86 increases expression EXP fenvalerate results in increased expression of KRT86 mRNA CTD PMID:30307764 NCBI chr 7:132,591,489...132,598,142
Ensembl chr 7:132,591,545...132,598,021 		JBrowse link
G Krt90 keratin 90 increases expression EXP fenvalerate results in increased expression of KRT90 mRNA CTD PMID:30307764 NCBI chr 7:132,677,994...132,686,634
Ensembl chr 7:132,677,751...132,686,759 		JBrowse link
G Krtap13-2l1 keratin associated protein 13-2 like 1 increases expression EXP fenvalerate results in increased expression of KRTAP13-2L1 mRNA CTD PMID:30307764 NCBI chr11:28,121,625...28,122,158 JBrowse link
G Krtcap3 keratinocyte associated protein 3 increases expression EXP fenvalerate results in increased expression of KRTCAP3 mRNA CTD PMID:30307764 NCBI chr 6:25,120,938...25,122,522
Ensembl chr 6:25,120,938...25,122,507 		JBrowse link
G Kyat1 kynurenine aminotransferase 1 increases activity ISO fenvalerate results in increased activity of KYAT1 protein CTD PMID:7175102 NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355 		JBrowse link
G Kynu kynureninase decreases activity ISO fenvalerate results in decreased activity of KYNU protein CTD PMID:7175102 NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488 		JBrowse link
G L3mbtl2 L3MBTL histone methyl-lysine binding protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of L3MBTL2 protein CTD PMID:34896426 NCBI chr 7:113,186,303...113,209,706
Ensembl chr 7:113,186,370...113,207,489 		JBrowse link
G Lad1 ladinin 1 increases expression EXP fenvalerate results in increased expression of LAD1 mRNA CTD PMID:30307764 NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967 		JBrowse link
G Lama5 laminin subunit alpha 5 increases expression EXP fenvalerate results in increased expression of LAMA5 mRNA CTD PMID:30307764 NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451 		JBrowse link
G Lamc3 laminin subunit gamma 3 increases expression EXP fenvalerate results in increased expression of LAMC3 mRNA CTD PMID:30307764 NCBI chr 3:15,165,220...15,226,697
Ensembl chr 3:15,165,220...15,226,697 		JBrowse link
G Lap3 leucine aminopeptidase 3 decreases expression EXP fenvalerate results in decreased expression of LAP3 protein CTD PMID:33656234 NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359 		JBrowse link
G Lat linker for activation of T cells decreases expression EXP fenvalerate results in decreased expression of LAT mRNA CTD PMID:30307764 NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578 		JBrowse link
G Lbr lamin B receptor increases expression EXP fenvalerate results in increased expression of LBR mRNA CTD PMID:30307764 NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017 		JBrowse link
G Lcn1 lipocalin 1 increases expression EXP fenvalerate results in increased expression of LCN1 mRNA CTD PMID:30307764 NCBI chr 3:9,532,860...9,537,859
Ensembl chr 3:9,532,915...9,536,577 		JBrowse link
G Lcn2 lipocalin 2 increases expression EXP fenvalerate results in increased expression of LCN2 mRNA CTD PMID:31524104 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095 		JBrowse link
G Lct lactase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LCT protein CTD PMID:34896426 NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456 		JBrowse link
G Ldha lactate dehydrogenase A decreases expression EXP fenvalerate results in decreased expression of LDHA protein CTD PMID:33656234 NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Ldhc lactate dehydrogenase C increases expression EXP fenvalerate results in increased expression of LDHC mRNA CTD PMID:30307764 NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378 		JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEF1 protein CTD PMID:34896426 NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794 		JBrowse link
G Lemd3 LEM domain containing 3 increases expression EXP fenvalerate results in increased expression of LEMD3 mRNA CTD PMID:30307764 NCBI chr 7:56,415,053...56,499,047
Ensembl chr 7:56,305,448...56,502,474 		JBrowse link
G Leng1 leukocyte receptor cluster member 1 increases expression EXP fenvalerate results in increased expression of LENG1 mRNA CTD PMID:30307764 NCBI chr 1:65,551,983...65,556,915
Ensembl chr 1:65,551,983...65,556,915 		JBrowse link
G Lep leptin increases expression EXP fenvalerate results in increased expression of LEP mRNA CTD PMID:30307764 NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Lepr leptin receptor increases expression
multiple interactions		 EXP fenvalerate results in increased expression of LEPR mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEPR protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908 		JBrowse link
G Letmd1 LETM1 domain containing 1 increases expression EXP fenvalerate results in increased expression of LETMD1 mRNA CTD PMID:30307764 NCBI chr 7:131,584,241...131,597,797
Ensembl chr 7:131,584,259...131,597,796 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHB protein CTD PMID:34896426 PMID:36053783 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor increases expression
multiple interactions		 EXP fenvalerate results in increased expression of LHCGR mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHR mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521 		JBrowse link
G Lhx5 LIM homeobox 5 increases expression EXP fenvalerate results in increased expression of LHX5 mRNA CTD PMID:30307764 NCBI chr12:36,126,186...36,134,625
Ensembl chr12:36,126,186...36,134,625 		JBrowse link
G Limd1 LIM domain containing 1 increases expression EXP fenvalerate results in increased expression of LIMD1 mRNA CTD PMID:30307764 NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:123,122,460...123,167,714 		JBrowse link
G Limk1 LIM domain kinase 1 increases expression EXP fenvalerate results in increased expression of LIMK1 mRNA CTD PMID:30307764 NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606 		JBrowse link
G Lin37 lin-37 DREAM MuvB core complex component increases expression EXP fenvalerate results in increased expression of LIN37 mRNA CTD PMID:30307764 NCBI chr 1:85,809,065...85,813,235
Ensembl chr 1:85,809,074...85,812,991 		JBrowse link
G Lix1 limb and CNS expressed 1 increases expression EXP fenvalerate results in increased expression of LIX1 mRNA CTD PMID:30307764 NCBI chr 1:58,128,961...58,187,554
Ensembl chr 1:58,128,961...58,185,964 		JBrowse link
G Lnpep leucyl and cystinyl aminopeptidase increases expression EXP fenvalerate results in increased expression of LNPEP mRNA CTD PMID:30307764 NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544 		JBrowse link
G Lnx1 ligand of numb-protein X 1 increases expression EXP fenvalerate results in increased expression of LNX1 mRNA CTD PMID:30307764 NCBI chr14:33,514,429...33,617,086
Ensembl chr14:33,514,436...33,617,086 		JBrowse link
G Lonp1 lon peptidase 1, mitochondrial increases expression EXP fenvalerate results in increased expression of LONP1 mRNA CTD PMID:30307764 NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771 		JBrowse link
G Lox lysyl oxidase increases expression EXP fenvalerate results in increased expression of LOX mRNA CTD PMID:30307764 NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477 		JBrowse link
G Loxl1 lysyl oxidase-like 1 increases expression EXP fenvalerate results in increased expression of LOXL1 mRNA CTD PMID:30307764 NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356 		JBrowse link
G Loxl2 lysyl oxidase-like 2 increases expression EXP fenvalerate results in increased expression of LOXL2 mRNA CTD PMID:30307764 NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067 		JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein CTD PMID:34896426 NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357 		JBrowse link
G Lpo lactoperoxidase decreases expression ISO fenvalerate results in decreased expression of LPO mRNA CTD PMID:34748853 NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535 		JBrowse link
G Lpp LIM domain containing preferred translocation partner in lipoma multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPP protein CTD PMID:34896426 NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597 		JBrowse link
G Lrfn1 leucine rich repeat and fibronectin type III domain containing 1 increases expression EXP fenvalerate results in increased expression of LRFN1 mRNA CTD PMID:30307764 NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449 		JBrowse link
G Lrfn5 leucine rich repeat and fibronectin type III domain containing 5 increases expression EXP fenvalerate results in increased expression of LRFN5 mRNA CTD PMID:30307764 NCBI chr 6:79,466,403...79,822,821
Ensembl chr 6:79,467,961...79,822,815 		JBrowse link
G Lrpap1 LDL receptor related protein associated protein 1 increases expression EXP fenvalerate results in increased expression of LRPAP1 mRNA CTD PMID:30307764 NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414 		JBrowse link
G Lrrc1 leucine rich repeat containing 1 increases expression EXP fenvalerate results in increased expression of LRRC1 mRNA CTD PMID:30307764 NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490 		JBrowse link
G Lrrc20 leucine rich repeat containing 20 increases expression EXP fenvalerate results in increased expression of LRRC20 mRNA CTD PMID:30307764 NCBI chr20:29,422,858...29,528,372
Ensembl chr20:29,422,925...29,528,369 		JBrowse link
G Lrrc29 leucine rich repeat containing 29 decreases expression EXP fenvalerate results in decreased expression of LRRC29 mRNA CTD PMID:30307764 NCBI chr19:33,181,713...33,203,583
Ensembl chr19:33,188,352...33,203,545 		JBrowse link
G Lrrc38 leucine rich repeat containing 38 increases expression EXP fenvalerate results in increased expression of LRRC38 mRNA CTD PMID:30307764 NCBI chr 5:155,685,495...155,707,578
Ensembl chr 5:155,685,495...155,707,578 		JBrowse link
G Lrrc39 leucine rich repeat containing 39 increases expression EXP fenvalerate results in increased expression of LRRC39 mRNA CTD PMID:30307764 NCBI chr 2:204,516,122...204,535,463
Ensembl chr 2:204,516,123...204,535,463 		JBrowse link
G Lrrc4b leucine rich repeat containing 4B increases expression EXP fenvalerate results in increased expression of LRRC4B mRNA CTD PMID:30307764 NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263 		JBrowse link
G Lrrc51 leucine rich repeat containing 51 increases expression EXP fenvalerate results in increased expression of LRRC51 mRNA CTD PMID:30307764 NCBI chr 1:156,278,617...156,297,838
Ensembl chr 1:156,278,618...156,297,773 		JBrowse link
G Lrrc73 leucine rich repeat containing 73 increases expression EXP fenvalerate results in increased expression of LRRC73 mRNA CTD PMID:30307764 NCBI chr 9:14,726,157...14,730,144
Ensembl chr 9:14,726,158...14,729,158 		JBrowse link
G Lrrc8c leucine rich repeat containing 8 VRAC subunit C multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LRRC8C protein CTD PMID:34896426 NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249 		JBrowse link
G Lsamp limbic system-associated membrane protein increases expression EXP fenvalerate results in increased expression of LSAMP mRNA CTD PMID:30307764 NCBI chr11:58,547,533...60,717,328
Ensembl chr11:58,554,805...60,717,029 		JBrowse link
G Lsg1 large 60S subunit nuclear export GTPase 1 increases expression EXP fenvalerate results in increased expression of LSG1 mRNA CTD PMID:30307764 NCBI chr11:70,132,919...70,168,526
Ensembl chr11:70,143,847...70,168,518 		JBrowse link
G Lsp1 lymphocyte-specific protein 1 increases expression EXP fenvalerate results in increased expression of LSP1 mRNA CTD PMID:30307764 NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416 		JBrowse link
G Ltbp2 latent transforming growth factor beta binding protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LTBP2 protein CTD PMID:34896426 NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208 		JBrowse link
G Lypla1 lysophospholipase 1 increases expression EXP fenvalerate results in increased expression of LYPLA1 protein CTD PMID:33656234 NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746 		JBrowse link
G Mab21l1 mab-21 like 1 increases expression EXP fenvalerate results in increased expression of MAB21L1 mRNA CTD PMID:30307764 NCBI chr 2:139,943,496...139,945,885
Ensembl chr 2:139,943,496...139,945,885 		JBrowse link
G Mab21l2 mab-21 like 2 increases expression EXP fenvalerate results in increased expression of MAB21L2 mRNA CTD PMID:30307764 NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655 		JBrowse link
G Maff MAF bZIP transcription factor F increases expression EXP fenvalerate results in increased expression of MAFF mRNA CTD PMID:30307764 NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851 		JBrowse link
G Mag myelin-associated glycoprotein increases expression EXP fenvalerate results in increased expression of MAG mRNA CTD PMID:30307764 NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656 		JBrowse link
G Mageb16 MAGE family member B16 increases expression EXP fenvalerate results in increased expression of MAGEB16 mRNA CTD PMID:30307764 NCBI chr  X:43,693,205...43,725,664
Ensembl chr  X:43,693,211...43,725,657 		JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAGI2 protein CTD PMID:34896426 NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240 		JBrowse link
G Mak male germ cell-associated kinase increases expression EXP fenvalerate results in increased expression of MAK mRNA CTD PMID:30307764 NCBI chr17:23,683,753...23,731,125
Ensembl chr17:23,693,878...23,730,001 		JBrowse link
G Mak16 MAK16 homolog increases expression EXP fenvalerate results in increased expression of MAK16 mRNA CTD PMID:30307764 NCBI chr16:60,972,699...60,981,250
Ensembl chr16:60,972,697...60,983,243 		JBrowse link
G Mal mal, T-cell differentiation protein increases expression EXP fenvalerate results in increased expression of MAL mRNA CTD PMID:30307764 PMID:31524104 NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136 		JBrowse link
G Mamdc4 MAM domain containing 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of MAMDC4 protein CTD PMID:34896426 NCBI chr 3:8,382,387...8,391,003
Ensembl chr 3:8,382,387...8,391,003 		JBrowse link
G Man1a2 mannosidase, alpha, class 1A, member 2 increases expression EXP fenvalerate results in increased expression of MAN1A2 mRNA CTD PMID:30307764 NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332 		JBrowse link
G Man1b1 mannosidase, alpha, class 1B, member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN1B1 protein CTD PMID:34896426 NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006 		JBrowse link
G Man2c1 mannosidase, alpha, class 2C, member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN2C1 protein CTD PMID:34896426 NCBI chr 8:57,537,879...57,549,691
Ensembl chr 8:57,537,321...57,549,690 		JBrowse link
G Maoa monoamine oxidase A decreases activity EXP fenvalerate results in decreased activity of MAOA protein CTD PMID:8385837 NCBI chr  X:6,032,172...6,098,308
Ensembl chr  X:6,030,795...6,099,593 		JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463 		JBrowse link
G Map3k19 mitogen-activated protein kinase kinase kinase 19 increases expression EXP fenvalerate results in increased expression of MAP3K19 mRNA CTD PMID:30307764 NCBI chr13:39,300,150...39,343,502
Ensembl chr13:39,300,163...39,343,767 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 increases expression EXP fenvalerate results in increased expression of MAP3K6 mRNA CTD PMID:30307764 NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212 		JBrowse link
G Map3k9 mitogen-activated protein kinase kinase kinase 9 increases expression EXP fenvalerate results in increased expression of MAP3K9 mRNA CTD PMID:30307764 NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:101,430,292...101,488,822 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 increases expression EXP fenvalerate results in increased expression of MAP4K4 mRNA CTD PMID:30307764 NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698 		JBrowse link
G Map7 microtubule-associated protein 7 increases expression EXP fenvalerate results in increased expression of MAP7 mRNA CTD PMID:30307764 NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:14,910,551...15,037,574 		JBrowse link
G Map7d2 MAP7 domain containing 2 increases expression EXP fenvalerate results in increased expression of MAP7D2 mRNA CTD PMID:30307764 NCBI chr  X:35,372,453...35,488,073
Ensembl chr  X:35,372,700...35,488,091 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation
increases phosphorylation
multiple interactions		 ISO
EXP		 fenvalerate results in decreased phosphorylation of MAPK1 protein
fenvalerate results in increased phosphorylation of MAPK1 protein
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of MAPK1 protein		 CTD PMID:22210404 PMID:28949029 PMID:30307764 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation
multiple interactions
increases phosphorylation		 ISO
EXP		 fenvalerate results in decreased phosphorylation of MAPK3 protein
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of MAPK3 protein
fenvalerate results in increased phosphorylation of MAPK3 protein		 CTD PMID:22210404 PMID:28949029 PMID:30307764 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein] CTD PMID:28949029 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Marchf10 membrane associated ring-CH-type finger 10 increases expression EXP fenvalerate results in increased expression of MARCHF10 mRNA CTD PMID:30307764 NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588 		JBrowse link
G Mark1 microtubule affinity regulating kinase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MARK1 protein CTD PMID:34896426 NCBI chr13:96,450,189...96,555,304
Ensembl chr13:96,451,487...96,555,173 		JBrowse link
G Marveld1 MARVEL domain containing 1 increases expression EXP fenvalerate results in increased expression of MARVELD1 mRNA CTD PMID:30307764 NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384 		JBrowse link
G MAST1 microtubule associated serine/threonine kinase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAST1 protein CTD PMID:34896426 NCBI chr19:23,216,418...23,244,224
Ensembl chr19:23,207,991...23,244,235 		JBrowse link
G Mast2 microtubule associated serine/threonine kinase 2 increases expression EXP fenvalerate results in increased expression of MAST2 mRNA CTD PMID:30307764 NCBI chr 5:129,776,293...129,915,502
Ensembl chr 5:129,775,676...129,915,606 		JBrowse link
G Matn1 matrilin 1 increases expression EXP fenvalerate results in increased expression of MATN1 mRNA CTD PMID:30307764 NCBI chr 5:143,117,198...143,127,140
Ensembl chr 5:143,117,504...143,127,059 		JBrowse link
G Mau2 MAU2 sister chromatid cohesion factor increases expression EXP fenvalerate results in increased expression of MAU2 mRNA CTD PMID:30307764 NCBI chr16:19,383,847...19,414,996
Ensembl chr16:19,383,492...19,408,727 		JBrowse link
G Mbd5 methyl-CpG binding domain protein 5 increases expression EXP fenvalerate results in increased expression of MBD5 mRNA CTD PMID:30307764 NCBI chr 3:33,588,854...33,738,730
Ensembl chr 3:33,333,554...33,730,156 		JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 increases expression EXP fenvalerate results in increased expression of MBNL1 mRNA CTD PMID:30307764 NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368 		JBrowse link
G Mchr1 melanin-concentrating hormone receptor 1 decreases expression EXP fenvalerate results in decreased expression of MCHR1 mRNA CTD PMID:30307764 NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032 		JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member multiple interactions ISO [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of MCL1 protein CTD PMID:28949029 NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303 		JBrowse link
G Mcm10 minichromosome maintenance 10 replication initiation factor increases expression EXP fenvalerate results in increased expression of MCM10 mRNA CTD PMID:30307764 NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364 		JBrowse link
G Mcm9 minichromosome maintenance 9 homologous recombination repair factor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein CTD PMID:34896426 NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600 		JBrowse link
G Mcmdc2 minichromosome maintenance domain containing 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCMDC2 protein CTD PMID:34896426 NCBI chr 5:9,291,967...9,337,526
Ensembl chr 5:9,298,101...9,338,300 		JBrowse link
G Mcts2 MCTS family member 2 increases expression EXP fenvalerate results in increased expression of MCTS2 mRNA CTD PMID:30307764 NCBI chr 3:141,163,330...141,164,108 JBrowse link
G Mdga2 MAM domain containing glycosylphosphatidylinositol anchor 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of MDGA2 protein CTD PMID:34896426 NCBI chr 6:84,746,422...85,608,640
Ensembl chr 6:84,761,941...85,608,126 		JBrowse link
G Me2 malic enzyme 2 increases expression
decreases expression		 EXP fenvalerate results in increased expression of ME2 mRNA
fenvalerate results in decreased expression of ME2 protein		 CTD PMID:30307764 PMID:33656234 NCBI chr18:67,350,833...67,400,987
Ensembl chr18:67,355,795...67,400,987 		JBrowse link
G Med20 mediator complex subunit 20 increases expression EXP fenvalerate results in increased expression of MED20 mRNA CTD PMID:30307764 NCBI chr 9:13,370,146...13,382,756
Ensembl chr 9:13,370,146...13,382,476 		JBrowse link
G Med23 mediator complex subunit 23 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MED23 protein CTD PMID:34896426 NCBI chr 1:20,490,315...20,558,461
Ensembl chr 1:20,490,315...20,537,463 		JBrowse link
G Med31 mediator complex subunit 31 increases expression EXP fenvalerate results in increased expression of MED31 mRNA CTD PMID:30307764 NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326 		JBrowse link
G Medag mesenteric estrogen-dependent adipogenesis increases expression EXP fenvalerate results in increased expression of MEDAG mRNA CTD PMID:30307764 NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767 		JBrowse link
G Mef2c myocyte enhancer factor 2C decreases expression EXP fenvalerate results in decreased expression of MEF2C mRNA CTD PMID:30307764 NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880 		JBrowse link
G Mef2d myocyte enhancer factor 2D increases expression EXP fenvalerate results in increased expression of MEF2D mRNA CTD PMID:30307764 NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457 		JBrowse link
G Megf10 multiple EGF-like domains 10 increases expression EXP fenvalerate results in increased expression of MEGF10 mRNA CTD PMID:30307764 NCBI chr18:50,605,231...50,755,441
Ensembl chr18:50,605,656...50,754,456 		JBrowse link
G Megf6 multiple EGF-like-domains 6 increases expression EXP fenvalerate results in increased expression of MEGF6 mRNA CTD PMID:30307764 NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139 		JBrowse link
G Megf8 multiple EGF-like-domains 8 increases expression EXP fenvalerate results in increased expression of MEGF8 mRNA CTD PMID:30307764 NCBI chr 1:80,902,236...80,951,614
Ensembl chr 1:80,902,574...80,951,613 		JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression EXP fenvalerate results in increased expression of MEIG1 mRNA CTD PMID:30307764 NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433 		JBrowse link
G Metap1 methionyl aminopeptidase 1 decreases expression EXP fenvalerate results in decreased expression of METAP1 mRNA CTD PMID:30307764 NCBI chr 2:226,991,305...227,024,360
Ensembl chr 2:226,991,301...227,024,434 		JBrowse link
G Mex3c mex-3 RNA binding family member C increases expression EXP fenvalerate results in increased expression of MEX3C mRNA CTD PMID:30307764 NCBI chr18:67,167,600...67,188,595
Ensembl chr18:67,166,718...67,188,595 		JBrowse link
G Mfap3l microfibril associated protein 3 like increases expression EXP fenvalerate results in increased expression of MFAP3L mRNA CTD PMID:30307764 NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863 		JBrowse link
G Mfsd11 major facilitator superfamily domain containing 11 increases expression EXP fenvalerate results in increased expression of MFSD11 mRNA CTD PMID:30307764 NCBI chr10:102,055,516...102,075,064
Ensembl chr10:102,056,051...102,075,064 		JBrowse link
G Mgat3 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase increases expression EXP fenvalerate results in increased expression of MGAT3 mRNA CTD PMID:30307764 NCBI chr 7:111,708,353...111,761,825
Ensembl chr 7:111,675,730...111,762,026 		JBrowse link
G Mgat5b alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B increases expression EXP fenvalerate results in increased expression of MGAT5B mRNA CTD PMID:30307764 NCBI chr10:102,120,757...102,190,235
Ensembl chr10:102,120,445...102,190,233 		JBrowse link
G Mgll monoglyceride lipase decreases expression EXP fenvalerate results in decreased expression of MGLL protein CTD PMID:33656234 NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179 		JBrowse link
G Mical1 microtubule associated monooxygenase, calponin and LIM domain containing 1 increases expression EXP fenvalerate results in increased expression of MICAL1 mRNA CTD PMID:30307764 NCBI chr20:44,974,137...44,986,089
Ensembl chr20:44,974,138...44,986,089 		JBrowse link
G Mid1 midline 1 increases expression EXP fenvalerate results in increased expression of MID1 mRNA CTD PMID:30307764 NCBI chr  X:24,116,674...24,491,205
Ensembl chr  X:24,120,293...24,248,353 		JBrowse link
G Mlec malectin multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MLEC protein CTD PMID:34896426 NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708 		JBrowse link
G Mlip muscular LMNA-interacting protein increases expression EXP fenvalerate results in increased expression of MLIP mRNA CTD PMID:30307764 NCBI chr 8:77,935,087...78,204,725
Ensembl chr 8:77,935,079...78,204,254 		JBrowse link
G Mllt6 MLLT6, PHD finger containing increases expression EXP fenvalerate results in increased expression of MLLT6 mRNA CTD PMID:30307764 NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073 		JBrowse link
G Mmel1 membrane metallo-endopeptidase-like 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of MMEL1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MMEL1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716 		JBrowse link
G Mmp28 matrix metallopeptidase 28 increases expression EXP fenvalerate results in increased expression of MMP28 mRNA CTD PMID:30307764 NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression EXP fenvalerate results in increased expression of MMP9 mRNA CTD PMID:30307764 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mobp myelin-associated oligodendrocyte basic protein increases expression EXP fenvalerate results in increased expression of MOBP mRNA CTD PMID:30307764 NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563 		JBrowse link
G Mog myelin oligodendrocyte glycoprotein increases expression EXP fenvalerate results in increased expression of MOG mRNA CTD PMID:30307764 NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474 		JBrowse link
G Morn4 MORN repeat containing 4 decreases expression EXP fenvalerate results in decreased expression of MORN4 mRNA CTD PMID:30307764 NCBI chr 1:240,888,338...240,898,644
Ensembl chr 1:240,888,344...240,898,716 		JBrowse link
G Moxd1 monooxygenase, DBH-like 1 increases expression EXP fenvalerate results in increased expression of MOXD1 mRNA CTD PMID:30307764 NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779 		JBrowse link
G Mpp2 MAGUK p55 scaffold protein 2 increases expression EXP fenvalerate results in increased expression of MPP2 mRNA CTD PMID:30307764 NCBI chr10:87,011,434...87,043,883
Ensembl chr10:87,011,434...87,043,896 		JBrowse link
G Mpp7 MAGUK p55 scaffold protein 7 increases expression EXP fenvalerate results in increased expression of MPP7 mRNA CTD PMID:30307764 NCBI chr17:55,439,939...55,706,810
Ensembl chr17:55,442,696...55,706,748 		JBrowse link
G Mpped1 metallophosphoesterase domain containing 1 increases expression EXP fenvalerate results in increased expression of MPPED1 mRNA CTD PMID:30307764 NCBI chr 7:114,932,221...115,011,797
Ensembl chr 7:114,944,764...115,011,787 		JBrowse link
G Mrap2 melanocortin 2 receptor accessory protein 2 increases expression EXP fenvalerate results in increased expression of MRAP2 mRNA CTD PMID:30307764 NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886 		JBrowse link
G Mrc2 mannose receptor, C type 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MRC2 protein CTD PMID:34896426 NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856 		JBrowse link
G Mre11 MRE11 homolog, double strand break repair nuclease increases expression EXP fenvalerate results in increased expression of MRE11 mRNA CTD PMID:30307764 NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279 		JBrowse link
G Mrpl17 mitochondrial ribosomal protein L17 increases expression EXP fenvalerate results in increased expression of MRPL17 mRNA CTD PMID:30307764 NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815 		JBrowse link
G Ms4a2 membrane spanning 4-domains A2 increases expression EXP fenvalerate results in increased expression of MS4A2 mRNA CTD PMID:30307764 NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310 		JBrowse link
G Ms4a7 membrane spanning 4-domains A7 decreases expression EXP fenvalerate results in decreased expression of MS4A7 mRNA CTD PMID:30307764 NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260 		JBrowse link
G Mstn myostatin increases expression EXP fenvalerate results in increased expression of MSTN mRNA CTD PMID:30307764 NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933 		JBrowse link
G Mtcl1 microtubule crosslinking factor 1 increases expression EXP fenvalerate results in increased expression of MTCL1 mRNA CTD PMID:30307764 NCBI chr 9:106,305,282...106,441,782
Ensembl chr 9:106,321,098...106,442,203 		JBrowse link
G Mtfr2 mitochondrial fission regulator 2 increases expression EXP fenvalerate results in increased expression of MTFR2 mRNA CTD PMID:30307764 NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832 		JBrowse link
G Mthfd2l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like increases expression EXP fenvalerate results in increased expression of MTHFD2L mRNA CTD PMID:30307764 NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112 		JBrowse link
G Mtmr1 myotubularin related protein 1 decreases expression EXP fenvalerate results in decreased expression of MTMR1 mRNA CTD PMID:30307764 NCBI chr18:215,031...248,541
Ensembl chr18:215,089...248,541 		JBrowse link
G Mtmr11 myotubularin related protein 11 increases expression EXP fenvalerate results in increased expression of MTMR11 mRNA CTD PMID:30307764 NCBI chr 2:183,721,983...183,732,148
Ensembl chr 2:183,723,530...183,732,148 		JBrowse link
G Mtmr2 myotubularin related protein 2 increases expression EXP fenvalerate results in increased expression of MTMR2 mRNA CTD PMID:30307764 NCBI chr 8:10,617,993...10,670,724
Ensembl chr 8:10,617,993...10,668,172 		JBrowse link
G Mto1 mitochondrial tRNA translation optimization 1 increases expression EXP fenvalerate results in increased expression of MTO1 mRNA CTD PMID:30307764 NCBI chr 8:79,309,681...79,335,231
Ensembl chr 8:79,309,982...79,335,231 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation
multiple interactions
decreases expression		 EXP
ISO		 fenvalerate results in decreased phosphorylation of MTOR protein
SB 203580 inhibits the reaction [fenvalerate results in decreased phosphorylation of MTOR protein]
fenvalerate results in decreased expression of MTOR mRNA		 CTD PMID:31734597 PMID:34748853 NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Mtrf1l mitochondrial translation release factor 1 like increases expression EXP fenvalerate results in increased expression of MTRF1L mRNA CTD PMID:30307764 NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 increases expression EXP fenvalerate results in increased expression of MYBL2 mRNA CTD PMID:30307764 NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708 		JBrowse link
G Mybpc1 myosin binding protein C1 increases expression EXP fenvalerate results in increased expression of MYBPC1 mRNA CTD PMID:30307764 NCBI chr 7:22,930,350...23,015,981
Ensembl chr 7:22,930,350...23,015,957 		JBrowse link
G Mycn MYCN proto-oncogene, bHLH transcription factor increases expression EXP fenvalerate results in increased expression of MYCN mRNA CTD PMID:30307764 NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590 		JBrowse link
G Myef2 myelin expression factor 2 increases expression EXP fenvalerate results in increased expression of MYEF2 mRNA CTD PMID:30307764 NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181 		JBrowse link
G Myh4 myosin heavy chain 4 increases expression EXP fenvalerate results in increased expression of MYH4 mRNA CTD PMID:30307764 NCBI chr10:51,923,149...51,946,297
Ensembl chr10:51,885,913...51,946,295 		JBrowse link
G Mylip myosin regulatory light chain interacting protein multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein CTD PMID:34896426 NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295 		JBrowse link
G Myo1a myosin IA multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYO1A protein CTD PMID:34896426 NCBI chr 7:63,542,988...63,557,944
Ensembl chr 7:63,542,988...63,557,944 		JBrowse link
G Myo1c myosin 1C increases expression EXP fenvalerate results in increased expression of MYO1C mRNA CTD PMID:30307764 NCBI chr10:60,498,372...60,520,752
Ensembl chr10:60,498,280...60,520,752 		JBrowse link
G Myom2 myomesin 2 increases expression EXP fenvalerate results in increased expression of MYOM2 mRNA CTD PMID:30307764 NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772 		JBrowse link
G Myzap myocardial zonula adherens protein increases expression EXP fenvalerate results in increased expression of MYZAP mRNA CTD PMID:30307764 NCBI chr 8:72,155,817...72,243,036
Ensembl chr 8:72,131,530...72,243,036 		JBrowse link
G Naa25 N(alpha)-acetyltransferase 25, NatB auxiliary subunit increases expression EXP fenvalerate results in increased expression of NAA25 mRNA CTD PMID:30307764 NCBI chr12:35,098,256...35,150,498
Ensembl chr12:35,098,075...35,150,467 		JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression EXP fenvalerate results in increased expression of NAAA mRNA CTD PMID:30307764 NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410 		JBrowse link
G Naalad2 N-acetylated alpha-linked acidic dipeptidase 2 increases expression EXP fenvalerate results in increased expression of NAALAD2 protein CTD PMID:33656234 NCBI chr 8:15,406,119...15,479,714
Ensembl chr 8:15,407,043...15,479,714 		JBrowse link
G Nap1l2 nucleosome assembly protein 1-like 2 increases expression EXP fenvalerate results in increased expression of NAP1L2 mRNA CTD PMID:30307764 NCBI chr  X:68,174,051...68,176,449
Ensembl chr  X:68,173,987...68,176,666 		JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NBR1 protein CTD PMID:34896426 NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412 		JBrowse link
G Ncoa7 nuclear receptor coactivator 7 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NCOA7 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871 		JBrowse link
G Ndufb10 NADH:ubiquinone oxidoreductase subunit B10 decreases expression EXP fenvalerate results in decreased expression of NDUFB10 protein CTD PMID:33656234 NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442 		JBrowse link
G Ndufb9 NADH:ubiquinone oxidoreductase subunit B9 decreases expression EXP fenvalerate results in decreased expression of NDUFB9 protein CTD PMID:33656234 NCBI chr 7:90,480,948...90,487,367
Ensembl chr 7:90,436,621...90,488,009 		JBrowse link
G Necab1 N-terminal EF-hand calcium binding protein 1 increases expression EXP fenvalerate results in increased expression of NECAB1 mRNA CTD PMID:30307764 NCBI chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642 		JBrowse link
G Necab3 N-terminal EF-hand calcium binding protein 3 increases expression EXP fenvalerate results in increased expression of NECAB3 mRNA CTD PMID:30307764 NCBI chr 3:143,049,477...143,064,372
Ensembl chr 3:143,049,478...143,075,361 		JBrowse link
G Nectin2 nectin cell adhesion molecule 2 increases expression EXP fenvalerate results in increased expression of NECTIN2 mRNA CTD PMID:30307764 NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360 		JBrowse link
G Nedd4 NEDD4 E3 ubiquitin protein ligase increases expression EXP fenvalerate results in increased expression of NEDD4 mRNA CTD PMID:30307764 NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951 		JBrowse link
G Nedd4l NEDD4 like E3 ubiquitin protein ligase increases expression EXP fenvalerate results in increased expression of NEDD4L mRNA CTD PMID:30307764 NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137 		JBrowse link
G Nefh neurofilament heavy chain increases expression EXP fenvalerate results in increased expression of NEFH mRNA CTD PMID:30307764 NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351 		JBrowse link
G Nefl neurofilament light chain increases expression EXP fenvalerate results in increased expression of NEFL mRNA CTD PMID:30307764 NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793 		JBrowse link
G Nek9 NIMA-related kinase 9 increases expression EXP fenvalerate results in increased expression of NEK9 mRNA CTD PMID:30307764 NCBI chr 6:104,944,056...104,984,538
Ensembl chr 6:104,944,056...104,984,538 		JBrowse link
G Neo1 neogenin 1 increases expression EXP fenvalerate results in increased expression of NEO1 mRNA CTD PMID:30307764 NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA CTD PMID:33396045 PMID:34896426 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfix nuclear factor I X increases expression EXP fenvalerate results in increased expression of NFIX mRNA CTD PMID:30307764 NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265 		JBrowse link
G Ngb neuroglobin increases expression EXP fenvalerate results in increased expression of NGB mRNA CTD PMID:30307764 NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830 		JBrowse link
G Ngfr nerve growth factor receptor increases expression
decreases expression		 EXP
ISO		 fenvalerate results in increased expression of NGFR mRNA
fenvalerate results in decreased expression of NGFR mRNA		 CTD PMID:30307764 PMID:34358930 NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518 		JBrowse link
G Nhsl2 NHS-like 2 increases expression EXP fenvalerate results in increased expression of NHSL2 mRNA CTD PMID:30307764 NCBI chr  X:66,969,953...67,209,464
Ensembl chr  X:66,970,151...67,200,911 		JBrowse link
G Nim1k NIM1 serine/threonine protein kinase increases expression EXP fenvalerate results in increased expression of NIM1K mRNA CTD PMID:30307764 NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762 		JBrowse link
G Ninj2 ninjurin 2 increases expression EXP fenvalerate results in increased expression of NINJ2 mRNA CTD PMID:30307764 NCBI chr 4:153,306,439...153,408,618
Ensembl chr 4:153,306,553...153,408,617 		JBrowse link
G Nit2 nitrilase family, member 2 decreases expression EXP fenvalerate results in decreased expression of NIT2 protein CTD PMID:33656234 NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024 		JBrowse link
G Nkx2-1 NK2 homeobox 1 increases expression EXP fenvalerate results in increased expression of NKX2-1 mRNA CTD PMID:30307764 NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791 		JBrowse link
G Nkx2-2 NK2 homeobox 2 increases expression EXP fenvalerate results in increased expression of NKX2-2 mRNA CTD PMID:30307764 NCBI chr 3:134,619,701...134,630,282
Ensembl chr 3:134,620,039...134,622,411 		JBrowse link
G Nkx2-3 NK2 homeobox 3 increases expression EXP fenvalerate results in increased expression of NKX2-3 mRNA CTD PMID:30307764 NCBI chr 1:242,478,130...242,481,083
Ensembl chr 1:242,478,130...242,481,083 		JBrowse link
G Nlk nemo like kinase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NLK protein CTD PMID:34896426 NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 increases expression EXP fenvalerate results in increased expression of NME4 mRNA CTD PMID:30307764 NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479 		JBrowse link
G Nmu neuromedin U increases expression EXP fenvalerate results in increased expression of NMU mRNA CTD PMID:30307764 NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192 		JBrowse link
G Noc3l NOC3-like DNA replication regulator increases expression EXP fenvalerate results in increased expression of NOC3L mRNA CTD PMID:30307764 NCBI chr 1:236,556,037...236,585,372
Ensembl chr 1:236,556,789...236,585,318 		JBrowse link
G Noc4l nucleolar complex associated 4 homolog multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NOC4L protein CTD PMID:34896426 NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614 		JBrowse link
G Nol4 nucleolar protein 4 increases expression EXP fenvalerate results in increased expression of NOL4 mRNA CTD PMID:30307764 NCBI chr18:13,932,499...14,294,873
Ensembl chr18:13,932,510...14,296,286 		JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 increases expression EXP fenvalerate results in increased expression of NOLC1 mRNA CTD PMID:30307764 NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088 		JBrowse link
G Noxo1 NADPH oxidase organizer 1 increases expression EXP fenvalerate results in increased expression of NOXO1 mRNA CTD PMID:30307764 NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061 		JBrowse link
G Npas2 neuronal PAS domain protein 2 decreases expression EXP fenvalerate results in decreased expression of NPAS2 mRNA CTD PMID:30307764 NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320 		JBrowse link
G Npc2 NPC intracellular cholesterol transporter 2 decreases expression EXP fenvalerate results in decreased expression of NPC2 protein CTD PMID:33656234 NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155 		JBrowse link
G Npffr2 neuropeptide FF receptor 2 increases expression EXP fenvalerate results in increased expression of NPFFR2 mRNA CTD PMID:30307764 NCBI chr14:18,513,120...18,558,074
Ensembl chr14:18,513,277...18,521,919 		JBrowse link
G Npl N-acetylneuraminate pyruvate lyase decreases expression
multiple interactions		 EXP fenvalerate results in decreased expression of NPL mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPL protein		 CTD PMID:30307764 PMID:34896426 NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372 		JBrowse link
G Nppa natriuretic peptide A increases expression EXP fenvalerate results in increased expression of NPPA mRNA CTD PMID:30307764 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351 		JBrowse link
G Npr2 natriuretic peptide receptor 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein CTD PMID:34896426 NCBI chr 5:57,883,171...57,901,590
Ensembl chr 5:57,883,171...57,901,580 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NQO1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NQO1 mRNA CTD PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G Nr0b1 nuclear receptor subfamily 0, group B, member 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr  X:50,756,886...50,761,014
Ensembl chr  X:50,756,886...50,761,011 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 decreases expression EXP fenvalerate results in decreased expression of NR0B2 mRNA CTD PMID:30307764 NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 decreases expression EXP fenvalerate results in decreased expression of NR1D1 mRNA CTD PMID:30307764 NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 multiple interactions ISO fenvalerate inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] CTD PMID:25257666 NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
multiple interactions		 EXP
ISO		 fenvalerate results in increased activity of NR1I2 protein
fenvalerate binds to and results in increased activity of NR1I2 protein
fenvalerate results in increased activity of NR1I2 protein; fenvalerate results in increased activity of NR1I2 protein polymorphism		 CTD PMID:15548381 PMID:16054614 PMID:19249324 PMID:21115097 PMID:22206814 More... NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 increases expression
multiple interactions		 ISO
EXP		 fenvalerate results in increased expression of NR1I3 mRNA
fenvalerate binds to and results in decreased activity of NR1I3 protein; fenvalerate inhibits the reaction [artemisinin binds to and results in increased activity of NR1I3 protein]		 CTD PMID:22310298 PMID:31538121 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases expression EXP fenvalerate results in increased expression of NR3C1 mRNA CTD PMID:30307764 NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 affects methylation
multiple interactions		 ISO
EXP		 fenvalerate affects the methylation of NR3C2 gene
fenvalerate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR3C2 protein		 CTD PMID:23548413 PMID:29149346 PMID:34896426 NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 increases expression EXP fenvalerate results in increased expression of NR4A2 mRNA CTD PMID:30307764 NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877 		JBrowse link
G Nr5a1 nuclear receptor subfamily 5, group A, member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA CTD PMID:33396045 NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328 		JBrowse link
G Nrf1 nuclear respiratory factor 1 increases expression EXP fenvalerate results in increased expression of NRF1 mRNA CTD PMID:30307764 NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328 		JBrowse link
G Nrg1 neuregulin 1 increases expression EXP fenvalerate results in increased expression of NRG1 mRNA CTD PMID:30307764 NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884 		JBrowse link
G Nrg2 neuregulin 2 increases expression EXP fenvalerate results in increased expression of NRG2 mRNA CTD PMID:30307764 NCBI chr18:27,616,542...27,798,505
Ensembl chr18:27,619,661...27,798,505 		JBrowse link
G Nrip3 nuclear receptor interacting protein 3 increases expression EXP fenvalerate results in increased expression of NRIP3 mRNA CTD PMID:30307764 NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600 		JBrowse link
G Nrl neural retina leucine zipper increases expression EXP fenvalerate results in increased expression of NRL mRNA CTD PMID:30307764 NCBI chr15:29,007,059...29,011,480
Ensembl chr15:29,008,104...29,009,832 		JBrowse link
G Nrsn1 neurensin 1 increases expression EXP fenvalerate results in increased expression of NRSN1 mRNA CTD PMID:30307764 NCBI chr17:39,806,238...39,824,550
Ensembl chr17:39,806,238...39,823,813 		JBrowse link
G Nrxn2 neurexin 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NRXN2 protein CTD PMID:34896426 NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297 		JBrowse link
G Ntn5 netrin 5 increases expression EXP fenvalerate results in increased expression of NTN5 mRNA CTD PMID:30307764 NCBI chr 1:96,156,948...96,165,997
Ensembl chr 1:96,156,985...96,165,630 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 increases expression
decreases expression		 EXP
ISO		 fenvalerate results in increased expression of NTRK2 mRNA
fenvalerate results in decreased expression of NTRK2 mRNA		 CTD PMID:30307764 PMID:34358930 NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136 		JBrowse link
G Ntsr1 neurotensin receptor 1 increases expression EXP fenvalerate results in increased expression of NTSR1 mRNA CTD PMID:30307764 NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377 		JBrowse link
G Nudc nuclear distribution C, dynein complex regulator increases expression EXP fenvalerate results in increased expression of NUDC protein CTD PMID:33656234 NCBI chr 5:145,758,006...145,771,390
Ensembl chr 5:145,758,002...145,771,425 		JBrowse link
G Nudt13 nudix hydrolase 13 decreases expression EXP fenvalerate results in decreased expression of NUDT13 mRNA CTD PMID:30307764 NCBI chr15:4,001,787...4,022,404
Ensembl chr15:4,001,794...4,022,293 		JBrowse link
G Nup214 nucleoporin 214 increases expression EXP fenvalerate results in increased expression of NUP214 mRNA CTD PMID:30307764 NCBI chr 3:15,255,111...15,340,568
Ensembl chr 3:15,255,119...15,340,568 		JBrowse link
G Nup58 nucleoporin 58 increases expression EXP fenvalerate results in increased expression of NUP58 mRNA CTD PMID:30307764 NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060 		JBrowse link
G Nxf2 nuclear RNA export factor 2 increases expression EXP fenvalerate results in increased expression of NXF7 mRNA CTD PMID:30307764 NCBI chr  X:98,135,953...98,157,117
Ensembl chr  X:98,135,950...98,157,089 		JBrowse link
G Oas3 2'-5'-oligoadenylate synthetase 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein CTD PMID:34896426 NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781 		JBrowse link
G Oat ornithine aminotransferase decreases expression EXP fenvalerate results in decreased expression of OAT protein CTD PMID:33656234 NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682 		JBrowse link
G Odad4 outer dynein arm docking complex subunit 4 increases expression EXP fenvalerate results in increased expression of ODAD4 mRNA CTD PMID:30307764 NCBI chr10:85,480,089...85,508,603
Ensembl chr10:85,480,094...85,508,603 		JBrowse link
G Odf1 outer dense fiber of sperm tails 1 decreases expression EXP fenvalerate results in decreased expression of ODF1 protein CTD PMID:33656234 NCBI chr 7:69,377,427...69,389,662
Ensembl chr 7:69,380,116...69,389,664 		JBrowse link
G Odf2 outer dense fiber of sperm tails 2 decreases expression
multiple interactions		 EXP fenvalerate results in decreased expression of ODF2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ODF2 protein		 CTD PMID:33656234 PMID:34896426 NCBI chr 3:13,160,981...13,207,223
Ensembl chr 3:13,161,494...13,206,985 		JBrowse link
G Odr4 odr-4 GPCR localization factor homolog increases expression EXP fenvalerate results in increased expression of ODR4 mRNA CTD PMID:30307764 NCBI chr13:62,369,109...62,424,287
Ensembl chr13:62,394,608...62,424,209 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase increases expression EXP fenvalerate results in increased expression of OGT mRNA CTD PMID:30307764 NCBI chr  X:66,771,278...66,816,148
Ensembl chr  X:66,771,349...66,816,146 		JBrowse link
G Olfml2a olfactomedin-like 2A increases expression EXP fenvalerate results in increased expression of OLFML2A mRNA CTD PMID:30307764 NCBI chr 3:22,688,590...22,717,917
Ensembl chr 3:22,688,598...22,717,909 		JBrowse link
G Olig2 oligodendrocyte transcription factor 2 decreases expression ISO fenvalerate results in decreased expression of OLIG2 mRNA CTD PMID:34748853 NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152 		JBrowse link
G Olr1493 olfactory receptor gene Olr1493 increases expression EXP fenvalerate results in increased expression of OLR1493 mRNA CTD PMID:30307764 NCBI chr10:58,495,709...58,496,647
Ensembl chr10:58,491,442...58,498,164 		JBrowse link
G Opalin oligodendrocytic myelin paranodal and inner loop protein increases expression EXP fenvalerate results in increased expression of OPALIN mRNA CTD PMID:30307764 NCBI chr 1:239,891,137...239,909,388
Ensembl chr 1:239,891,142...239,908,788 		JBrowse link
G Opcml opioid binding protein/cell adhesion molecule-like increases expression EXP fenvalerate results in increased expression of OPCML mRNA CTD PMID:30307764 NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620 		JBrowse link
G Opn1sw opsin 1, short wave sensitive increases expression EXP fenvalerate results in increased expression of OPN1SW mRNA CTD PMID:30307764 NCBI chr 4:57,977,317...57,980,457
Ensembl chr 4:57,977,313...57,980,457 		JBrowse link
G Oprk1 opioid receptor, kappa 1 increases expression EXP fenvalerate results in increased expression of OPRK1 mRNA CTD PMID:30307764 NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823 		JBrowse link
G Oprl1 opioid related nociceptin receptor 1 increases expression EXP fenvalerate results in increased expression of OPRL1 mRNA CTD PMID:30307764 NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920 		JBrowse link
G Optc opticin increases expression EXP fenvalerate results in increased expression of OPTC mRNA CTD PMID:30307764 NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237 		JBrowse link
G Or1n1 olfactory receptor family 1 subfamily N member 1 increases expression EXP fenvalerate results in increased expression of OR1N1 mRNA CTD PMID:30307764 NCBI chr 3:20,413,262...20,414,197
Ensembl chr 3:20,413,262...20,414,203 		JBrowse link
G Or6a2 olfactory receptor family 6 subfamily A member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OR6A2 protein CTD PMID:34896426 NCBI chr 1:160,827,258...160,828,241
Ensembl chr 1:160,793,997...160,831,557 		JBrowse link
G Orc4 origin recognition complex, subunit 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ORC4 protein CTD PMID:34896426 NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824 		JBrowse link
G Orc6 origin recognition complex, subunit 6 increases expression EXP fenvalerate results in increased expression of ORC6 mRNA CTD PMID:30307764 NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662 		JBrowse link
G Osbp oxysterol binding protein increases expression EXP fenvalerate results in increased expression of OSBP mRNA CTD PMID:30307764 NCBI chr 1:208,888,697...208,918,511
Ensembl chr 1:208,887,895...208,918,506 		JBrowse link
G Osbpl1a oxysterol binding protein-like 1A increases expression EXP fenvalerate results in increased expression of OSBPL1A mRNA CTD PMID:30307764 NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585 		JBrowse link
G Otulinl OTU deubiquitinase with linear linkage specificity like increases expression EXP fenvalerate results in increased expression of OTULINL mRNA CTD PMID:30307764 NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838 		JBrowse link
G Ovol1 ovo like transcriptional repressor 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831 		JBrowse link
G P2rx2 purinergic receptor P2X 2 increases expression EXP fenvalerate results in increased expression of P2RX2 mRNA CTD PMID:30307764 NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891 		JBrowse link
G P2rx3 purinergic receptor P2X 3 increases expression EXP fenvalerate results in increased expression of P2RX3 mRNA CTD PMID:30307764 NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178 		JBrowse link
G P2rx5 purinergic receptor P2X 5 increases expression EXP fenvalerate results in increased expression of P2RX5 mRNA CTD PMID:30307764 NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423 		JBrowse link
G P2ry4 pyrimidinergic receptor P2Y4 increases expression EXP fenvalerate results in increased expression of P2RY4 mRNA CTD PMID:30307764 NCBI chr  X:65,681,680...65,717,404
Ensembl chr  X:65,683,232...65,721,748 		JBrowse link
G Pacs1 phosphofurin acidic cluster sorting protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PACS1 protein CTD PMID:34896426 NCBI chr 1:202,437,503...202,569,473
Ensembl chr 1:202,437,505...202,569,473 		JBrowse link
G Padi3 peptidyl arginine deiminase 3 increases expression EXP fenvalerate results in increased expression of PADI3 mRNA CTD PMID:30307764 NCBI chr 5:153,089,717...153,117,146
Ensembl chr 5:153,089,717...153,117,146 		JBrowse link
G Paf1 PAF1 homolog, Paf1/RNA polymerase II complex component multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein CTD PMID:34896426 NCBI chr 1:83,683,654...83,689,233
Ensembl chr 1:83,668,813...83,689,237 		JBrowse link
G Pakap paralemmin A kinase anchor protein increases expression EXP fenvalerate results in increased expression of PAKAP mRNA CTD PMID:30307764 NCBI chr 5:72,536,986...72,648,524
NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524 		JBrowse link
G Palm paralemmin multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PALM protein CTD PMID:34896426 NCBI chr 7:9,886,634...9,912,389
Ensembl chr 7:9,886,643...9,912,555 		JBrowse link
G Palmd palmdelphin increases expression EXP fenvalerate results in increased expression of PALMD mRNA CTD PMID:30307764 NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage
multiple interactions		 EXP fenvalerate results in increased cleavage of PARP1 protein
CAT protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein]		 CTD PMID:30307764 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Parpbp PARP1 binding protein increases expression EXP fenvalerate results in increased expression of PARPBP mRNA CTD PMID:30307764 NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695 		JBrowse link
G Parvb parvin, beta increases expression EXP fenvalerate results in increased expression of PARVB mRNA CTD PMID:30307764 NCBI chr 7:115,360,254...115,445,767
Ensembl chr 7:115,360,261...115,445,766 		JBrowse link
G Pask PAS domain containing serine/threonine kinase increases expression EXP fenvalerate results in increased expression of PASK mRNA CTD PMID:30307764 NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111 		JBrowse link
G Patl1 PAT1 homolog 1, processing body mRNA decay factor increases expression EXP fenvalerate results in increased expression of PATL1 mRNA CTD PMID:30307764 NCBI chr 1:208,831,115...208,862,904
Ensembl chr 1:208,831,115...208,862,857 		JBrowse link
G Pcdh20 protocadherin 20 increases expression EXP fenvalerate results in increased expression of PCDH20 mRNA CTD PMID:30307764 NCBI chr15:64,425,534...64,431,790
Ensembl chr15:64,425,534...64,431,790 		JBrowse link
G Pcdh9 protocadherin 9 increases expression EXP fenvalerate results in increased expression of PCDH9 mRNA CTD PMID:30307764 NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538 		JBrowse link
G Pcdhb21 protocadherin beta 21 increases expression EXP fenvalerate results in increased expression of PCDHB9 mRNA CTD PMID:30307764 NCBI chr18:29,218,209...29,221,142
Ensembl chr18:29,218,225...29,221,142 		JBrowse link
G Pced1a PC-esterase domain containing 1A decreases expression EXP fenvalerate results in decreased expression of PCED1A mRNA CTD PMID:30307764 NCBI chr 3:117,600,958...117,622,992
Ensembl chr 3:117,616,921...117,622,962 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PCNA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of PCNA mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Pcsk1n proprotein convertase subtilisin/kexin type 1 inhibitor increases expression EXP fenvalerate results in increased expression of PCSK1N mRNA CTD PMID:30307764 NCBI chr  X:14,580,036...14,583,478
Ensembl chr  X:14,580,038...14,583,566 		JBrowse link
G Pcsk5 proprotein convertase subtilisin/kexin type 5 increases expression EXP fenvalerate results in increased expression of PCSK5 mRNA CTD PMID:30307764 NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600 		JBrowse link
G Pde12 phosphodiesterase 12 increases expression EXP fenvalerate results in increased expression of PDE12 mRNA CTD PMID:30307764 NCBI chr16:1,920,062...1,925,638
Ensembl chr16:1,915,386...1,925,887 		JBrowse link
G Pde4a phosphodiesterase 4A increases expression EXP fenvalerate results in increased expression of PDE4A mRNA CTD PMID:30307764 NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961 		JBrowse link
G Pde4b phosphodiesterase 4B multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696 		JBrowse link
G Pde8b phosphodiesterase 8B increases expression EXP fenvalerate results in increased expression of PDE8B mRNA CTD PMID:30307764 NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209 		JBrowse link
G Pdgfd platelet derived growth factor D increases expression EXP fenvalerate results in increased expression of PDGFD mRNA CTD PMID:30307764 NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395 		JBrowse link
G Pdha2 pyruvate dehydrogenase E1 subunit alpha 2 increases expression
decreases expression		 EXP fenvalerate results in increased expression of PDHA2 mRNA
fenvalerate results in decreased expression of PDHA2 protein		 CTD PMID:30307764 PMID:33656234 NCBI chr 2:229,872,300...229,873,848 JBrowse link
G Pdlim2 PDZ and LIM domain 2 increases expression EXP fenvalerate results in increased expression of PDLIM2 mRNA CTD PMID:30307764 NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 decreases expression EXP fenvalerate results in decreased expression of PDLIM7 mRNA CTD PMID:30307764 NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811 		JBrowse link
G Pds5a PDS5 cohesin associated factor A multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDS5A protein CTD PMID:34896426 NCBI chr14:42,551,653...42,651,074
Ensembl chr14:42,552,647...42,648,669 		JBrowse link
G Pdxkl1 pyridoxal kinase like 1 decreases expression EXP fenvalerate results in decreased expression of PDXKL1 mRNA CTD PMID:30307764 NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739 		JBrowse link
G Pdzd4 PDZ domain containing 4 increases expression EXP fenvalerate results in increased expression of PDZD4 mRNA CTD PMID:30307764 NCBI chr  X:151,530,390...151,560,779
Ensembl chr  X:151,530,390...151,560,826 		JBrowse link
G Pelp1 proline, glutamate and leucine rich protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PELP1 protein CTD PMID:34896426 NCBI chr10:55,094,798...55,111,833
Ensembl chr10:55,094,796...55,111,994 		JBrowse link
G Pex11a peroxisomal biogenesis factor 11 alpha increases expression EXP fenvalerate results in increased expression of PEX11A mRNA CTD PMID:30307764 NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172 		JBrowse link
G Pex6 peroxisomal biogenesis factor 6 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PEX6 protein CTD PMID:34896426 NCBI chr 9:14,258,145...14,270,335
Ensembl chr 9:14,258,145...14,270,303 		JBrowse link
G Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 increases expression EXP fenvalerate results in increased expression of PFKFB2 mRNA CTD PMID:30307764 NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699 		JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression EXP fenvalerate results in decreased expression of PGAM1 protein CTD PMID:33656234 NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452 		JBrowse link
G Pgam2 phosphoglycerate mutase 2 decreases expression EXP fenvalerate results in decreased expression of PGAM2 protein CTD PMID:33656234 NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940 		JBrowse link
G Pgap1 post-GPI attachment to proteins inositol deacylase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein CTD PMID:34896426 NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464 		JBrowse link
G Pgbd5 piggyBac transposable element derived 5 increases expression EXP fenvalerate results in increased expression of PGBD5 mRNA CTD PMID:30307764 NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397 		JBrowse link
G Pgc progastricsin increases expression EXP fenvalerate results in increased expression of PGC mRNA CTD PMID:30307764 NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682 		JBrowse link
G Pgk2 phosphoglycerate kinase 2 increases expression EXP fenvalerate results in increased expression of PGK2 protein CTD PMID:33656234 NCBI chr 9:20,480,367...20,481,933
Ensembl chr 9:20,480,203...20,571,481 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO fenvalerate inhibits the reaction [Progesterone results in increased expression of PGR protein] CTD PMID:16326432 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344 		JBrowse link
G Phactr1 phosphatase and actin regulator 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein CTD PMID:34896426 NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831 		JBrowse link
G Phb2 prohibitin 2 increases expression EXP fenvalerate results in increased expression of PHB2 mRNA CTD PMID:30307764 NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272 		JBrowse link
G Pheta2 PH domain containing endocytic trafficking adaptor 2 increases expression EXP fenvalerate results in increased expression of PHETA2 mRNA CTD PMID:30307764 NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871 		JBrowse link
G Phex phosphate regulating endopeptidase X-linked increases expression EXP fenvalerate results in increased expression of PHEX mRNA CTD PMID:30307764 NCBI chr  X:37,607,553...37,856,183
Ensembl chr  X:37,610,760...37,854,469 		JBrowse link
G Phf14 PHD finger protein 14 increases expression EXP fenvalerate results in increased expression of PHF14 mRNA CTD PMID:30307764 NCBI chr 4:40,009,691...40,195,877
Ensembl chr 4:40,009,264...40,195,885 		JBrowse link
G Phf21a PHD finger protein 21A increases expression EXP fenvalerate results in increased expression of PHF21A mRNA CTD PMID:30307764 NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression EXP fenvalerate results in increased expression of PHLDA1 mRNA; fenvalerate results in increased expression of PHLDA1 protein CTD PMID:31524104 NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861 		JBrowse link
G Phospho1 phosphoethanolamine/phosphocholine phosphatase 1 decreases expression EXP fenvalerate results in decreased expression of PHOSPHO1 protein CTD PMID:33656234 NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342 		JBrowse link
G Pierce1 piercer of microtubule wall 1 increases expression EXP fenvalerate results in increased expression of PIERCE1 mRNA CTD PMID:30307764 NCBI chr 3:11,797,031...11,801,568
Ensembl chr 3:11,797,031...11,801,568 		JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CA protein CTD PMID:34896426 NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032 		JBrowse link
G Pik3cb phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CB protein CTD PMID:34896426 NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663 		JBrowse link
G Pink1 PTEN induced kinase 1 increases expression EXP fenvalerate results in increased expression of PINK1 mRNA CTD PMID:31734597 NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635 		JBrowse link
G Pinlyp phospholipase A2 inhibitor and Ly6/Plaur domain containing increases expression EXP fenvalerate results in increased expression of PINLYP mRNA CTD PMID:30307764 NCBI chr 1:80,134,642...80,140,488
Ensembl chr 1:80,134,643...80,139,996 		JBrowse link
G Pip5k1a phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein CTD PMID:34896426 NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598 		JBrowse link
G Pitx1 paired-like homeodomain 1 increases expression EXP fenvalerate results in increased expression of PITX1 mRNA CTD PMID:30307764 NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291 		JBrowse link
G Pkhd1l1 PKHD1 like 1 increases expression EXP fenvalerate results in increased expression of PKHD1L1 mRNA CTD PMID:30307764 NCBI chr 7:75,620,384...75,795,335
Ensembl chr 7:75,620,484...75,795,335 		JBrowse link
G Pknox1 PBX/knotted 1 homeobox 1 decreases expression EXP fenvalerate results in decreased expression of PKNOX1 mRNA CTD PMID:30307764 NCBI chr20:9,662,866...9,705,030
Ensembl chr20:9,662,899...9,703,727 		JBrowse link
G Pkp3 plakophilin 3 decreases expression EXP fenvalerate results in decreased expression of PKP3 mRNA CTD PMID:30307764 NCBI chr 1:196,187,914...196,198,843
Ensembl chr 1:196,187,835...196,198,844 		JBrowse link
G Pla2g2a phospholipase A2 group IIA decreases expression EXP fenvalerate results in decreased expression of PLA2G2A mRNA CTD PMID:30307764 NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014 		JBrowse link
G Pla2g2d phospholipase A2, group IID increases expression EXP fenvalerate results in increased expression of PLA2G2D mRNA CTD PMID:30307764 NCBI chr 5:151,016,010...151,022,531
Ensembl chr 5:151,018,870...151,022,525 		JBrowse link
G Pla2g6 phospholipase A2 group VI decreases expression EXP fenvalerate results in decreased expression of PLA2G6 mRNA CTD PMID:30307764 NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114 		JBrowse link
G Plaat5 phospholipase A and acyltransferase 5 increases expression EXP fenvalerate results in increased expression of PLAAT5 mRNA CTD PMID:30307764 NCBI chr 1:204,847,600...204,878,456
Ensembl chr 1:204,847,600...204,878,184 		JBrowse link
G Plaur plasminogen activator, urokinase receptor decreases expression EXP fenvalerate results in decreased expression of PLAUR mRNA CTD PMID:30307764 NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595 		JBrowse link
G Plcb2 phospholipase C, beta 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein CTD PMID:34896426 NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302 		JBrowse link
G Plcd4 phospholipase C, delta 4 increases expression EXP fenvalerate results in increased expression of PLCD4 mRNA CTD PMID:30307764 NCBI chr 9:76,115,523...76,158,602
Ensembl chr 9:76,117,168...76,142,453 		JBrowse link
G Plcxd3 phosphatidylinositol-specific phospholipase C, X domain containing 3 increases expression EXP fenvalerate results in increased expression of PLCXD3 mRNA CTD PMID:30307764 NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:53,567,022...53,746,384 		JBrowse link
G Pld1 phospholipase D1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLD1 protein CTD PMID:34896426 NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692 		JBrowse link
G Plekhd1 pleckstrin homology and coiled-coil domain containing D1 increases expression EXP fenvalerate results in increased expression of PLEKHD1 mRNA CTD PMID:30307764 NCBI chr 6:100,340,655...100,371,942
Ensembl chr 6:100,340,655...100,371,941 		JBrowse link
G Plekhh2 pleckstrin homology, MyTH4 and FERM domain containing H2 increases expression EXP fenvalerate results in increased expression of PLEKHH2 mRNA CTD PMID:30307764 NCBI chr 6:10,032,837...10,132,081
Ensembl chr 6:10,032,660...10,140,794 		JBrowse link
G Plekhm3 pleckstrin homology domain containing M3 increases expression EXP fenvalerate results in increased expression of PLEKHM3 mRNA CTD PMID:30307764 NCBI chr 9:66,166,233...66,325,332
Ensembl chr 9:66,166,321...66,325,294 		JBrowse link
G Plk3 polo-like kinase 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLK3 protein CTD PMID:34896426 NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317 		JBrowse link
G Pllp plasmolipin increases expression EXP fenvalerate results in increased expression of PLLP mRNA CTD PMID:30307764 NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892 		JBrowse link
G Plod3 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLOD3 protein CTD PMID:34896426 NCBI chr12:19,676,384...19,686,945
Ensembl chr12:19,676,386...19,686,960 		JBrowse link
G Plp1 proteolipid protein 1 increases expression EXP fenvalerate results in increased expression of PLP1 mRNA CTD PMID:30307764 NCBI chr  X:100,184,039...100,201,035
Ensembl chr  X:100,185,767...100,201,032 		JBrowse link
G Plppr5 phospholipid phosphatase related 5 increases expression EXP fenvalerate results in increased expression of PLPPR5 mRNA CTD PMID:30307764 NCBI chr 2:205,525,466...205,737,892
Ensembl chr 2:205,458,176...205,717,599 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMAIP1 protein] CTD PMID:28949029 NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429 		JBrowse link
G Pmch pro-melanin-concentrating hormone increases expression EXP fenvalerate results in increased expression of PMCH mRNA CTD PMID:30307764 NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250 		JBrowse link
G Pml PML nuclear body scaffold affects methylation ISO fenvalerate affects the methylation of PML gene CTD PMID:23548413 NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971 		JBrowse link
G Pmm2 phosphomannomutase 2 increases expression EXP fenvalerate results in increased expression of PMM2 mRNA CTD PMID:30307764 NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098 		JBrowse link
G Pmp22 peripheral myelin protein 22 increases expression EXP fenvalerate results in increased expression of PMP22 mRNA CTD PMID:30307764 NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714 		JBrowse link
G Pnlip pancreatic lipase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PNLIP protein CTD PMID:34896426 NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654 		JBrowse link
G Pnn pinin, desmosome associated protein increases expression EXP fenvalerate results in increased expression of PNN mRNA CTD PMID:30307764 NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889 		JBrowse link
G Pnpla8 patatin-like phospholipase domain containing 8 increases expression EXP fenvalerate results in increased expression of PNPLA8 mRNA CTD PMID:30307764 NCBI chr 6:61,329,810...61,391,736
Ensembl chr 6:61,329,810...61,391,734 		JBrowse link
G Poc1a POC1 centriolar protein A increases expression EXP fenvalerate results in increased expression of POC1A mRNA CTD PMID:30307764 NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089 		JBrowse link
G Pofut2 protein O-fucosyltransferase 2 increases expression EXP fenvalerate results in increased expression of POFUT2 mRNA CTD PMID:30307764 NCBI chr20:11,367,073...11,377,788
Ensembl chr20:11,367,096...11,377,743 		JBrowse link
G Poln DNA polymerase nu increases expression EXP fenvalerate results in increased expression of POLN mRNA CTD PMID:30307764 NCBI chr14:76,579,983...76,752,460
Ensembl chr14:76,580,546...76,752,463 		JBrowse link
G Porcn porcupine O-acyltransferase increases expression EXP fenvalerate results in increased expression of PORCN mRNA CTD PMID:30307764 NCBI chr  X:14,285,864...14,298,481
Ensembl chr  X:14,285,871...14,298,481 		JBrowse link
G Postn periostin increases expression EXP fenvalerate results in increased expression of POSTN mRNA CTD PMID:30307764 NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099 		JBrowse link
G Pou1f1 POU class 1 homeobox 1 increases expression EXP fenvalerate results in increased expression of POU1F1 mRNA CTD PMID:30307764 NCBI chr11:3,316,818...3,334,804
Ensembl chr11:3,317,058...3,334,801 		JBrowse link
G Pou2af3 POU class 2 homeobox associating factor 3 increases expression EXP fenvalerate results in increased expression of POU2AF3 mRNA CTD PMID:30307764 NCBI chr 8:51,588,237...51,597,114
Ensembl chr 8:51,588,237...51,603,855 		JBrowse link
G Ppbp pro-platelet basic protein increases expression EXP fenvalerate results in increased expression of PPBP mRNA CTD PMID:30307764 NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130 		JBrowse link
G Ppfia2 PTPRF interacting protein alpha 2 increases expression EXP fenvalerate results in increased expression of PPFIA2 mRNA CTD PMID:30307764 NCBI chr 7:41,765,716...42,240,104
Ensembl chr 7:41,765,575...42,239,599 		JBrowse link
G Ppfia4 PTPRF interacting protein alpha 4 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of PPFIA4 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PPFIA4 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261 		JBrowse link
G Ppia peptidylprolyl isomerase A decreases expression EXP fenvalerate results in decreased expression of PPIA protein CTD PMID:33656234 NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601 		JBrowse link
G Ppig peptidylprolyl isomerase G increases expression
multiple interactions		 EXP fenvalerate results in increased expression of PPIG mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PPIG protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 3:54,484,023...54,512,929
Ensembl chr 3:54,484,023...54,512,926 		JBrowse link
G Ppp1cc protein phosphatase 1 catalytic subunit gamma increases expression EXP fenvalerate results in increased expression of PPP1CC protein CTD PMID:33656234 NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553 		JBrowse link
G Ppp1r1c protein phosphatase 1, regulatory (inhibitor) subunit 1C increases expression EXP fenvalerate results in increased expression of PPP1R1C mRNA CTD PMID:30307764 NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104 		JBrowse link
G Ppp1r36 protein phosphatase 1, regulatory subunit 36 increases expression EXP fenvalerate results in increased expression of PPP1R36 mRNA CTD PMID:30307764 NCBI chr 6:95,138,526...95,159,102
Ensembl chr 6:95,139,007...95,159,102 		JBrowse link
G Ppp1r3b protein phosphatase 1, regulatory subunit 3B increases expression EXP fenvalerate results in increased expression of PPP1R3B mRNA CTD PMID:30307764 NCBI chr16:56,830,011...56,842,395
Ensembl chr16:56,829,660...56,842,406 		JBrowse link
G Ppp3cc protein phosphatase 3 catalytic subunit gamma increases expression EXP fenvalerate results in increased expression of PPP3CC mRNA CTD PMID:30307764 NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832 		JBrowse link
G Ppp3r1 protein phosphatase 3, regulatory subunit B, alpha increases expression EXP fenvalerate results in increased expression of PPP3R1 mRNA CTD PMID:30307764 NCBI chr14:91,556,743...91,606,391
Ensembl chr14:91,604,121...91,606,907 		JBrowse link
G Prb3 proline-rich protein BstNI subfamily 3 increases expression EXP fenvalerate results in increased expression of PRB3 mRNA CTD PMID:30307764 NCBI chr 4:165,564,424...165,569,229
Ensembl chr 4:165,564,424...165,569,227 		JBrowse link
G Prdm2 PR/SET domain 2 increases expression EXP fenvalerate results in increased expression of PRDM2 mRNA CTD PMID:30307764 NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825 		JBrowse link
G Prex2 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 increases expression EXP fenvalerate results in increased expression of PREX2 mRNA CTD PMID:30307764 NCBI chr 5:7,937,692...8,253,112
Ensembl chr 5:7,942,573...8,253,068 		JBrowse link
G Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRKAR1B protein CTD PMID:34896426 NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942 		JBrowse link
G Prkcb protein kinase C, beta increases expression EXP fenvalerate results in increased expression of PRKCB mRNA CTD PMID:30307764 NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536 		JBrowse link
G Prkci protein kinase C, iota increases expression EXP fenvalerate results in increased expression of PRKCI mRNA CTD PMID:30307764 NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352 		JBrowse link
G Prkd1 protein kinase D1 increases expression EXP fenvalerate results in increased expression of PRKD1 mRNA CTD PMID:30307764 NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042 		JBrowse link
G Prkg2 protein kinase cGMP-dependent 2 increases expression EXP fenvalerate results in increased expression of PRKG2 mRNA CTD PMID:30307764 NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888 		JBrowse link
G Prkx protein kinase cAMP-dependent X-linked catalytic subunit increases expression EXP fenvalerate results in increased expression of PRKX mRNA CTD PMID:30307764 NCBI chr  X:41,823,349...41,866,844
Ensembl chr  X:41,823,355...41,866,669 		JBrowse link
G Prl prolactin multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRL protein CTD PMID:34896426 NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062 		JBrowse link
G Prl8a3 prolactin family 8, subfamily A, member 3 increases expression EXP fenvalerate results in increased expression of PRL8A3 mRNA CTD PMID:30307764 NCBI chr17:37,508,328...37,514,832
Ensembl chr17:37,508,328...37,514,825 		JBrowse link
G Prm1 protamine 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of PRM1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM1 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr10:4,871,817...4,872,312 JBrowse link
G Prm2 protamine 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA CTD PMID:33396045 PMID:34896426 NCBI chr10:4,876,285...4,877,026
Ensembl chr10:4,873,372...4,877,026 		JBrowse link
G Prm3 protamine 3 increases expression EXP fenvalerate results in increased expression of PRM3 mRNA CTD PMID:30307764 NCBI chr10:4,877,471...4,877,985
Ensembl chr10:4,877,471...4,877,985 		JBrowse link
G Prp2l1 proline rich protein 2-like 1 increases expression EXP fenvalerate results in increased expression of PRP2L1 mRNA CTD PMID:30307764 NCBI chr10:88,462,262...88,540,642
Ensembl chr10:88,462,289...88,523,061 		JBrowse link
G Prpf38b pre-mRNA processing factor 38B increases expression EXP fenvalerate results in increased expression of PRPF38B mRNA CTD PMID:30307764 NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250 		JBrowse link
G Prps2 phosphoribosyl pyrophosphate synthetase 2 increases expression EXP fenvalerate results in increased expression of PRPS2 mRNA CTD PMID:30307764 NCBI chr  X:26,975,915...27,013,184
Ensembl chr  X:26,976,061...27,013,181 		JBrowse link
G Prr27 proline rich 27 increases expression EXP fenvalerate results in increased expression of PRR27 mRNA CTD PMID:30307764 NCBI chr14:20,232,757...20,248,617
Ensembl chr14:20,232,758...20,248,595 		JBrowse link
G Prr36 proline rich 36 increases expression EXP fenvalerate results in increased expression of PRR36 mRNA CTD PMID:30307764 NCBI chr12:2,560,533...2,567,766
Ensembl chr12:2,560,536...2,567,742 		JBrowse link
G Prrc2b proline-rich coiled-coil 2B increases expression EXP fenvalerate results in increased expression of PRRC2B mRNA CTD PMID:30307764 NCBI chr 3:15,433,357...15,519,105
Ensembl chr 3:15,465,294...15,519,104 		JBrowse link
G Prrt1 proline-rich transmembrane protein 1 increases expression EXP fenvalerate results in increased expression of PRRT1 mRNA CTD PMID:30307764 NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600 		JBrowse link
G Prrt3 proline-rich transmembrane protein 3 increases expression EXP fenvalerate results in increased expression of PRRT3 mRNA CTD PMID:30307764 NCBI chr 4:146,641,173...146,650,487
Ensembl chr 4:146,641,173...146,650,317 		JBrowse link
G Prss21 serine protease 21 increases expression EXP fenvalerate results in increased expression of PRSS21 mRNA CTD PMID:30307764 NCBI chr10:12,899,820...12,905,612
Ensembl chr10:12,900,535...12,905,618 		JBrowse link
G Prss22 serine protease 22 increases expression EXP fenvalerate results in increased expression of PRSS22 mRNA CTD PMID:30307764 NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863 		JBrowse link
G Prss36 serine protease 36 increases expression EXP fenvalerate results in increased expression of PRSS36 mRNA CTD PMID:30307764 NCBI chr 1:182,543,085...182,561,141
Ensembl chr 1:182,543,085...182,559,280 		JBrowse link
G Prss37 serine protease 37 decreases expression EXP fenvalerate results in decreased expression of PRSS37 mRNA CTD PMID:30307764 NCBI chr 4:69,322,977...69,334,555
Ensembl chr 4:69,322,977...69,334,555 		JBrowse link
G Psgb1 pregnancy-specific beta 1-glycoprotein increases expression EXP fenvalerate results in increased expression of PSGB1 mRNA CTD PMID:30307764 NCBI chr 1:77,923,170...77,932,605
Ensembl chr 1:77,923,170...77,932,053 		JBrowse link
G Psip1 PC4 and SRSF1 interacting protein 1 increases expression EXP fenvalerate results in increased expression of PSIP1 mRNA CTD PMID:30307764 NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 decreases expression EXP fenvalerate results in decreased expression of PSMA2 protein CTD PMID:33656234 NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938 		JBrowse link
G Psmb1 proteasome 20S subunit beta 1 decreases expression EXP fenvalerate results in decreased expression of PSMB1 protein CTD PMID:33656234 NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560 		JBrowse link
G Psmb5 proteasome 20S subunit beta 5 decreases expression EXP fenvalerate results in decreased expression of PSMB5 protein CTD PMID:33656234 NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440 		JBrowse link
G Psmc4 proteasome 26S subunit, ATPase 4 increases expression EXP fenvalerate results in increased expression of PSMC4 protein CTD PMID:33656234 NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494 		JBrowse link
G Psmd2 proteasome 26S subunit ubiquitin receptor, non-ATPase 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein CTD PMID:34896426 NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043 		JBrowse link
G Ptafr platelet-activating factor receptor increases expression EXP fenvalerate results in increased expression of PTAFR mRNA CTD PMID:30307764 NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251 		JBrowse link
G Ptdss2 phosphatidylserine synthase 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTDSS2 protein CTD PMID:34896426 NCBI chr 1:196,241,439...196,267,632
Ensembl chr 1:196,241,494...196,267,685 		JBrowse link
G Ptgfrn prostaglandin F2 receptor inhibitor affects methylation ISO fenvalerate affects the methylation of PTGFRN gene CTD PMID:23548413 NCBI chr 2:188,469,521...188,544,795
Ensembl chr 2:188,469,521...188,544,795 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PTGS1 protein CTD PMID:34896426 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586 		JBrowse link
G Pth1r parathyroid hormone 1 receptor increases expression EXP fenvalerate results in increased expression of PTH1R mRNA CTD PMID:30307764 NCBI chr 8:110,693,910...110,725,458
Ensembl chr 8:110,697,485...110,719,729 		JBrowse link
G Ptk2b protein tyrosine kinase 2 beta increases expression EXP fenvalerate results in increased expression of PTK2B mRNA CTD PMID:30307764 NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282 		JBrowse link
G Ptk7 protein tyrosine kinase 7 increases expression EXP fenvalerate results in increased expression of PTK7 mRNA CTD PMID:30307764 NCBI chr 9:14,352,155...14,418,473
Ensembl chr 9:14,351,202...14,418,494 		JBrowse link
G Ptp4a3 protein tyrosine phosphatase 4A3 increases expression EXP fenvalerate results in increased expression of PTP4A3 mRNA CTD PMID:30307764 NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919 		JBrowse link
G Ptpn5 protein tyrosine phosphatase, non-receptor type 5 increases expression EXP fenvalerate results in increased expression of PTPN5 mRNA CTD PMID:30307764 NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882 		JBrowse link
G Ptprk protein tyrosine phosphatase, receptor type, K increases expression EXP fenvalerate results in increased expression of PTPRK mRNA CTD PMID:30307764 NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605 		JBrowse link
G Ptprs protein tyrosine phosphatase, receptor type, S multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTPRS protein CTD PMID:34896426 NCBI chr 9:1,245,408...1,307,015
Ensembl chr 9:1,245,410...1,306,947 		JBrowse link
G Ptprz1 protein tyrosine phosphatase, receptor type Z1 increases expression EXP fenvalerate results in increased expression of PTPRZ1 mRNA CTD PMID:30307764 NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218 		JBrowse link
G Purg purine-rich element binding protein G increases expression EXP fenvalerate results in increased expression of PURG mRNA CTD PMID:30307764 NCBI chr16:58,732,327...58,763,356
Ensembl chr16:58,720,335...58,763,359 		JBrowse link
G Pus10 pseudouridine synthase 10 increases expression EXP fenvalerate results in increased expression of PUS10 mRNA CTD PMID:30307764 NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046 		JBrowse link
G Pus3 pseudouridine synthase 3 increases expression EXP fenvalerate results in increased expression of PUS3 mRNA CTD PMID:30307764 NCBI chr 8:33,910,461...33,918,716
Ensembl chr 8:33,911,357...33,918,714 		JBrowse link
G Pygm glycogen phosphorylase, muscle associated increases expression EXP fenvalerate results in increased expression of PYGM mRNA CTD PMID:30307764 NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368 		JBrowse link
G Pygo2 pygopus family PHD finger 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758 		JBrowse link
G Qrich2 glutamine rich 2 increases expression EXP fenvalerate results in increased expression of QRICH2 mRNA CTD PMID:30307764 NCBI chr10:101,669,240...101,697,643
Ensembl chr10:101,669,224...101,697,656 		JBrowse link
G Qsox1 quiescin sulfhydryl oxidase 1 increases expression EXP fenvalerate results in increased expression of QSOX1 mRNA CTD PMID:30307764 NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459 		JBrowse link
G Rab14 RAB14, member RAS oncogene family increases expression EXP fenvalerate results in increased expression of RAB14 mRNA CTD PMID:30307764 NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172 		JBrowse link
G Rab6b RAB6B, member RAS oncogene family increases expression EXP fenvalerate results in increased expression of RAB6B mRNA CTD PMID:30307764 NCBI chr 8:103,695,328...103,764,023
Ensembl chr 8:103,695,631...103,805,732 		JBrowse link
G Rab7b Rab7b, member RAS oncogene family increases expression EXP fenvalerate results in increased expression of RAB7B mRNA CTD PMID:30307764 NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581 		JBrowse link
G Rabep2 rabaptin, RAB GTPase binding effector protein 2 decreases expression EXP fenvalerate results in decreased expression of RABEP2 mRNA CTD PMID:30307764 NCBI chr 1:181,010,305...181,026,651
Ensembl chr 1:181,010,305...181,026,648 		JBrowse link
G Rabgap1 RAB GTPase activating protein 1 increases expression EXP fenvalerate results in increased expression of RABGAP1 mRNA CTD PMID:30307764 NCBI chr 3:21,208,012...21,326,013
Ensembl chr 3:21,208,055...21,326,013 		JBrowse link
G Rabl6 RAB, member RAS oncogene family-like 6 increases expression EXP fenvalerate results in increased expression of RABL6 mRNA CTD PMID:30307764 NCBI chr 3:8,402,666...8,428,588
Ensembl chr 3:8,402,672...8,428,611 		JBrowse link
G Rad50 RAD50 double strand break repair protein increases expression EXP fenvalerate results in increased expression of RAD50 mRNA CTD PMID:30307764 NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396 		JBrowse link
G Rae1 ribonucleic acid export 1 increases expression EXP fenvalerate results in increased expression of RAE1 mRNA CTD PMID:30307764 NCBI chr 3:161,779,096...161,794,048
Ensembl chr 3:161,779,088...161,794,038 		JBrowse link
G Ralgapa1 Ral GTPase activating protein catalytic subunit alpha 1 increases expression EXP fenvalerate results in increased expression of RALGAPA1 mRNA CTD PMID:30307764 NCBI chr 6:72,977,432...73,252,378
Ensembl chr 6:72,977,432...73,252,378 		JBrowse link
G Rap1gap2 RAP1 GTPase activating protein 2 increases expression EXP fenvalerate results in increased expression of RAP1GAP2 mRNA CTD PMID:30307764 NCBI chr10:59,255,400...59,472,536
Ensembl chr10:59,255,278...59,472,170 		JBrowse link
G Rap1gds1 Rap1 GTPase-GDP dissociation stimulator 1 increases expression EXP fenvalerate results in increased expression of RAP1GDS1 mRNA CTD PMID:30307764 NCBI chr 2:227,500,366...227,645,213
Ensembl chr 2:227,500,367...227,645,169 		JBrowse link
G Rapgef2 Rap guanine nucleotide exchange factor 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein CTD PMID:34896426 NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247 		JBrowse link
G Raph1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 increases expression EXP fenvalerate results in increased expression of RAPH1 mRNA CTD PMID:30307764 NCBI chr 9:61,907,476...61,990,170
Ensembl chr 9:61,907,758...61,961,209 		JBrowse link
G Rapsn receptor-associated protein of the synapse increases expression EXP fenvalerate results in increased expression of RAPSN mRNA CTD PMID:30307764 NCBI chr 3:77,015,073...77,024,378
Ensembl chr 3:76,983,471...77,024,373 		JBrowse link
G Rasa2 RAS p21 protein activator 2 increases expression EXP fenvalerate results in increased expression of RASA2 mRNA CTD PMID:30307764 NCBI chr 8:97,119,983...97,236,687
Ensembl chr 8:97,118,802...97,236,671 		JBrowse link
G Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 increases expression EXP fenvalerate results in increased expression of RASGRF1 mRNA CTD PMID:30307764 NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269 		JBrowse link
G Rasl11b RAS-like family 11 member B decreases expression EXP fenvalerate results in decreased expression of RASL11B mRNA CTD PMID:30307764 NCBI chr14:34,014,924...34,019,146
Ensembl chr14:34,014,509...34,019,152 		JBrowse link
G RatNP-3b defensin RatNP-3 precursor increases expression EXP fenvalerate results in increased expression of RATNP-3B mRNA CTD PMID:30307764 NCBI chr16:70,544,364...70,546,533
Ensembl chr16:70,513,888...70,546,522 		JBrowse link
G Rax retina and anterior neural fold homeobox increases expression EXP fenvalerate results in increased expression of RAX mRNA CTD PMID:30307764 NCBI chr18:59,463,347...59,467,469
Ensembl chr18:59,463,737...59,467,431 		JBrowse link
G Rbbp9 RB binding protein 9, serine hydrolase increases expression EXP fenvalerate results in increased expression of RBBP9 mRNA CTD PMID:30307764 NCBI chr 3:131,925,095...131,939,042
Ensembl chr 3:131,925,341...131,932,156 		JBrowse link
G Rbck1 RANBP2-type and C3HC4-type zinc finger containing 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of RBCK1 protein CTD PMID:34896426 NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005 		JBrowse link
G Rbfox3 RNA binding fox-1 homolog 3 increases expression EXP fenvalerate results in increased expression of RBFOX3 mRNA CTD PMID:30307764 NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935 		JBrowse link
G Rbm17 RNA binding motif protein 17 increases expression EXP fenvalerate results in increased expression of RBM17 mRNA CTD PMID:30307764 NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014 		JBrowse link
G Rbm18 RNA binding motif protein 18 increases expression EXP fenvalerate results in increased expression of RBM18 mRNA CTD PMID:30307764 NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178 		JBrowse link
G Rbm19 RNA binding motif protein 19 decreases expression EXP fenvalerate results in decreased expression of RBM19 mRNA CTD PMID:30307764 NCBI chr12:36,365,775...36,451,033
Ensembl chr12:36,365,772...36,450,993 		JBrowse link
G Rbm20 RNA binding motif protein 20 increases expression EXP fenvalerate results in increased expression of RBM20 mRNA CTD PMID:30307764 NCBI chr 1:252,683,760...252,907,465
Ensembl chr 1:252,683,771...252,886,060 		JBrowse link
G Rbm7 RNA binding motif protein 7 increases expression EXP fenvalerate results in increased expression of RBM7 mRNA CTD PMID:30307764 NCBI chr 8:48,831,894...48,838,399
Ensembl chr 8:48,831,894...48,838,411 		JBrowse link
G Rbp2 retinol binding protein 2 increases expression EXP fenvalerate results in increased expression of RBP2 mRNA CTD PMID:30307764 NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region increases expression EXP fenvalerate results in increased expression of RBPJ mRNA CTD PMID:30307764 NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353 		JBrowse link
G Rcbtb2 RCC1 and BTB domain containing protein 2 increases expression EXP fenvalerate results in increased expression of RCBTB2 mRNA CTD PMID:30307764 NCBI chr15:48,319,809...48,364,441
Ensembl chr15:48,323,866...48,383,750 		JBrowse link
G Rd3l RD3 like increases expression EXP fenvalerate results in increased expression of RD3L mRNA CTD PMID:30307764 NCBI chr 6:131,042,274...131,044,178
Ensembl chr 6:131,042,185...131,044,163 		JBrowse link
G Rdh14 retinol dehydrogenase 14 decreases expression EXP fenvalerate results in decreased expression of RDH14 protein CTD PMID:33656234 NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712 		JBrowse link
G Reck reversion-inducing-cysteine-rich protein with kazal motifs decreases expression EXP fenvalerate results in decreased expression of RECK mRNA CTD PMID:30307764 NCBI chr 5:58,102,961...58,169,516
Ensembl chr 5:58,102,981...58,169,502 		JBrowse link
G Recql RecQ like helicase multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RECQL protein CTD PMID:34896426 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945 		JBrowse link
G Reep1 receptor accessory protein 1 increases expression EXP fenvalerate results in increased expression of REEP1 mRNA CTD PMID:30307764 NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338 		JBrowse link
G Reep2 receptor accessory protein 2 increases expression EXP fenvalerate results in increased expression of REEP2 mRNA CTD PMID:30307764 NCBI chr18:26,438,130...26,447,165
Ensembl chr18:26,438,346...26,447,161 		JBrowse link
G Rem1 RRAD and GEM like GTPase 1 increases expression EXP fenvalerate results in increased expression of REM1 mRNA CTD PMID:30307764 NCBI chr 3:141,103,722...141,112,206
Ensembl chr 3:141,103,766...141,112,203 		JBrowse link
G Repin1 replication initiator 1 increases expression EXP fenvalerate results in increased expression of REPIN1 mRNA CTD PMID:30307764 NCBI chr 4:77,548,724...77,554,242
Ensembl chr 4:77,548,849...77,554,257 		JBrowse link
G Retreg3 reticulophagy regulator family member 3 increases expression EXP fenvalerate results in increased expression of RETREG3 mRNA CTD PMID:30307764 NCBI chr10:86,028,767...86,052,575
Ensembl chr10:86,028,774...86,052,692 		JBrowse link
G Rexo1 RNA exonuclease 1 homolog increases expression EXP fenvalerate results in increased expression of REXO1 mRNA CTD PMID:30307764 NCBI chr 7:9,154,050...9,174,035
Ensembl chr 7:9,154,061...9,173,454 		JBrowse link
G Rexo5 RNA exonuclease 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein CTD PMID:34896426 NCBI chr 1:174,168,633...174,264,526
Ensembl chr 1:174,168,694...174,241,486 		JBrowse link
G Rfc1 replication factor C subunit 1 decreases expression EXP fenvalerate results in decreased expression of RFC1 mRNA CTD PMID:30307764 NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370 		JBrowse link
G Rfx3 regulatory factor X3 increases expression EXP fenvalerate results in increased expression of RFX3 mRNA CTD PMID:30307764 NCBI chr 1:225,449,872...225,709,622
Ensembl chr 1:225,456,187...225,709,402 		JBrowse link
G Rfx7 regulatory factor X, 7 increases expression EXP fenvalerate results in increased expression of RFX7 mRNA CTD PMID:30307764 NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209 		JBrowse link
G RGD1565959 RGD1565959 increases expression EXP fenvalerate results in increased expression of RGD1565959 mRNA CTD PMID:30307764 NCBI chr 9:12,873,697...12,886,364
Ensembl chr 9:12,873,697...12,886,364 		JBrowse link
G Rgs22 regulator of G-protein signaling 22 increases expression EXP fenvalerate results in increased expression of RGS22 mRNA CTD PMID:30307764 NCBI chr 7:67,188,531...67,308,805
Ensembl chr 7:67,188,519...67,308,875 		JBrowse link
G Rgs8 regulator of G-protein signaling 8 increases expression EXP fenvalerate results in increased expression of RGS8 mRNA CTD PMID:30307764 NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807 		JBrowse link
G Rhag Rh-associated glycoprotein increases expression EXP fenvalerate results in increased expression of RHAG mRNA CTD PMID:30307764 NCBI chr 9:20,069,800...20,097,836
Ensembl chr 9:20,069,807...20,097,836 		JBrowse link
G Rhbdf1 rhomboid 5 homolog 1 decreases expression EXP fenvalerate results in decreased expression of RHBDF1 mRNA CTD PMID:30307764 NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763 		JBrowse link
G Riiad1 regulatory subunit of type II PKA R-subunit domain containing 1 increases expression EXP fenvalerate results in increased expression of RIIAD1 mRNA CTD PMID:30307764 NCBI chr 2:182,099,924...182,110,544
Ensembl chr 2:182,101,795...182,110,319 		JBrowse link
G Rimbp2 RIMS binding protein 2 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of RIMBP2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIMBP2 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr12:27,747,615...27,946,256
Ensembl chr12:27,747,980...27,956,763 		JBrowse link
G Rims2 regulating synaptic membrane exocytosis 2 increases expression EXP fenvalerate results in increased expression of RIMS2 mRNA CTD PMID:30307764 NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491 		JBrowse link
G Ring1 ring finger protein 1 decreases expression EXP fenvalerate results in decreased expression of RING1 mRNA CTD PMID:30307764 NCBI chr20:4,830,120...4,833,623
Ensembl chr20:4,830,053...4,833,620 		JBrowse link
G Ripor2 RHO family interacting cell polarization regulator 2 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of RIPOR2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092 		JBrowse link
G Ripply3 ripply transcriptional repressor 3 increases expression EXP fenvalerate results in increased expression of RIPPLY3 mRNA CTD PMID:30307764 NCBI chr11:33,648,471...33,656,587
Ensembl chr11:33,648,486...33,656,584 		JBrowse link
G Rlig1 RNA 5'-phosphate and 3'-OH ligase 1 increases expression EXP fenvalerate results in increased expression of RLIG1 mRNA CTD PMID:30307764 NCBI chr 7:35,396,876...35,408,633
Ensembl chr 7:35,397,995...35,409,600 		JBrowse link
G Rln1 relaxin 1 increases expression EXP fenvalerate results in increased expression of RLN1 mRNA CTD PMID:30307764 NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:227,079,966...227,082,882 		JBrowse link
G Rln3 relaxin 3 increases expression EXP fenvalerate results in increased expression of RLN3 mRNA CTD PMID:30307764 NCBI chr19:24,107,401...24,109,432
Ensembl chr19:24,107,401...24,109,886 		JBrowse link
G Rnase1l2 ribonuclease, RNase A family, 1-like 2 increases expression EXP fenvalerate results in increased expression of RNASE1L2 mRNA CTD PMID:30307764 NCBI chr15:24,421,825...24,423,513
Ensembl chr15:24,421,859...24,423,611 		JBrowse link
G Rnase2 ribonuclease A family member 2 increases expression EXP fenvalerate results in increased expression of RNASE2 mRNA CTD PMID:30307764 NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479 		JBrowse link
G Rnd1 Rho family GTPase 1 increases expression EXP fenvalerate results in increased expression of RND1 mRNA CTD PMID:30307764 NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399 		JBrowse link
G Rnf157 ring finger protein 157 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF157 protein CTD PMID:34896426 NCBI chr10:101,571,972...101,639,874
Ensembl chr10:101,566,295...101,639,942 		JBrowse link
G Rnf182 ring finger protein 182 increases expression EXP fenvalerate results in increased expression of RNF182 mRNA CTD PMID:30307764 NCBI chr17:21,026,110...21,081,760
Ensembl chr17:21,030,214...21,094,911 		JBrowse link
G Rnf2 ring finger protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein CTD PMID:34896426 NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099 		JBrowse link
G Rnf20 ring finger protein 20 increases expression EXP fenvalerate results in increased expression of RNF20 mRNA CTD PMID:30307764 NCBI chr 5:63,976,063...64,001,754
Ensembl chr 5:63,976,045...64,001,754 		JBrowse link
G Rnf207 ring finger protein 207 increases expression EXP fenvalerate results in increased expression of RNF207 mRNA CTD PMID:30307764 NCBI chr 5:162,815,351...162,828,325
Ensembl chr 5:162,815,357...162,828,375 		JBrowse link
G Rnf213 ring finger protein 213 increases expression EXP fenvalerate results in increased expression of RNF213 mRNA CTD PMID:30307764 NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918 		JBrowse link
G Rnf227 ring finger protein 227 increases expression EXP fenvalerate results in increased expression of RNF227 mRNA CTD PMID:30307764 NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010 		JBrowse link
G Rnf31 ring finger protein 31 increases expression EXP fenvalerate results in increased expression of RNF31 mRNA CTD PMID:30307764 NCBI chr15:29,083,047...29,095,328
Ensembl chr15:29,083,631...29,101,915 		JBrowse link
G Rnf8 ring finger protein 8 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF8 protein CTD PMID:34896426 NCBI chr20:7,682,258...7,710,448
Ensembl chr20:7,682,322...7,708,491 		JBrowse link
G Rnpc3 RNA-binding region (RNP1, RRM) containing 3 increases expression EXP fenvalerate results in increased expression of RNPC3 mRNA CTD PMID:30307764 NCBI chr 2:201,432,769...201,457,015
Ensembl chr 2:201,432,684...201,456,747 		JBrowse link
G Ropn1 rhophilin associated tail protein 1 decreases expression EXP fenvalerate results in decreased expression of ROPN1 protein CTD PMID:33656234 NCBI chr11:66,097,854...66,127,148
Ensembl chr11:66,097,856...66,127,148 		JBrowse link
G Ropn1l rhophilin associated tail protein 1-like increases expression EXP fenvalerate results in increased expression of ROPN1L mRNA CTD PMID:30307764 NCBI chr 2:82,442,645...82,453,332
Ensembl chr 2:82,441,891...82,453,485 		JBrowse link
G Rpia ribose 5-phosphate isomerase A increases expression EXP fenvalerate results in increased expression of RPIA mRNA CTD PMID:30307764 NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355 		JBrowse link
G Rpl39 ribosomal protein L39 increases expression EXP fenvalerate results in increased expression of RPL39 mRNA CTD PMID:30307764 NCBI chr  X:116,327,216...116,330,211
Ensembl chr18:6,326,330...6,326,692
Ensembl chr  X:6,326,330...6,326,692 		JBrowse link
G Rps4x-ps1 ribosomal protein S4, X-linked, pseudogene 1 increases expression EXP fenvalerate results in increased expression of RPS4X-PS1 mRNA CTD PMID:30307764 NCBI chr 1:231,210,277...231,211,564 JBrowse link
G Rps6ka5 ribosomal protein S6 kinase A5 decreases expression EXP fenvalerate results in decreased expression of RPS6KA5 mRNA CTD PMID:30307764 NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224 		JBrowse link
G Rpusd1 RNA pseudouridine synthase domain containing 1 increases expression EXP fenvalerate results in increased expression of RPUSD1 mRNA CTD PMID:30307764 NCBI chr10:14,751,310...14,755,213
Ensembl chr10:14,751,384...14,755,207 		JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator increases expression EXP fenvalerate results in increased expression of RRAD mRNA CTD PMID:30307764 NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417 		JBrowse link
G Rragd Ras-related GTP binding D increases expression EXP fenvalerate results in increased expression of RRAGD mRNA CTD PMID:30307764 NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356 		JBrowse link
G Rrm1 ribonucleotide reductase catalytic subunit M1 decreases expression EXP fenvalerate results in decreased expression of RRM1 mRNA CTD PMID:30307764 NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261 		JBrowse link
G RT1-N3 RT1 class Ib, locus N3 increases expression EXP fenvalerate results in increased expression of RT1-N3 mRNA CTD PMID:30307764 NCBI chr20:2,659,132...2,665,536
Ensembl chr20:2,661,584...2,665,530 		JBrowse link
G Rtel1 regulator of telomere elongation helicase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RTEL1 protein CTD PMID:34896426 NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348 		JBrowse link
G Runx1t1 RUNX1 partner transcriptional co-repressor 1 increases expression EXP fenvalerate results in increased expression of RUNX1T1 mRNA CTD PMID:30307764 NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592 		JBrowse link
G Rxra retinoid X receptor alpha increases activity ISO fenvalerate results in increased activity of RXRA protein CTD PMID:20143881 NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712 		JBrowse link
G Rxrg retinoid X receptor gamma affects binding ISO fenvalerate binds to RXRG protein CTD PMID:32278787 NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167 		JBrowse link
G Ryr1 ryanodine receptor 1 decreases expression ISO fenvalerate results in decreased expression of RYR1 mRNA CTD PMID:19428952 NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812 		JBrowse link
G Ryr2 ryanodine receptor 2 increases expression EXP fenvalerate results in increased expression of RYR2 mRNA CTD PMID:30307764 NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142 		JBrowse link
G S100a3 S100 calcium binding protein A3 increases expression EXP fenvalerate results in increased expression of S100A3 mRNA CTD PMID:30307764 NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702 		JBrowse link
G S100vp S100 calcium-binding protein, ventral prostate increases expression EXP fenvalerate results in increased expression of S100VP mRNA CTD PMID:30307764 NCBI chr 2:176,748,273...176,751,624
Ensembl chr 2:176,748,273...176,751,624 		JBrowse link
G S1pr5 sphingosine-1-phosphate receptor 5 increases expression EXP fenvalerate results in increased expression of S1PR5 mRNA CTD PMID:30307764 NCBI chr 8:19,786,676...19,791,862
Ensembl chr 8:19,786,663...19,791,795 		JBrowse link
G Samd9 sterile alpha motif domain containing 9 increases expression EXP fenvalerate results in increased expression of SAMD9 mRNA CTD PMID:30307764 NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322 		JBrowse link
G Sars2 seryl-tRNA synthetase 2, mitochondrial decreases expression EXP fenvalerate results in decreased expression of SARS2 mRNA CTD PMID:30307764 NCBI chr 1:84,028,972...84,040,725
Ensembl chr 1:84,028,986...84,040,725 		JBrowse link
G Sart1 spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SART1 protein CTD PMID:34896426 NCBI chr 1:202,690,472...202,699,136
Ensembl chr 1:202,690,459...202,699,136 		JBrowse link
G Sash3 SAM and SH3 domain containing 3 increases expression EXP fenvalerate results in increased expression of SASH3 mRNA CTD PMID:30307764 NCBI chr  X:127,326,815...127,341,521
Ensembl chr  X:127,326,859...127,341,519 		JBrowse link
G Scaf1 SR-related CTD-associated factor 1 decreases expression EXP fenvalerate results in decreased expression of SCAF1 mRNA CTD PMID:30307764 NCBI chr 1:95,485,448...95,499,389
Ensembl chr 1:95,485,448...95,496,029 		JBrowse link
G Scamp5 secretory carrier membrane protein 5 decreases expression EXP fenvalerate results in decreased expression of SCAMP5 mRNA CTD PMID:30307764 NCBI chr 8:57,845,831...57,884,516
Ensembl chr 8:57,846,659...57,872,027 		JBrowse link
G Scap SREBF chaperone increases expression EXP fenvalerate results in increased expression of SCAP mRNA CTD PMID:30307764 NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666 		JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of SCARB1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647 		JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 increases expression EXP fenvalerate results in increased expression of SCD2 mRNA CTD PMID:30307764 NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232 		JBrowse link
G Scel sciellin increases expression EXP fenvalerate results in increased expression of SCEL mRNA CTD PMID:30307764 NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372 		JBrowse link
G Scg2 secretogranin II multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCG2 protein CTD PMID:34896426 NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097 		JBrowse link
G Scg5 secretogranin V increases expression EXP fenvalerate results in increased expression of SCG5 mRNA CTD PMID:30307764 NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463 		JBrowse link
G Scgb1a1 secretoglobin family 1A member 1 increases expression EXP fenvalerate results in increased expression of SCGB1A1 mRNA CTD PMID:30307764 NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610 		JBrowse link
G Scgb1d2 secretoglobin, family 1D, member 2 increases expression EXP fenvalerate results in increased expression of SCGB1D2 mRNA CTD PMID:30307764 NCBI chr 1:206,228,546...206,233,587
Ensembl chr 1:206,228,778...206,231,785 		JBrowse link
G Scn10a sodium voltage-gated channel alpha subunit 10 multiple interactions EXP fenvalerate affects the reaction [SCN10A protein results in increased transport of Sodium] CTD PMID:16051293 NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614 		JBrowse link
G Scn11a sodium voltage-gated channel alpha subunit 11 increases expression EXP fenvalerate results in increased expression of SCN11A mRNA CTD PMID:30307764 NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044 		JBrowse link
G Scn1b sodium voltage-gated channel beta subunit 1 multiple interactions EXP fenvalerate affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 1:86,353,917...86,363,820
Ensembl chr 1:86,353,917...86,363,739 		JBrowse link
G Scn2a sodium voltage-gated channel alpha subunit 2 multiple interactions EXP fenvalerate affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 3:50,302,781...50,437,504
Ensembl chr 3:50,302,877...50,437,214 		JBrowse link
G Scn2b sodium voltage-gated channel beta subunit 2 increases expression EXP fenvalerate results in increased expression of SCN2B mRNA CTD PMID:30307764 NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765 		JBrowse link
G Scn3a sodium voltage-gated channel alpha subunit 3 multiple interactions EXP fenvalerate affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 3:50,146,411...50,258,119
Ensembl chr 3:50,148,139...50,258,119 		JBrowse link
G Scn3b sodium voltage-gated channel beta subunit 3 multiple interactions EXP fenvalerate affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868 		JBrowse link
G Scn4b sodium voltage-gated channel beta subunit 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCN4B protein CTD PMID:34896426 NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCNN1A protein CTD PMID:34896426 NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181 		JBrowse link
G Scx scleraxis bHLH transcription factor decreases expression EXP fenvalerate results in decreased expression of SCX mRNA CTD PMID:30307764 NCBI chr 7:108,176,608...108,178,626
Ensembl chr 7:108,176,608...108,178,626 		JBrowse link
G Sdccag8 SHH signaling and ciliogenesis regulator SDCCAG8 increases expression EXP fenvalerate results in increased expression of SDCCAG8 mRNA CTD PMID:30307764 NCBI chr13:88,754,521...88,979,363
Ensembl chr13:88,754,626...89,097,111 		JBrowse link
G Sdr39u1 short chain dehydrogenase/reductase family 39U, member 1 increases expression EXP fenvalerate results in increased expression of SDR39U1 mRNA CTD PMID:30307764 NCBI chr15:29,378,156...29,380,989
Ensembl chr15:29,378,026...29,381,560 		JBrowse link
G Sec16b SEC16 homolog B, endoplasmic reticulum export factor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEC16B protein CTD PMID:34896426 NCBI chr13:69,665,757...69,727,199
Ensembl chr13:69,684,291...69,727,196 		JBrowse link
G Sel1l3 SEL1L family member 3 increases expression EXP fenvalerate results in increased expression of SEL1L3 mRNA CTD PMID:30307764 NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644 		JBrowse link
G Selp selectin P increases expression EXP fenvalerate results in increased expression of SELP mRNA CTD PMID:30307764 NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845 		JBrowse link
G Sema3g semaphorin 3G increases expression EXP fenvalerate results in increased expression of SEMA3G mRNA CTD PMID:30307764 NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221 		JBrowse link
G Sema5a semaphorin 5A increases expression EXP fenvalerate results in increased expression of SEMA5A mRNA CTD PMID:30307764 NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084 		JBrowse link
G Sema6c semaphorin 6C multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEMA6C protein CTD PMID:34896426 NCBI chr 2:182,733,635...182,750,066
Ensembl chr 2:182,737,474...182,746,856 		JBrowse link
G Septin5 septin 5 increases expression EXP fenvalerate results in increased expression of SEPTIN5 mRNA CTD PMID:30307764 NCBI chr11:82,373,601...82,379,393
Ensembl chr11:82,369,754...82,379,393 		JBrowse link
G Septin6 septin 6 increases expression EXP fenvalerate results in increased expression of SEPTIN6 mRNA CTD PMID:30307764 NCBI chr  X:116,153,255...116,230,334
Ensembl chr  X:116,153,255...116,230,115 		JBrowse link
G Serpina5 serpin family A member 5 increases expression EXP fenvalerate results in increased expression of SERPINA5 mRNA CTD PMID:30307764 NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407 		JBrowse link
G Serpinb11 serpin family B member 11 increases expression EXP fenvalerate results in increased expression of SERPINB11 mRNA CTD PMID:30307764 NCBI chr13:23,304,775...23,344,604
Ensembl chr13:23,304,456...23,344,604 		JBrowse link
G Serpinb3 serpin family B member 3 increases expression EXP fenvalerate results in increased expression of SERPINB3 mRNA CTD PMID:30307764 NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682 		JBrowse link
G Sertm1 serine-rich and transmembrane domain containing 1 increases expression EXP fenvalerate results in increased expression of SERTM1 mRNA CTD PMID:30307764 NCBI chr 2:139,086,905...139,106,528
Ensembl chr 2:139,086,908...139,106,459 		JBrowse link
G Setd1a SET domain containing 1A, histone lysine methyltransferase increases expression EXP fenvalerate results in increased expression of SETD1A mRNA CTD PMID:30307764 NCBI chr 1:182,386,197...182,411,695
Ensembl chr 1:182,388,060...182,411,090 		JBrowse link
G Sez6l seizure related 6 homolog like increases expression EXP fenvalerate results in increased expression of SEZ6L mRNA CTD PMID:30307764 NCBI chr12:44,064,901...44,221,814
Ensembl chr12:44,064,935...44,219,663 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 increases expression EXP fenvalerate results in increased expression of SFRP2 mRNA CTD PMID:30307764 NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063 		JBrowse link
G Sftpb surfactant protein B increases expression EXP fenvalerate results in increased expression of SFTPB mRNA CTD PMID:30307764 NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436 		JBrowse link
G Sgsm1 small G protein signaling modulator 1 increases expression EXP fenvalerate results in increased expression of SGSM1 mRNA CTD PMID:30307764 NCBI chr12:43,320,500...43,386,469
Ensembl chr12:43,321,256...43,386,457 		JBrowse link
G Sh3d21 SH3 domain containing 21 increases expression EXP fenvalerate results in increased expression of SH3D21 mRNA CTD PMID:30307764 NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407 		JBrowse link
G Shank1 SH3 and multiple ankyrin repeat domains 1 increases expression EXP fenvalerate results in increased expression of SHANK1 mRNA CTD PMID:30307764 NCBI chr 1:94,807,879...94,857,356
Ensembl chr 1:94,808,276...94,855,824 		JBrowse link
G Shank2 SH3 and multiple ankyrin repeat domains 2 decreases expression ISO fenvalerate results in decreased expression of SHANK2 mRNA CTD PMID:34748853 NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394 		JBrowse link
G Shbg sex hormone binding globulin affects binding ISO fenvalerate binds to SHBG protein CTD PMID:32278787 NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057 		JBrowse link
G Shisa7 shisa family member 7 increases expression EXP fenvalerate results in increased expression of SHISA7 mRNA CTD PMID:30307764 NCBI chr 1:68,993,900...69,012,943
Ensembl chr 1:68,994,025...69,012,943 		JBrowse link
G Shisa8 shisa family member 8 increases expression EXP fenvalerate results in increased expression of SHISA8 mRNA CTD PMID:30307764 NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858 		JBrowse link
G Shisal2b shisa like 2B increases expression EXP fenvalerate results in increased expression of SHISAL2B mRNA CTD PMID:30307764 NCBI chr 2:36,002,622...36,019,529
Ensembl chr 2:36,002,651...36,019,123 		JBrowse link
G Shprh SNF2 histone linker PHD RING helicase increases expression EXP fenvalerate results in increased expression of SHPRH mRNA CTD PMID:30307764 NCBI chr 1:5,528,827...5,602,537
Ensembl chr 1:5,528,888...5,602,527 		JBrowse link
G Shroom3 shroom family member 3 increases expression EXP fenvalerate results in increased expression of SHROOM3 mRNA CTD PMID:30307764 NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915 		JBrowse link
G Sidt2 SID1 transmembrane family, member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SIDT2 protein CTD PMID:34896426 NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700 		JBrowse link
G Sipa1l2 signal-induced proliferation-associated 1 like 2 increases expression EXP fenvalerate results in increased expression of SIPA1L2 mRNA CTD PMID:30307764 NCBI chr19:53,389,792...53,540,466
Ensembl chr19:53,389,805...53,540,428 		JBrowse link
G Sipa1l3 signal-induced proliferation-associated 1 like 3 increases expression EXP fenvalerate results in increased expression of SIPA1L3 mRNA CTD PMID:30307764 NCBI chr 1:84,618,714...84,825,956
Ensembl chr 1:84,618,719...84,703,802 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SIRT1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Sirt4 sirtuin 4 increases expression EXP fenvalerate results in increased expression of SIRT4 mRNA CTD PMID:30307764 NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439 		JBrowse link
G Six3 SIX homeobox 3 increases expression EXP fenvalerate results in increased expression of SIX3 mRNA CTD PMID:30307764 NCBI chr 6:9,039,017...9,043,336
Ensembl chr 6:9,036,434...9,053,301 		JBrowse link
G Six4 SIX homeobox 4 increases expression EXP fenvalerate results in increased expression of SIX4 mRNA CTD PMID:30307764 NCBI chr 6:91,802,328...91,816,002
Ensembl chr 6:91,802,329...91,815,992 		JBrowse link
G Six6 SIX homeobox 6 increases expression EXP fenvalerate results in increased expression of SIX6 mRNA CTD PMID:30307764 NCBI chr 6:91,634,568...91,639,548
Ensembl chr 6:91,634,568...91,639,548 		JBrowse link
G Slain1 SLAIN motif family, member 1 increases expression EXP fenvalerate results in increased expression of SLAIN1 mRNA CTD PMID:30307764 NCBI chr15:80,482,818...80,542,461
Ensembl chr15:80,482,367...80,542,350 		JBrowse link
G Slc12a1 solute carrier family 12 member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SLC12A1 protein CTD PMID:34896426 NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899 		JBrowse link
G Slc12a6 solute carrier family 12, member 6 increases expression EXP fenvalerate results in increased expression of SLC12A6 mRNA CTD PMID:30307764 NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258 		JBrowse link
G Slc12a8 solute carrier family 12, member 8 increases expression EXP fenvalerate results in increased expression of SLC12A8 mRNA CTD PMID:30307764 NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834 		JBrowse link
G Slc14a2 solute carrier family 14 member 2 increases expression EXP fenvalerate results in increased expression of SLC14A2 mRNA CTD PMID:30307764 NCBI chr18:71,612,460...72,039,462
Ensembl chr18:71,612,460...71,792,968 		JBrowse link
G Slc16a1 solute carrier family 16 member 1 increases expression EXP fenvalerate results in increased expression of SLC16A1 mRNA CTD PMID:30307764 NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611 		JBrowse link
G Slc16a13 solute carrier family 16, member 13 increases expression EXP fenvalerate results in increased expression of SLC16A13 mRNA CTD PMID:30307764 NCBI chr10:54,925,973...54,937,860
Ensembl chr10:54,926,760...54,937,788 		JBrowse link
G Slc16a8 solute carrier family 16 member 8 increases expression EXP fenvalerate results in increased expression of SLC16A8 mRNA CTD PMID:30307764 NCBI chr 7:110,818,274...110,822,069
Ensembl chr 7:110,818,274...110,822,069 		JBrowse link
G Slc17a7 solute carrier family 17 member 7 increases expression EXP fenvalerate results in increased expression of SLC17A7 mRNA CTD PMID:30307764 NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588 		JBrowse link
G Slc1a6 solute carrier family 1 member 6 increases expression EXP fenvalerate results in increased expression of SLC1A6 mRNA CTD PMID:30307764 NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:10,841,837...10,870,449 		JBrowse link
G Slc22a23 solute carrier family 22, member 23 increases expression EXP fenvalerate results in increased expression of SLC22A23 mRNA CTD PMID:30307764 NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790 		JBrowse link
G Slc24a3 solute carrier family 24 member 3 increases expression EXP fenvalerate results in increased expression of SLC24A3 mRNA CTD PMID:30307764 NCBI chr 3:132,552,119...133,051,192
Ensembl chr 3:132,551,595...133,051,192 		JBrowse link
G Slc24a4 solute carrier family 24 member 4 increases expression EXP fenvalerate results in increased expression of SLC24A4 mRNA CTD PMID:30307764 NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949 		JBrowse link
G Slc25a21 solute carrier family 25 member 21 decreases expression EXP fenvalerate results in decreased expression of SLC25A21 mRNA CTD PMID:30307764 NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680 		JBrowse link
G Slc26a3 solute carrier family 26 member 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC26A3 protein CTD PMID:34896426 NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772 		JBrowse link
G Slc30a9 solute carrier family 30 member 9 increases expression EXP fenvalerate results in increased expression of SLC30A9 mRNA CTD PMID:30307764 NCBI chr14:40,816,284...40,870,992
Ensembl chr14:40,816,290...40,870,929 		JBrowse link
G Slc32a1 solute carrier family 32 member 1 increases expression EXP fenvalerate results in increased expression of SLC32A1 mRNA CTD PMID:30307764 NCBI chr 3:147,267,373...147,271,842
Ensembl chr 3:147,267,373...147,271,844 		JBrowse link
G Slc35c2 solute carrier family 35 member C2 increases expression EXP fenvalerate results in increased expression of SLC35C2 mRNA CTD PMID:30307764 NCBI chr 3:154,012,262...154,023,549
Ensembl chr 3:154,012,416...154,023,488 		JBrowse link
G Slc36a3 solute carrier family 36, member 3 increases expression EXP fenvalerate results in increased expression of SLC36A3 mRNA CTD PMID:30307764 NCBI chr10:39,243,531...39,273,433
Ensembl chr10:39,243,595...39,270,567 		JBrowse link
G Slc38a1 solute carrier family 38, member 1 decreases expression
increases expression		 ISO
EXP		 fenvalerate results in decreased expression of SLC38A1 mRNA
fenvalerate results in increased expression of SLC38A1 mRNA		 CTD PMID:28369636 PMID:30307764 NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218 		JBrowse link
G Slc38a2 solute carrier family 38, member 2 decreases expression ISO fenvalerate results in decreased expression of SLC38A2 mRNA CTD PMID:28369636 NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436 		JBrowse link
G Slc38a5 solute carrier family 38, member 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC38A5 protein CTD PMID:34896426 NCBI chr  X:14,213,727...14,222,498
Ensembl chr  X:14,213,729...14,222,498 		JBrowse link
G Slc39a5 solute carrier family 39 member 5 increases expression EXP fenvalerate results in increased expression of SLC39A5 mRNA CTD PMID:30307764 NCBI chr 7:822,873...830,865
Ensembl chr 7:824,818...830,242 		JBrowse link
G Slc44a2 solute carrier family 44 member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC44A2 protein CTD PMID:34896426 NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342 		JBrowse link
G Slc45a1 solute carrier family 45, member 1 increases expression EXP fenvalerate results in increased expression of SLC45A1 mRNA CTD PMID:30307764 NCBI chr 5:161,105,137...161,129,375
Ensembl chr 5:161,105,235...161,129,303 		JBrowse link
G Slc45a3 solute carrier family 45, member 3 increases expression EXP fenvalerate results in increased expression of SLC45A3 mRNA CTD PMID:30307764 NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588 		JBrowse link
G Slc4a4 solute carrier family 4 member 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC4A4 protein CTD PMID:34896426 NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883 		JBrowse link
G Slc51a solute carrier family 51 member A increases expression EXP fenvalerate results in increased expression of SLC51A mRNA CTD PMID:30307764 NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485 		JBrowse link
G Slc52a2 solute carrier family 52 member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC52A2 protein CTD PMID:34896426 NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034 		JBrowse link
G Slc52a3 solute carrier family 52 member 3 increases expression EXP fenvalerate results in increased expression of SLC52A3 mRNA CTD PMID:30307764 NCBI chr 3:140,498,924...140,515,845
Ensembl chr 3:140,509,473...140,514,096 		JBrowse link
G Slc5a1 solute carrier family 5 member 1 increases expression EXP fenvalerate results in increased expression of SLC5A1 mRNA CTD PMID:30307764 NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547 		JBrowse link
G Slc66a3 solute carrier family 66 member 3 decreases expression EXP fenvalerate results in decreased expression of SLC66A3 mRNA CTD PMID:30307764 NCBI chr 6:39,774,801...39,786,554
Ensembl chr 6:39,774,808...39,786,303 		JBrowse link
G Slc7a1 solute carrier family 7 member 1 increases expression EXP fenvalerate results in increased expression of SLC7A1 mRNA CTD PMID:30307764 NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849 		JBrowse link
G Slc9a4 solute carrier family 9 member A4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC9A4 protein CTD PMID:34896426 NCBI chr 9:42,825,334...42,879,729
Ensembl chr 9:42,825,064...42,879,422 		JBrowse link
G Slc9a6 solute carrier family 9 member A6 increases expression EXP fenvalerate results in increased expression of SLC9A6 mRNA CTD PMID:30307764 NCBI chr  X:134,430,677...134,486,747
Ensembl chr  X:134,420,756...134,485,375 		JBrowse link
G Slco3a1 solute carrier organic anion transporter family, member 3a1 increases expression EXP fenvalerate results in increased expression of SLCO3A1 mRNA CTD PMID:30307764 NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925 		JBrowse link
G Slfn4 schlafen family member 4 increases expression EXP fenvalerate results in increased expression of SLFN4 mRNA CTD PMID:30307764 NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138
Ensembl chr10:68,000,028...68,018,138 		JBrowse link
G Slirp SRA stem-loop interacting RNA binding protein increases expression EXP fenvalerate results in increased expression of SLIRP mRNA CTD PMID:30307764 NCBI chr 6:107,088,760...107,097,791
Ensembl chr 6:107,088,403...107,097,791 		JBrowse link
G Slit1 slit guidance ligand 1 increases expression EXP fenvalerate results in increased expression of SLIT1 mRNA CTD PMID:30307764 NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127 		JBrowse link
G Slit2 slit guidance ligand 2 increases expression EXP fenvalerate results in increased expression of SLIT2 mRNA CTD PMID:30307764 NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948 		JBrowse link
G Slitrk3 SLIT and NTRK-like family, member 3 increases expression EXP fenvalerate results in increased expression of SLITRK3 mRNA CTD PMID:30307764 NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709 		JBrowse link
G Sln sarcolipin increases expression EXP fenvalerate results in increased expression of SLN mRNA CTD PMID:30307764 NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791 		JBrowse link
G Slurp2 secreted Ly6/Plaur domain containing 2 increases expression EXP fenvalerate results in increased expression of SLURP2 mRNA CTD PMID:30307764 NCBI chr 7:106,627,775...106,631,655
Ensembl chr 7:106,627,775...106,631,655 		JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 increases expression EXP fenvalerate results in increased expression of SMARCA4 mRNA CTD PMID:30307764 NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975 		JBrowse link
G Smarcad1 SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1` multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMARCAD1 protein CTD PMID:34896426 NCBI chr 4:94,311,441...94,379,184
Ensembl chr 4:94,311,489...94,372,563 		JBrowse link
G Smarcc2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 increases expression EXP fenvalerate results in increased expression of SMARCC2 mRNA CTD PMID:30307764 NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978 		JBrowse link
G Smc3 structural maintenance of chromosomes 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMC3 protein CTD PMID:34896426 NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522 		JBrowse link
G Smim29 small integral membrane protein 29 increases expression EXP fenvalerate results in increased expression of SMIM29 mRNA CTD PMID:30307764 NCBI chr20:5,618,845...5,620,856
Ensembl chr20:5,618,845...5,620,813 		JBrowse link
G Smpx small muscle protein, X-linked increases expression EXP fenvalerate results in increased expression of SMPX mRNA CTD PMID:30307764 NCBI chr  X:37,233,209...37,292,266
Ensembl chr  X:37,234,294...37,276,708 		JBrowse link
G Smr3b submaxillary gland androgen regulated protein 3B increases expression EXP fenvalerate results in increased expression of SMR3B mRNA CTD PMID:30307764 NCBI chr14:19,783,815...19,788,557
Ensembl chr14:19,783,816...19,788,492 		JBrowse link
G Snap29 synaptosome associated protein 29 increases expression EXP fenvalerate results in increased expression of SNAP29 mRNA CTD PMID:30307764 NCBI chr11:83,578,479...83,608,953
Ensembl chr11:83,578,489...83,608,958 		JBrowse link
G Snap91 synaptosome associated protein 91 increases expression EXP fenvalerate results in increased expression of SNAP91 mRNA CTD PMID:30307764 NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367 		JBrowse link
G Sncaip synuclein, alpha interacting protein increases expression EXP fenvalerate results in increased expression of SNCAIP mRNA CTD PMID:30307764 NCBI chr18:46,205,846...46,343,932
Ensembl chr18:46,207,152...46,343,929 		JBrowse link
G Sncg synuclein, gamma increases expression EXP fenvalerate results in increased expression of SNCG mRNA CTD PMID:30307764 NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368 		JBrowse link
G Sned1 sushi, nidogen and EGF-like domains 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of SNED1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SNED1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 9:93,774,087...93,834,003
Ensembl chr 9:93,774,119...93,830,694 		JBrowse link
G Snhg11 small nucleolar RNA host gene 11 increases expression EXP fenvalerate results in increased expression of SNHG11 mRNA CTD PMID:30307764 NCBI chr 3:147,031,367...147,037,043 JBrowse link
G Snrnp48 small nuclear ribonucleoprotein U11/U12 subunit 48 increases expression EXP fenvalerate results in increased expression of SNRNP48 mRNA CTD PMID:30307764 NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040 		JBrowse link
G Sntg2 syntrophin, gamma 2 increases expression EXP fenvalerate results in increased expression of SNTG2 mRNA CTD PMID:30307764 NCBI chr 6:46,801,893...47,003,390
Ensembl chr 6:46,801,377...47,003,372 		JBrowse link
G Snx18 sorting nexin 18 increases expression EXP fenvalerate results in increased expression of SNX18 mRNA CTD PMID:30307764 NCBI chr 2:45,232,325...45,258,345
Ensembl chr 2:45,232,325...45,258,345 		JBrowse link
G Snx5 sorting nexin 5 increases expression EXP fenvalerate results in increased expression of SNX5 mRNA CTD PMID:30307764 NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192 		JBrowse link
G Sobp sine oculis binding protein homolog multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOBP protein CTD PMID:34896426 NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541 		JBrowse link
G Socs1 suppressor of cytokine signaling 1 increases expression EXP fenvalerate results in increased expression of SOCS1 mRNA CTD PMID:30307764 NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
decreases activity
increases activity		 EXP [cypermethrin co-treated with fenvalerate] results in increased activity of SOD1 protein
fenvalerate metabolite results in decreased activity of SOD1 protein; fenvalerate results in decreased activity of SOD1 protein
fenvalerate results in increased activity of SOD1 protein		 CTD PMID:10355540 PMID:15892188 NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Sorbs3 sorbin and SH3 domain containing 3 increases expression EXP fenvalerate results in increased expression of SORBS3 mRNA CTD PMID:30307764 NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758 		JBrowse link
G Sorcs2 sortilin-related VPS10 domain containing receptor 2 increases expression EXP fenvalerate results in increased expression of SORCS2 mRNA CTD PMID:30307764 NCBI chr14:74,371,089...74,735,943
Ensembl chr14:74,371,415...74,735,943 		JBrowse link
G Sorcs3 sortilin-related VPS10 domain containing receptor 3 increases expression EXP fenvalerate results in increased expression of SORCS3 mRNA CTD PMID:30307764 NCBI chr 1:247,099,178...247,734,027
Ensembl chr 1:247,099,408...247,734,027 		JBrowse link
G Sorl1 sortilin related receptor 1 increases expression EXP fenvalerate results in increased expression of SORL1 mRNA CTD PMID:30307764 NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513 		JBrowse link
G Sost sclerostin increases expression EXP fenvalerate results in increased expression of SOST mRNA CTD PMID:30307764 NCBI chr10:86,912,517...86,915,561
Ensembl chr10:86,911,517...86,915,561 		JBrowse link
G Sowaha sosondowah ankyrin repeat domain family member A increases expression EXP fenvalerate results in increased expression of SOWAHA mRNA CTD PMID:30307764 NCBI chr10:37,641,823...37,645,390
Ensembl chr10:37,643,444...37,645,102 		JBrowse link
G Sox17 SRY-box transcription factor 17 increases expression EXP fenvalerate results in increased expression of SOX17 mRNA CTD PMID:30307764 NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228 		JBrowse link
G Sox4 SRY-box transcription factor 4 increases expression EXP fenvalerate results in increased expression of SOX4 mRNA CTD PMID:30307764 NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665 		JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOX9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SOX9 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994 		JBrowse link
G Sp3 Sp3 transcription factor increases expression EXP fenvalerate results in increased expression of SP3 mRNA CTD PMID:30307764 NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342 		JBrowse link
G Spaca6 sperm acrosome associated 6 increases expression EXP fenvalerate results in increased expression of SPACA6 mRNA CTD PMID:30307764 NCBI chr 1:58,672,128...58,689,309
Ensembl chr 1:58,677,797...58,688,562 		JBrowse link
G Spag1 sperm associated antigen 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SPAG1 protein CTD PMID:34896426 NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368 		JBrowse link
G Spam1 sperm adhesion molecule 1 increases expression EXP fenvalerate results in increased expression of SPAM1 mRNA CTD PMID:30307764 NCBI chr 4:53,302,745...53,312,913
Ensembl chr 4:53,302,745...53,312,908 		JBrowse link
G Spata13 spermatogenesis associated 13 increases expression EXP fenvalerate results in increased expression of SPATA13 mRNA CTD PMID:30307764 NCBI chr15:34,778,479...34,907,645
Ensembl chr15:34,778,473...34,905,114 		JBrowse link
G Spata24 spermatogenesis associated 24 decreases expression EXP fenvalerate results in decreased expression of SPATA24 mRNA CTD PMID:30307764 NCBI chr18:27,249,047...27,257,129
Ensembl chr18:27,248,609...27,257,124 		JBrowse link
G Spata2L spermatogenesis associated 2-like increases expression EXP fenvalerate results in increased expression of SPATA2L mRNA CTD PMID:30307764 NCBI chr19:51,269,078...51,273,605
Ensembl chr19:51,269,078...51,273,510 		JBrowse link
G Spata6 spermatogenesis associated 6 increases expression EXP fenvalerate results in increased expression of SPATA6 mRNA CTD PMID:30307764 NCBI chr 5:126,593,122...126,676,557
Ensembl chr 5:126,593,122...126,676,557 		JBrowse link
G Spdya speedy/RINGO cell cycle regulator family member A increases expression EXP fenvalerate results in increased expression of SPDYA mRNA CTD PMID:30307764 NCBI chr 6:23,905,574...23,954,926
Ensembl chr 6:23,910,223...23,954,850 		JBrowse link
G Sphkap SPHK1 interactor, AKAP domain containing increases expression EXP fenvalerate results in increased expression of SPHKAP mRNA CTD PMID:30307764 NCBI chr 9:84,509,383...84,657,582
Ensembl chr 9:84,510,964...84,657,559 		JBrowse link
G Spink8 serine peptidase inhibitor, Kazal type 8 increases expression EXP fenvalerate results in increased expression of SPINK8 mRNA CTD PMID:30307764 NCBI chr 8:109,814,062...109,828,994
Ensembl chr 8:109,817,365...109,828,994 		JBrowse link
G Spry3 sprouty RTK signaling antagonist 3 increases expression EXP fenvalerate results in increased expression of SPRY3 mRNA CTD PMID:30307764 NCBI chr12:16,663,188...16,673,124
Ensembl chr12:16,663,389...16,672,531 		JBrowse link
G Spryd4 SPRY domain containing 4 decreases expression EXP fenvalerate results in decreased expression of SPRYD4 protein CTD PMID:33656234 NCBI chr 7:633,400...637,564
Ensembl chr 7:633,394...637,557 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 increases expression EXP fenvalerate results in increased expression of SPTBN1 mRNA CTD PMID:30307764 NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression		 EXP 3-methyladenine inhibits the reaction [fenvalerate results in decreased expression of SQSTM1 protein]; SB 203580 inhibits the reaction [fenvalerate results in decreased expression of SQSTM1 protein] CTD PMID:31734597 NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Srebf2 sterol regulatory element binding transcription factor 2 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of SREBF2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SREBF2 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848 		JBrowse link
G Srpx sushi-repeat-containing protein, X-linked increases expression EXP fenvalerate results in increased expression of SRPX mRNA CTD PMID:30307764 NCBI chr  X:12,676,984...12,751,296
Ensembl chr  X:12,566,645...12,747,882 		JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 increases expression EXP fenvalerate results in increased expression of SRSF10 mRNA CTD PMID:30307764 NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768 		JBrowse link
G Srsf11 serine and arginine rich splicing factor 11 decreases expression EXP fenvalerate results in decreased expression of SRSF11 mRNA CTD PMID:30307764 NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:247,074,631...247,101,425 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression EXP fenvalerate results in increased expression of SRXN1 mRNA CTD PMID:30307764 NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448 		JBrowse link
G Ssc4d scavenger receptor cysteine rich family member with 4 domains increases expression EXP fenvalerate results in increased expression of SSC4D mRNA CTD PMID:30307764 NCBI chr12:20,702,931...20,723,732
Ensembl chr12:20,702,950...20,718,706 		JBrowse link
G Ssrp1 structure specific recognition protein 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SSRP1 protein CTD PMID:34896426 NCBI chr 3:70,124,371...70,134,481
Ensembl chr 3:70,118,655...70,134,482 		JBrowse link
G Sst somatostatin increases expression EXP fenvalerate results in increased expression of SST mRNA CTD PMID:30307764 NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173 		JBrowse link
G St6gal1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 increases expression EXP fenvalerate results in increased expression of ST6GAL1 mRNA CTD PMID:30307764 NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310 		JBrowse link
G St6galnac6 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 increases expression EXP fenvalerate results in increased expression of ST6GALNAC6 mRNA CTD PMID:30307764 NCBI chr 3:15,894,275...15,907,502
Ensembl chr 3:15,885,968...15,907,496 		JBrowse link
G Stab2 stabilin 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STAB2 protein CTD PMID:34896426 NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042 		JBrowse link
G Stap1 signal transducing adaptor family member 1 increases expression EXP fenvalerate results in increased expression of STAP1 mRNA CTD PMID:30307764 NCBI chr14:21,950,466...21,981,395
Ensembl chr14:21,952,496...21,981,245 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
increases expression
multiple interactions		 ISO
EXP		 fenvalerate results in decreased expression of STAR mRNA; fenvalerate results in decreased expression of STAR protein
fenvalerate results in increased expression of STAR mRNA; fenvalerate results in increased expression of STAR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of STAR mRNA		 CTD PMID:15907653 PMID:18053657 PMID:19892000 PMID:33051911 PMID:33396045 More... NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672 		JBrowse link
G Stard9 StAR-related lipid transfer domain containing 9 increases expression EXP fenvalerate results in increased expression of STARD9 mRNA CTD PMID:30307764 NCBI chr 3:107,581,097...107,672,746
Ensembl chr 3:107,581,164...107,673,898 		JBrowse link
G Stk32c serine/threonine kinase 32C increases expression EXP fenvalerate results in increased expression of STK32C mRNA CTD PMID:30307764 NCBI chr 1:193,900,718...193,981,723
Ensembl chr 1:193,900,718...193,981,723 		JBrowse link
G Stk36 serine/threonine kinase 36 increases expression EXP fenvalerate results in increased expression of STK36 mRNA CTD PMID:30307764 NCBI chr 9:76,176,922...76,204,423
Ensembl chr 9:76,176,920...76,204,422 		JBrowse link
G Stmn3 stathmin 3 increases expression EXP fenvalerate results in increased expression of STMN3 mRNA CTD PMID:30307764 NCBI chr 3:168,416,810...168,424,946
Ensembl chr 3:168,416,810...168,425,056 		JBrowse link
G Stn1 STN1 subunit of CST complex increases expression EXP fenvalerate results in increased expression of STN1 mRNA CTD PMID:30307764 NCBI chr 1:246,391,311...246,429,844
Ensembl chr 1:246,395,613...246,429,531 		JBrowse link
G Stox2 storkhead box 2 increases expression EXP fenvalerate results in increased expression of STOX2 mRNA CTD PMID:30307764 NCBI chr16:44,848,179...45,087,238
Ensembl chr16:44,848,078...45,085,105 		JBrowse link
G Strada STE20 related adaptor alpha decreases expression EXP fenvalerate results in decreased expression of STRADA mRNA CTD PMID:30307764 NCBI chr10:91,094,849...91,123,890
Ensembl chr10:91,094,687...91,123,830 		JBrowse link
G Strn4 striatin 4 increases expression EXP fenvalerate results in increased expression of STRN4 mRNA CTD PMID:30307764 NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858 		JBrowse link
G Stx11 syntaxin 11 increases expression EXP fenvalerate results in increased expression of STX11 mRNA CTD PMID:30307764 NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164 		JBrowse link
G Stx12 syntaxin 12 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STX12 protein CTD PMID:34896426 NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377 		JBrowse link
G Stx1a syntaxin 1A increases expression EXP fenvalerate results in increased expression of STX1A mRNA CTD PMID:30307764 NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930 		JBrowse link
G Stxbp2 syntaxin binding protein 2 increases expression EXP fenvalerate results in increased expression of STXBP2 mRNA CTD PMID:30307764 NCBI chr12:1,689,364...1,701,145
Ensembl chr12:1,689,410...1,700,458 		JBrowse link
G Stxbp5 syntaxin binding protein 5 increases expression EXP fenvalerate results in increased expression of STXBP5 mRNA CTD PMID:30307764 NCBI chr 1:4,182,489...4,335,290
Ensembl chr 1:4,185,529...4,335,101 		JBrowse link
G Sucla2 succinate-CoA ligase ADP-forming subunit beta increases expression EXP fenvalerate results in increased expression of SUCLA2 mRNA CTD PMID:30307764 NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138 		JBrowse link
G Sulf1 sulfatase 1 increases expression EXP fenvalerate results in increased expression of SULF1 mRNA CTD PMID:30307764 NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584 		JBrowse link
G Sulf2 sulfatase 2 increases expression EXP fenvalerate results in increased expression of SULF2 mRNA CTD PMID:30307764 NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415 		JBrowse link
G Sv2b synaptic vesicle glycoprotein 2b increases expression EXP fenvalerate results in increased expression of SV2B mRNA CTD PMID:30307764 NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479 		JBrowse link
G Svep1 sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 increases expression EXP fenvalerate results in increased expression of SVEP1 mRNA CTD PMID:30307764 NCBI chr 5:72,811,200...72,988,185
Ensembl chr 5:72,811,410...72,988,525 		JBrowse link
G Svil supervillin increases expression EXP fenvalerate results in increased expression of SVIL mRNA CTD PMID:30307764 NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404 		JBrowse link
G Syce3 synaptonemal complex central element protein 3 decreases expression EXP fenvalerate results in decreased expression of SYCE3 mRNA CTD PMID:30307764 NCBI chr 7:120,456,800...120,482,882
Ensembl chr 7:120,456,800...120,482,973 		JBrowse link
G Syf2 SYF2 pre-mRNA-splicing factor increases expression EXP fenvalerate results in increased expression of SYF2 mRNA CTD PMID:30307764 NCBI chr 5:147,156,492...147,164,416
Ensembl chr 5:147,156,480...147,164,414 		JBrowse link
G Syn2 synapsin II increases expression EXP fenvalerate results in increased expression of SYN2 mRNA CTD PMID:30307764 NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192 		JBrowse link
G Synj2bp synaptojanin 2 binding protein increases expression EXP fenvalerate results in increased expression of SYNJ2BP mRNA CTD PMID:30307764 NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406 		JBrowse link
G Synrg synergin, gamma multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SYNRG protein CTD PMID:34896426 NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250 		JBrowse link
G Sypl2 synaptophysin-like 2 increases expression EXP fenvalerate results in increased expression of SYPL2 mRNA CTD PMID:30307764 NCBI chr 2:195,849,062...195,863,794
Ensembl chr 2:195,849,062...195,863,794 		JBrowse link
G Syt13 synaptotagmin 13 increases expression EXP fenvalerate results in increased expression of SYT13 mRNA CTD PMID:30307764 NCBI chr 3:78,877,114...78,917,527
Ensembl chr 3:78,877,114...78,917,392 		JBrowse link
G Syt17 synaptotagmin 17 increases expression EXP fenvalerate results in increased expression of SYT17 mRNA CTD PMID:30307764 NCBI chr 1:172,695,275...172,761,906
Ensembl chr 1:172,696,120...172,761,960 		JBrowse link
G Syt2 synaptotagmin 2 increases expression EXP fenvalerate results in increased expression of SYT2 mRNA CTD PMID:30307764 NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859 		JBrowse link
G Syt5 synaptotagmin 5 increases expression EXP fenvalerate results in increased expression of SYT5 mRNA CTD PMID:30307764 NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067 		JBrowse link
G Syt7 synaptotagmin 7 increases expression EXP fenvalerate results in increased expression of SYT7 mRNA CTD PMID:30307764 NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026 		JBrowse link
G Syt9 synaptotagmin 9 increases expression EXP fenvalerate results in increased expression of SYT9 mRNA CTD PMID:30307764 NCBI chr 1:161,275,882...161,456,384
Ensembl chr 1:161,275,734...161,455,007 		JBrowse link
G Taar1 trace-amine-associated receptor 1 increases expression EXP fenvalerate results in increased expression of TAAR1 mRNA CTD PMID:30307764 NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084 		JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TAB2 protein CTD PMID:34896426 NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756 		JBrowse link
G Tacr1 tachykinin receptor 1 increases expression EXP fenvalerate results in increased expression of TACR1 mRNA CTD PMID:30307764 NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733 		JBrowse link
G Tacr2 tachykinin receptor 2 increases expression EXP fenvalerate results in increased expression of TACR2 mRNA CTD PMID:30307764 NCBI chr20:30,208,907...30,223,446
Ensembl chr20:30,208,907...30,223,446 		JBrowse link
G Tagln transgelin decreases expression EXP fenvalerate results in decreased expression of TAGLN mRNA CTD PMID:30307764 NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668 		JBrowse link
G Tagln3 transgelin 3 increases expression EXP fenvalerate results in increased expression of TAGLN3 mRNA CTD PMID:30307764 NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485 		JBrowse link
G Tamalin trafficking regulator and scaffold protein tamalin increases expression EXP fenvalerate results in increased expression of TAMALIN mRNA CTD PMID:30307764 NCBI chr 7:132,338,900...132,359,519
Ensembl chr 7:132,338,900...132,346,666 		JBrowse link
G Tardbp TAR DNA binding protein increases expression EXP fenvalerate results in increased expression of TARDBP mRNA CTD PMID:30307764 NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055 		JBrowse link
G Tas2r118 taste receptor, type 2, member 118 increases expression EXP fenvalerate results in increased expression of TAS2R118 mRNA CTD PMID:30307764 NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:52,449,208...52,450,107 		JBrowse link
G Tas2r126 taste receptor, type 2, member 126 increases expression EXP fenvalerate results in increased expression of TAS2R126 mRNA CTD PMID:30307764 NCBI chr 4:71,333,821...71,334,747
Ensembl chr 4:71,333,821...71,334,747 		JBrowse link
G Tax1bp3 Tax1 binding protein 3 increases expression EXP fenvalerate results in increased expression of TAX1BP3 mRNA CTD PMID:30307764 NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363 		JBrowse link
G Tbc1d17 TBC1 domain family, member 17 decreases expression EXP fenvalerate results in decreased expression of TBC1D17 mRNA CTD PMID:30307764 NCBI chr 1:95,324,770...95,333,156
Ensembl chr 1:95,322,737...95,333,005 		JBrowse link
G Tbc1d2 TBC1 domain family, member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBC1D2 protein CTD PMID:34896426 NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352 		JBrowse link
G Tbc1d22b TBC1 domain family, member 22B decreases expression EXP fenvalerate results in decreased expression of TBC1D22B mRNA CTD PMID:30307764 NCBI chr20:7,619,096...7,675,232
Ensembl chr20:7,619,240...7,675,231 		JBrowse link
G Tbc1d30 TBC1 domain family, member 30 increases expression EXP fenvalerate results in increased expression of TBC1D30 mRNA CTD PMID:30307764 NCBI chr 7:56,779,570...56,869,092
Ensembl chr 7:56,782,165...56,870,515 		JBrowse link
G Tbc1d4 TBC1 domain family, member 4 increases expression EXP fenvalerate results in increased expression of TBC1D4 mRNA CTD PMID:30307764 NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265 		JBrowse link
G Tbx15 T-box transcription factor 15 increases expression EXP fenvalerate results in increased expression of TBX15 mRNA CTD PMID:30307764 NCBI chr 2:186,576,650...186,687,748
Ensembl chr 2:186,576,676...186,687,663 		JBrowse link
G Tbx3 T-box transcription factor 3 increases expression ISO fenvalerate results in increased expression of TBX3 mRNA CTD PMID:23397585 NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708 		JBrowse link
G Tbx5 T-box transcription factor 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein CTD PMID:34896426 NCBI chr12:36,686,344...36,739,253
Ensembl chr12:36,688,014...36,734,885 		JBrowse link
G Tcaim T cell activation inhibitor, mitochondrial increases expression EXP fenvalerate results in increased expression of TCAIM mRNA CTD PMID:30307764 NCBI chr 8:122,414,827...122,446,105
Ensembl chr 8:122,414,818...122,446,092 		JBrowse link
G Tcf3 transcription factor 3 increases expression EXP fenvalerate results in increased expression of TCF3 mRNA CTD PMID:30307764 NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314 		JBrowse link
G Tcp11l1 t-complex 11 like 1 increases expression EXP fenvalerate results in increased expression of TCP11L1 mRNA CTD PMID:30307764 NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006 		JBrowse link
G Tctn1 tectonic family member 1 increases expression EXP fenvalerate results in increased expression of TCTN1 mRNA CTD PMID:30307764 NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267 		JBrowse link
G Tdh L-threonine dehydrogenase increases expression EXP fenvalerate results in increased expression of TDH mRNA CTD PMID:30307764 NCBI chr15:37,739,823...37,753,365
Ensembl chr15:37,739,823...37,753,365 		JBrowse link
G Tedc1 tubulin epsilon and delta complex 1 increases expression EXP fenvalerate results in increased expression of TEDC1 mRNA CTD PMID:30307764 NCBI chr 6:132,234,764...132,245,164
Ensembl chr 6:132,236,925...132,244,928 		JBrowse link
G Teddm1b transmembrane epididymal protein 1B increases expression EXP fenvalerate results in increased expression of TEDDM1 mRNA CTD PMID:30307764 NCBI chr13:66,000,188...66,002,536
Ensembl chr13:66,000,281...66,001,189 		JBrowse link
G Teddm3 transmembrane epididymal family member 3 increases expression EXP fenvalerate results in increased expression of TEDDM3 mRNA CTD PMID:30307764 NCBI chr11:79,988,984...79,990,143
Ensembl chr11:79,989,077...79,989,961 		JBrowse link
G Tekt3 tektin 3 increases expression EXP fenvalerate results in increased expression of TEKT3 mRNA CTD PMID:30307764 NCBI chr10:47,729,635...47,763,589
Ensembl chr10:47,729,635...47,763,588 		JBrowse link
G Tenm2 teneurin transmembrane protein 2 increases expression EXP fenvalerate results in increased expression of TENM2 mRNA CTD PMID:30307764 NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597 		JBrowse link
G Tenm3 teneurin transmembrane protein 3 increases expression EXP fenvalerate results in increased expression of TENM3 mRNA CTD PMID:30307764 NCBI chr16:41,251,909...43,978,594
Ensembl chr16:41,252,182...43,978,594 		JBrowse link
G Tet1 tet methylcytosine dioxygenase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052 		JBrowse link
G Tex14 testis expressed 14, intercellular bridge forming factor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein CTD PMID:34896426 NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805 		JBrowse link
G Tex46 testis expressed 46 increases expression EXP fenvalerate results in increased expression of TEX46 mRNA CTD PMID:30307764 NCBI chr 5:148,849,307...148,853,742
Ensembl chr 5:148,849,307...148,853,742 		JBrowse link
G Tfcp2 transcription factor CP2 increases expression EXP fenvalerate results in increased expression of TFCP2 mRNA CTD PMID:30307764 NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939 		JBrowse link
G Tfe3 transcription factor binding to IGHM enhancer 3 increases expression EXP fenvalerate results in increased expression of TFE3 mRNA CTD PMID:30307764 NCBI chr  X:14,729,547...14,742,830
Ensembl chr  X:14,729,550...14,742,571 		JBrowse link
G Tff1 trefoil factor 1 increases expression ISO fenvalerate results in increased expression of TFF1 mRNA CTD PMID:10064545 PMID:12396874 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGFB1 protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tgfb2 transforming growth factor, beta 2 multiple interactions EXP [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TGFB2 mRNA CTD PMID:36053783 NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405 		JBrowse link
G Tgm1 transglutaminase 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGM1 protein CTD PMID:34896426 NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523 		JBrowse link
G Tgoln2 trans-golgi network protein 2 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of TGOLN2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGOLN2 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164 		JBrowse link
G Th tyrosine hydroxylase multiple interactions
decreases expression		 EXP 3-methyladenine inhibits the reaction [fenvalerate results in decreased expression of TH protein]; SB 203580 inhibits the reaction [fenvalerate results in decreased expression of TH protein] CTD PMID:31734597 NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767 		JBrowse link
G Thap3 THAP domain containing 3 increases expression EXP fenvalerate results in increased expression of THAP3 mRNA CTD PMID:30307764 NCBI chr 5:162,488,480...162,494,149
Ensembl chr 5:162,488,480...162,494,149 		JBrowse link
G Thbd thrombomodulin increases expression EXP fenvalerate results in increased expression of THBD mRNA CTD PMID:30307764 NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193 		JBrowse link
G Thbs3 thrombospondin 3 increases expression EXP fenvalerate results in increased expression of THBS3 mRNA CTD PMID:30307764 NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594 		JBrowse link
G Thoc2 THO complex subunit 2 increases expression EXP fenvalerate results in increased expression of THOC2 mRNA CTD PMID:30307764 NCBI chr  X:120,634,966...120,749,569
Ensembl chr  X:120,634,968...120,749,513 		JBrowse link
G Thop1 thimet oligopeptidase 1 decreases expression EXP fenvalerate results in decreased expression of THOP1 protein CTD PMID:33656234 NCBI chr 7:8,632,911...8,645,339
Ensembl chr 7:8,632,916...8,645,275 		JBrowse link
G Thra thyroid hormone receptor alpha decreases expression ISO
EXP		 fenvalerate results in decreased expression of THRA mRNA
fenvalerate results in decreased expression of THRA protein		 CTD PMID:28369636 PMID:32693020 PMID:34358930 NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936 		JBrowse link
G Thrb thyroid hormone receptor beta decreases expression
decreases localization		 ISO
EXP		 fenvalerate results in decreased expression of THRB mRNA
fenvalerate results in decreased localization of THRB protein
fenvalerate results in decreased expression of THRB protein		 CTD PMID:28369636 PMID:32693020 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916 		JBrowse link
G Thy1 Thy-1 cell surface antigen decreases expression
multiple interactions		 EXP fenvalerate results in decreased expression of THY1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659 		JBrowse link
G Tia1 TIA1 cytotoxic granule-associated RNA binding protein increases expression EXP fenvalerate results in increased expression of TIA1 mRNA CTD PMID:30307764 NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586 		JBrowse link
G Tigd5 tigger transposable element derived 5 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TIGD5 protein CTD PMID:34896426 NCBI chr 7:107,596,724...107,599,243
Ensembl chr 7:107,596,724...107,599,243 		JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 increases expression EXP fenvalerate results in increased expression of TIMP2 mRNA CTD PMID:30307764 NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611 		JBrowse link
G Tk1 thymidine kinase 1 increases expression EXP fenvalerate results in increased expression of TK1 mRNA CTD PMID:30307764 NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920 		JBrowse link
G Tlcd3b TLC domain containing 3B increases expression EXP fenvalerate results in increased expression of TLCD3B mRNA CTD PMID:30307764 NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743 		JBrowse link
G Tlk2 tousled-like kinase 2 increases expression EXP fenvalerate results in increased expression of TLK2 mRNA CTD PMID:30307764 NCBI chr10:90,154,449...90,248,562
Ensembl chr10:90,156,813...90,248,561 		JBrowse link
G Tmc8 transmembrane channel-like 8 increases expression EXP fenvalerate results in increased expression of TMC8 mRNA CTD PMID:30307764 NCBI chr10:103,000,038...103,010,601
Ensembl chr10:102,998,402...103,010,590 		JBrowse link
G Tmcc1 transmembrane and coiled-coil domain family 1 increases expression EXP fenvalerate results in increased expression of TMCC1 mRNA CTD PMID:30307764 NCBI chr 4:149,069,252...149,239,585
Ensembl chr 4:149,069,260...149,239,620 		JBrowse link
G Tmcc3 transmembrane and coiled-coil domain family 3 increases expression EXP fenvalerate results in increased expression of TMCC3 mRNA CTD PMID:30307764 NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926 		JBrowse link
G Tmco5a transmembrane and coiled-coil domains 5A increases expression EXP fenvalerate results in increased expression of TMCO5A mRNA CTD PMID:30307764 NCBI chr 3:103,732,936...103,746,242
Ensembl chr 3:103,732,945...103,746,249 		JBrowse link
G Tmed1 transmembrane p24 trafficking protein 1 decreases expression EXP fenvalerate results in decreased expression of TMED1 mRNA CTD PMID:30307764 NCBI chr 8:20,059,937...20,063,567
Ensembl chr 8:20,059,892...20,063,677 		JBrowse link
G Tmem116 transmembrane protein 116 increases expression EXP fenvalerate results in increased expression of TMEM116 mRNA CTD PMID:30307764 NCBI chr12:35,021,912...35,089,409
Ensembl chr12:35,041,572...35,089,430 		JBrowse link
G Tmem117 transmembrane protein 117 decreases expression EXP fenvalerate results in decreased expression of TMEM117 mRNA CTD PMID:30307764 NCBI chr 7:125,757,591...126,219,692
Ensembl chr 7:125,757,591...126,219,690 		JBrowse link
G Tmem120b transmembrane protein 120B increases expression EXP fenvalerate results in increased expression of TMEM120B mRNA CTD PMID:30307764 NCBI chr12:33,447,441...33,487,257
Ensembl chr12:33,446,660...33,487,200 		JBrowse link
G Tmem132e transmembrane protein 132E increases expression EXP fenvalerate results in increased expression of TMEM132E mRNA CTD PMID:30307764 NCBI chr10:67,330,863...67,386,790
Ensembl chr10:67,330,751...67,386,789 		JBrowse link
G Tmem178b transmembrane protein 178B increases expression EXP fenvalerate results in increased expression of TMEM178B mRNA CTD PMID:30307764 NCBI chr 4:68,659,425...69,035,690
Ensembl chr 4:68,657,343...69,035,690 		JBrowse link
G Tmem200c transmembrane protein 200C increases expression EXP fenvalerate results in increased expression of TMEM200C mRNA CTD PMID:30307764 NCBI chr 9:108,806,063...108,811,901
Ensembl chr 9:108,805,787...108,812,226 		JBrowse link
G Tmem237 transmembrane protein 237 increases expression EXP fenvalerate results in increased expression of TMEM237 mRNA CTD PMID:30307764 NCBI chr 9:60,533,348...60,569,253
Ensembl chr 9:60,535,233...60,572,567 		JBrowse link
G Tmem52 transmembrane protein 52 increases expression EXP fenvalerate results in increased expression of TMEM52 mRNA CTD PMID:30307764 NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433 		JBrowse link
G Tmem59l transmembrane protein 59-like increases expression EXP fenvalerate results in increased expression of TMEM59L mRNA CTD PMID:30307764 NCBI chr16:18,941,370...18,945,381
Ensembl chr16:18,941,567...18,945,381 		JBrowse link
G Tmem63c transmembrane protein 63c increases expression EXP fenvalerate results in increased expression of TMEM63C mRNA CTD PMID:30307764 NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990 		JBrowse link
G Tmem89 transmembrane protein 89 increases expression EXP fenvalerate results in increased expression of TMEM89 mRNA CTD PMID:30307764 NCBI chr 8:109,571,377...109,572,271
Ensembl chr 8:109,571,377...109,572,271 		JBrowse link
G Tmie transmembrane inner ear increases expression EXP fenvalerate results in increased expression of TMIE mRNA CTD PMID:30307764 NCBI chr 8:110,849,713...110,864,803
Ensembl chr 8:110,850,034...110,864,803 		JBrowse link
G Tmod4 tropomodulin 4 increases expression EXP fenvalerate results in increased expression of TMOD4 mRNA CTD PMID:30307764 NCBI chr 2:182,695,709...182,700,540
Ensembl chr 2:182,695,709...182,700,540 		JBrowse link
G Tnc tenascin C increases expression EXP fenvalerate results in increased expression of TNC mRNA CTD PMID:30307764 NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624 		JBrowse link
G Tnf tumor necrosis factor increases expression EXP fenvalerate results in increased expression of TNF mRNA CTD PMID:30307764 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B increases expression EXP fenvalerate results in increased expression of TNFRSF11B mRNA CTD PMID:30307764 NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538 		JBrowse link
G Tnfrsf21 TNF receptor superfamily member 21 increases expression EXP fenvalerate results in increased expression of TNFRSF21 mRNA CTD PMID:30307764 NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085 		JBrowse link
G Tnks1bp1 tankyrase 1 binding protein 1 decreases expression EXP fenvalerate results in decreased expression of TNKS1BP1 mRNA CTD PMID:30307764 NCBI chr 3:70,135,335...70,160,071
Ensembl chr 3:70,137,837...70,160,038 		JBrowse link
G Tnnc1 troponin C1, slow skeletal and cardiac type increases expression EXP fenvalerate results in increased expression of TNNC1 mRNA CTD PMID:30307764 NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634 		JBrowse link
G Tnnt2 troponin T2, cardiac type increases expression EXP fenvalerate results in increased expression of TNNT2 mRNA CTD PMID:30307764 NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388 		JBrowse link
G Tnp1 transition protein 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of TNP1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA		 CTD PMID:30307764 PMID:33051911 PMID:33396045 NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274 		JBrowse link
G Tnp2 transition protein 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538 		JBrowse link
G Tnrc6a trinucleotide repeat containing adaptor 6A increases expression EXP fenvalerate results in increased expression of TNRC6A mRNA CTD PMID:30307764 NCBI chr 1:177,561,898...177,715,669
Ensembl chr 1:177,646,030...177,715,660 		JBrowse link
G Tox3 TOX high mobility group box family member 3 increases expression EXP fenvalerate results in increased expression of TOX3 mRNA CTD PMID:30307764 NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148 		JBrowse link
G Tp53 tumor protein p53 increases expression EXP fenvalerate results in increased expression of TP53 mRNA; fenvalerate results in increased expression of TP53 protein CTD PMID:33656234 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tp53rka Tp53 tumor protein p53 regulating kinase A increases expression EXP fenvalerate results in increased expression of TP53RK mRNA CTD PMID:30307764 NCBI chr 3:154,219,672...154,224,841
Ensembl chr 3:154,220,851...154,224,328 		JBrowse link
G Tpgs1 tubulin polyglutamylase complex subunit 1 increases expression EXP fenvalerate results in increased expression of TPGS1 mRNA CTD PMID:30307764 NCBI chr 7:10,029,842...10,035,764
Ensembl chr 7:10,029,854...10,035,764 		JBrowse link
G Tppp2 tubulin polymerization-promoting protein family member 2 decreases expression EXP fenvalerate results in decreased expression of TPPP2 protein CTD PMID:33656234 NCBI chr15:24,614,284...24,627,123
Ensembl chr15:24,614,006...24,618,967 		JBrowse link
G Tpst1 tyrosylprotein sulfotransferase 1 increases expression EXP fenvalerate results in increased expression of TPST1 mRNA CTD PMID:30307764 NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704 		JBrowse link
G Tra2a transformer 2 alpha increases expression EXP fenvalerate results in increased expression of TRA2A mRNA CTD PMID:30307764 NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712 		JBrowse link
G Trabd2b TraB domain containing 2B increases expression EXP fenvalerate results in increased expression of TRABD2B mRNA CTD PMID:30307764 NCBI chr 5:127,941,198...128,158,946
Ensembl chr 5:127,941,114...128,143,747 		JBrowse link
G Trap1 TNF receptor-associated protein 1 decreases expression EXP fenvalerate results in decreased expression of TRAP1 protein CTD PMID:33656234 NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981 		JBrowse link
G Trat1 T cell receptor associated transmembrane adaptor 1 increases expression EXP fenvalerate results in increased expression of TRAT1 mRNA CTD PMID:30307764 NCBI chr11:52,035,750...52,077,805
Ensembl chr11:52,035,750...52,077,805 		JBrowse link
G Trdmt1 tRNA aspartic acid methyltransferase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TRDMT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT2 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439 		JBrowse link
G Trdn triadin increases expression EXP fenvalerate results in increased expression of TRDN mRNA CTD PMID:30307764 NCBI chr 1:23,955,651...24,410,494
Ensembl chr 1:23,955,651...24,410,595 		JBrowse link
G Treh trehalase increases expression EXP fenvalerate results in increased expression of TREH mRNA CTD PMID:30307764 NCBI chr 8:44,990,182...45,003,881
Ensembl chr 8:44,990,182...45,003,540 		JBrowse link
G Trh thyrotropin releasing hormone increases expression EXP fenvalerate results in increased expression of TRH mRNA CTD PMID:30307764 NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637 		JBrowse link
G Trhr thyrotropin releasing hormone receptor increases expression EXP fenvalerate results in increased expression of TRHR mRNA CTD PMID:30307764 NCBI chr 7:75,348,672...75,393,310
Ensembl chr 7:75,348,672...75,393,309 		JBrowse link
G Trim16 tripartite motif-containing 16 increases expression EXP fenvalerate results in increased expression of TRIM16 mRNA CTD PMID:30307764 NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907 		JBrowse link
G Trim35 tripartite motif-containing 35 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRIM35 protein CTD PMID:34896426 NCBI chr15:40,493,697...40,510,246
Ensembl chr15:40,493,755...40,510,240 		JBrowse link
G Trim47 tripartite motif-containing 47 decreases expression EXP fenvalerate results in decreased expression of TRIM47 mRNA CTD PMID:30307764 NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044 		JBrowse link
G Trim9 tripartite motif-containing 9 increases expression EXP fenvalerate results in increased expression of TRIM9 mRNA CTD PMID:30307764 NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542 		JBrowse link
G Trmt10a tRNA methyltransferase 10A increases expression EXP fenvalerate results in increased expression of TRMT10A mRNA CTD PMID:30307764 NCBI chr 2:226,669,445...226,684,166
Ensembl chr 2:226,669,832...226,684,151 		JBrowse link
G Trmt9b tRNA methyltransferase 9B (putative) increases expression EXP fenvalerate results in increased expression of TRMT9B mRNA CTD PMID:30307764 NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144 		JBrowse link
G Trpa1 transient receptor potential cation channel, subfamily A, member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein CTD PMID:34896426 NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570 		JBrowse link
G Trpc1 transient receptor potential cation channel, subfamily C, member 1 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of TRPC1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC1 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276 		JBrowse link
G Trpc3 transient receptor potential cation channel, subfamily C, member 3 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC3 protein CTD PMID:34896426 NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855 		JBrowse link
G Trpc4 transient receptor potential cation channel, subfamily C, member 4 increases expression
multiple interactions		 EXP fenvalerate results in increased expression of TRPC4 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC4 protein		 CTD PMID:30307764 PMID:34896426 NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768 		JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA CTD PMID:33396045 PMID:34896426 NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181 		JBrowse link
G Trpm8 transient receptor potential cation channel, subfamily M, member 8 increases expression EXP fenvalerate results in increased expression of TRPM8 mRNA CTD PMID:30307764 NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552 		JBrowse link
G Trps1 transcriptional repressor GATA binding 1 increases expression EXP fenvalerate results in increased expression of TRPS1 mRNA CTD PMID:30307764 NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905 		JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 increases expression EXP fenvalerate results in increased expression of TRPV1 mRNA CTD PMID:30307764 NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513 		JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSHB protein CTD PMID:34896426 NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559 		JBrowse link
G Tspo translocator protein multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TSPO mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450 		JBrowse link
G Tspy1 testis specific protein, Y-linked 1 increases expression EXP fenvalerate results in increased expression of TSPY1 mRNA CTD PMID:30307764
G Tspyl4 TSPY-like 4 increases expression EXP fenvalerate results in increased expression of TSPYL4 mRNA CTD PMID:30307764 NCBI chr20:38,098,756...38,100,752
Ensembl chr20:38,098,677...38,103,053 		JBrowse link
G Ttc39b tetratricopeptide repeat domain 39B increases expression EXP fenvalerate results in increased expression of TTC39B mRNA CTD PMID:30307764 NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270 		JBrowse link
G Ttc7b tetratricopeptide repeat domain 7B increases expression EXP fenvalerate results in increased expression of TTC7B mRNA CTD PMID:30307764 NCBI chr 6:119,587,389...119,799,167
Ensembl chr 6:119,587,390...119,799,330 		JBrowse link
G Ttc9 tetratricopeptide repeat domain 9 increases expression EXP fenvalerate results in increased expression of TTC9 mRNA CTD PMID:30307764 NCBI chr 6:101,333,274...101,368,110
Ensembl chr 6:101,333,141...101,368,110 		JBrowse link
G Tti2 TELO2 interacting protein 2 increases expression EXP fenvalerate results in increased expression of TTI2 mRNA CTD PMID:30307764 NCBI chr16:60,980,665...60,988,587
Ensembl chr16:60,979,039...60,988,569 		JBrowse link
G Ttyh1 tweety family member 1 increases expression EXP fenvalerate results in increased expression of TTYH1 mRNA CTD PMID:30307764 NCBI chr 1:70,053,312...70,071,872
Ensembl chr 1:70,053,324...70,071,845 		JBrowse link
G Tuba1c tubulin, alpha 1C increases expression EXP fenvalerate results in increased expression of TUBA1C protein CTD PMID:33656234 NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647
Ensembl chr  X:130,192,016...130,199,647 		JBrowse link
G Tubb4b tubulin, beta 4B class IVb decreases expression EXP fenvalerate results in decreased expression of TUBB4B protein CTD PMID:33656234 NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296 		JBrowse link
G Tube1 tubulin, epsilon 1 increases expression EXP fenvalerate results in increased expression of TUBE1 mRNA CTD PMID:30307764 NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314 		JBrowse link
G Tufm Tu translation elongation factor, mitochondrial increases expression EXP fenvalerate results in increased expression of TUFM mRNA CTD PMID:30307764 NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395 		JBrowse link
G Tulp1 TUB like protein 1 increases expression EXP fenvalerate results in increased expression of TULP1 mRNA CTD PMID:30307764 NCBI chr20:6,412,170...6,424,103
Ensembl chr20:6,412,171...6,424,073 		JBrowse link
G Tyro3 TYRO3 protein tyrosine kinase decreases expression EXP fenvalerate results in decreased expression of TYRO3 mRNA CTD PMID:30307764 NCBI chr 3:106,777,686...106,797,154
Ensembl chr 3:106,777,635...106,797,142 		JBrowse link
G Uba7 ubiquitin-like modifier activating enzyme 7 increases expression EXP fenvalerate results in increased expression of UBA7 mRNA CTD PMID:30307764 NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099 		JBrowse link
G Ubap1l ubiquitin associated protein 1-like increases expression EXP fenvalerate results in increased expression of UBAP1L mRNA CTD PMID:30307764 NCBI chr 8:65,877,488...65,897,593
Ensembl chr 8:65,884,729...65,897,593 		JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B increases expression EXP fenvalerate results in increased expression of UBE2B mRNA CTD PMID:30307764 NCBI chr10:36,248,434...36,263,379
Ensembl chr10:36,248,438...36,264,665 		JBrowse link
G Ube2n ubiquitin-conjugating enzyme E2N increases expression EXP fenvalerate results in increased expression of UBE2N protein CTD PMID:33656234 NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355 		JBrowse link
G Ube2ql1 ubiquitin conjugating enzyme E2 QL1 increases expression EXP fenvalerate results in increased expression of UBE2QL1 mRNA CTD PMID:30307764 NCBI chr 1:33,548,814...33,589,174
Ensembl chr 1:33,548,814...33,589,174 		JBrowse link
G Ube2u ubiquitin conjugating enzyme E2 U increases expression EXP fenvalerate results in increased expression of UBE2U mRNA CTD PMID:30307764 NCBI chr 5:115,118,234...115,187,296
Ensembl chr 5:115,118,495...115,186,874 		JBrowse link
G Ube3d ubiquitin protein ligase E3D decreases expression EXP fenvalerate results in decreased expression of UBE3D mRNA CTD PMID:30307764 NCBI chr 8:87,245,503...87,413,104
Ensembl chr 8:87,245,589...87,413,057 		JBrowse link
G Ube4a ubiquitination factor E4A increases expression EXP fenvalerate results in increased expression of UBE4A mRNA CTD PMID:30307764 NCBI chr 8:45,236,022...45,278,129
Ensembl chr 8:45,236,026...45,278,038 		JBrowse link
G Ubqln3 ubiquilin 3 increases expression EXP fenvalerate results in increased expression of UBQLN3 mRNA CTD PMID:30307764 NCBI chr 1:158,604,629...158,607,318
Ensembl chr 1:158,604,355...158,607,389 		JBrowse link
G Ubr4 ubiquitin protein ligase E3 component n-recognin 4 increases expression EXP fenvalerate results in increased expression of UBR4 mRNA CTD PMID:30307764 NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784 		JBrowse link
G Ubxn11 UBX domain protein 11 increases expression EXP fenvalerate results in increased expression of UBXN11 mRNA CTD PMID:30307764 NCBI chr 5:146,329,666...146,353,529
Ensembl chr 5:146,329,842...146,353,526 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression EXP fenvalerate results in increased expression of UCHL1 mRNA CTD PMID:31734597 NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590 		JBrowse link
G Ucma upper zone of growth plate and cartilage matrix associated increases expression EXP fenvalerate results in increased expression of UCMA mRNA CTD PMID:30307764 NCBI chr17:73,293,977...73,303,709
Ensembl chr17:73,293,978...73,303,611 		JBrowse link
G Uggt2 UDP-glucose glycoprotein glucosyltransferase 2 increases expression EXP fenvalerate results in increased expression of UGGT2 mRNA CTD PMID:30307764 NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806 		JBrowse link
G Ugt8 UDP glycosyltransferase 8 increases expression EXP fenvalerate results in increased expression of UGT8 mRNA CTD PMID:30307764 NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660 		JBrowse link
G Unc13b unc-13 homolog B multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC13B protein CTD PMID:34896426 NCBI chr 5:57,288,999...57,504,110
Ensembl chr 5:57,289,227...57,502,926 		JBrowse link
G Unc13c unc-13 homolog C increases expression EXP fenvalerate results in increased expression of UNC13C mRNA CTD PMID:30307764 NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223 		JBrowse link
G Unc5b unc-5 netrin receptor B increases expression EXP fenvalerate results in increased expression of UNC5B mRNA CTD PMID:30307764 NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537 		JBrowse link
G Unc5d unc-5 netrin receptor D multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC5D protein CTD PMID:34896426 NCBI chr16:62,860,119...63,406,932
Ensembl chr16:62,860,174...63,401,143 		JBrowse link
G Unc79 unc-79 homolog, NALCN channel complex subunit increases expression EXP fenvalerate results in increased expression of UNC79 mRNA CTD PMID:30307764 NCBI chr 6:122,082,369...122,327,641
Ensembl chr 6:122,080,308...122,327,591 		JBrowse link
G Upk2 uroplakin 2 increases expression EXP fenvalerate results in increased expression of UPK2 mRNA CTD PMID:30307764 NCBI chr 8:44,779,198...44,781,190
Ensembl chr 8:44,779,198...44,781,190 		JBrowse link
G Uqcrc2 ubiquinol cytochrome c reductase core protein 2 increases expression EXP fenvalerate results in increased expression of UQCRC2 mRNA CTD PMID:30307764 NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453 		JBrowse link
G Usp11 ubiquitin specific peptidase 11 increases expression EXP fenvalerate results in increased expression of USP11 mRNA CTD PMID:30307764 NCBI chr  X:1,473,349...1,489,520
Ensembl chr  X:1,473,350...1,489,520 		JBrowse link
G Usp25 ubiquitin specific peptidase 25 increases expression EXP fenvalerate results in increased expression of USP25 mRNA CTD PMID:30307764 NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348 		JBrowse link
G Usp31 ubiquitin specific peptidase 31 increases expression EXP fenvalerate results in increased expression of USP31 mRNA CTD PMID:30307764 NCBI chr 1:176,211,334...176,278,183
Ensembl chr 1:176,215,889...176,278,355 		JBrowse link
G Usp4 ubiquitin specific peptidase 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of USP4 protein CTD PMID:34896426 NCBI chr 8:109,035,402...109,079,382
Ensembl chr 8:109,036,099...109,080,427 		JBrowse link
G Usp49 ubiquitin specific peptidase 49 increases expression EXP fenvalerate results in increased expression of USP49 mRNA CTD PMID:30307764 NCBI chr 9:13,305,640...13,366,132
Ensembl chr 9:13,308,178...13,366,132 		JBrowse link
G Usp6nl USP6 N-terminal like increases expression EXP fenvalerate results in increased expression of USP6NL mRNA CTD PMID:30307764 NCBI chr17:71,828,433...71,956,878
Ensembl chr17:71,830,469...71,956,027 		JBrowse link
G Utrn utrophin increases expression EXP fenvalerate results in increased expression of UTRN mRNA CTD PMID:30307764 NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313 		JBrowse link
G Vamp1 vesicle-associated membrane protein 1 increases expression EXP fenvalerate results in increased expression of VAMP1 mRNA CTD PMID:30307764 NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349 		JBrowse link
G Vav1 vav guanine nucleotide exchange factor 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VAV1 protein CTD PMID:34896426 NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937 		JBrowse link
G Vax2 ventral anterior homeobox 2 increases expression EXP fenvalerate results in increased expression of VAX2 mRNA CTD PMID:30307764 NCBI chr 4:116,195,528...116,219,597
Ensembl chr 4:116,195,528...116,219,594 		JBrowse link
G Vcan versican increases expression EXP fenvalerate results in increased expression of VCAN mRNA CTD PMID:30307764 NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637 		JBrowse link
G Vcp valosin-containing protein decreases expression EXP fenvalerate results in decreased expression of VCP protein CTD PMID:33656234 NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571 		JBrowse link
G Vdac2 voltage-dependent anion channel 2 decreases expression EXP fenvalerate results in decreased expression of VDAC2 protein CTD PMID:33656234 NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553 		JBrowse link
G Vdr vitamin D receptor increases expression EXP fenvalerate results in increased expression of VDR mRNA CTD PMID:30307764 NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO fenvalerate results in decreased expression of VEGFA mRNA CTD PMID:28369636 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Veph1 ventricular zone expressed PH domain-containing 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VEPH1 protein CTD PMID:34896426 NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266 		JBrowse link
G Vim vimentin multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
G Vldlr very low density lipoprotein receptor increases expression EXP fenvalerate results in increased expression of VLDLR mRNA CTD PMID:30307764 NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920 		JBrowse link
G Vof16 ischemia related factor vof-16 increases expression EXP fenvalerate results in increased expression of VOF16 mRNA CTD PMID:30307764 NCBI chr 8:41,953,062...41,955,169 JBrowse link
G Vom1r100 vomeronasal 1 receptor 100 increases expression EXP fenvalerate results in increased expression of VOM1R100 mRNA CTD PMID:30307764 NCBI chr 4:122,468,150...122,471,495
Ensembl chr 4:122,462,283...122,473,701 		JBrowse link
G Vom1r101 vomeronasal 1 receptor 101 increases expression EXP fenvalerate results in increased expression of VOM1R101 mRNA CTD PMID:30307764 NCBI chr 4:122,499,102...122,500,235 JBrowse link
G Vom1r90 vomeronasal 1 receptor 90 increases expression EXP fenvalerate results in increased expression of VOM1R90 mRNA CTD PMID:30307764 NCBI chr 4:122,139,053...122,148,056
Ensembl chr 4:122,137,880...122,148,193 		JBrowse link
G Vom2r27 vomeronasal 2 receptor, 27 increases expression EXP fenvalerate results in increased expression of VOM2R27 mRNA CTD PMID:30307764 NCBI chr 1:66,102,631...66,137,116
Ensembl chr 1:66,102,632...66,137,281 		JBrowse link
G Vom2r31 vomeronasal 2 receptor, 31 increases expression EXP fenvalerate results in increased expression of VOM2R31 mRNA CTD PMID:30307764 NCBI chr 1:71,183,055...71,211,273
Ensembl chr 1:71,185,371...71,211,267
Ensembl chr 1:71,185,371...71,211,267 		JBrowse link
G Vom2r40 vomeronasal 2 receptor, 40 increases expression EXP fenvalerate results in increased expression of VOM2R40 mRNA CTD PMID:30307764 NCBI chr 1:139,409,429...139,457,552
Ensembl chr 1:139,409,430...139,457,552 		JBrowse link
G Vps25 vacuolar protein sorting 25 homolog increases expression EXP fenvalerate results in increased expression of VPS25 mRNA CTD PMID:30307764 NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,188,812...86,231,829 		JBrowse link
G Vsig8 V-set and immunoglobulin domain containing 8 increases expression EXP fenvalerate results in increased expression of VSIG8 mRNA CTD PMID:30307764 NCBI chr13:85,023,177...85,031,364
Ensembl chr13:85,023,177...85,031,364 		JBrowse link
G Vsnl1 visinin-like 1 increases expression EXP fenvalerate results in increased expression of VSNL1 mRNA CTD PMID:30307764 NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479 		JBrowse link
G Vwc2 von Willebrand factor C domain containing 2 increases expression EXP fenvalerate results in increased expression of VWC2 mRNA CTD PMID:30307764 NCBI chr14:85,683,670...85,825,068
Ensembl chr14:85,684,414...85,818,524 		JBrowse link
G Vwf von Willebrand factor decreases expression EXP fenvalerate results in decreased expression of VWF mRNA CTD PMID:30307764 NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539 		JBrowse link
G Washc2c WASH complex subunit 2C multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WASHC2 protein CTD PMID:34896426 NCBI chr 4:149,267,851...149,325,850
Ensembl chr 4:149,267,924...149,325,851 		JBrowse link
G Wdr12 WD repeat domain 12 decreases expression EXP fenvalerate results in decreased expression of WDR12 mRNA CTD PMID:30307764 NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469 		JBrowse link
G Wdr26 WD repeat domain 26 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR26 protein CTD PMID:34896426 NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295 		JBrowse link
G Wdr35 WD repeat domain 35 increases expression EXP fenvalerate results in increased expression of WDR35 mRNA CTD PMID:30307764 NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029 		JBrowse link
G Wdr44 WD repeat domain 44 increases expression EXP fenvalerate results in increased expression of WDR44 mRNA CTD PMID:30307764 NCBI chr  X:114,481,890...114,587,307
Ensembl chr  X:114,482,006...114,587,224 		JBrowse link
G Wdr81 WD repeat domain 81 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR81 protein CTD PMID:34896426 NCBI chr10:60,281,969...60,295,374
Ensembl chr10:60,281,972...60,295,296 		JBrowse link
G Wdr89 WD repeat domain 89 increases expression EXP fenvalerate results in increased expression of WDR89 mRNA CTD PMID:30307764 NCBI chr 6:94,350,468...94,382,085
Ensembl chr 6:94,350,303...94,382,026 		JBrowse link
G Wfdc18 WAP four-disulfide core domain 18 increases expression EXP fenvalerate results in increased expression of WFDC18 mRNA CTD PMID:30307764 NCBI chr10:68,588,818...68,590,972
Ensembl chr10:68,588,818...68,589,671 		JBrowse link
G Wfdc5 WAP four-disulfide core domain 5 increases expression EXP fenvalerate results in increased expression of WFDC5 mRNA CTD PMID:30307764 NCBI chr 3:152,849,025...152,854,868
Ensembl chr 3:152,849,025...152,854,904 		JBrowse link
G Wnt1 Wnt family member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA CTD PMID:33396045 NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651 		JBrowse link
G Wnt10b Wnt family member 10B increases expression ISO fenvalerate results in increased expression of WNT10B mRNA CTD PMID:12437293 NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892 		JBrowse link
G Wnt4 Wnt family member 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859 		JBrowse link
G Wnt6 Wnt family member 6 increases expression EXP fenvalerate results in increased expression of WNT6 mRNA CTD PMID:30307764 NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523 		JBrowse link
G Wnt7a Wnt family member 7A increases expression EXP fenvalerate results in increased expression of WNT7A mRNA CTD PMID:30307764 NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981 		JBrowse link
G Wt1 WT1 transcription factor multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA CTD PMID:34896426 PMID:36053783 NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643 		JBrowse link
G Wtip WT1 interacting protein increases expression EXP fenvalerate results in increased expression of WTIP mRNA CTD PMID:30307764 NCBI chr 1:86,731,214...86,764,939
Ensembl chr 1:86,731,265...86,765,014 		JBrowse link
G Wwc2 WW and C2 domain containing 2 increases expression EXP fenvalerate results in increased expression of WWC2 mRNA CTD PMID:30307764 NCBI chr16:44,258,372...44,421,815
Ensembl chr16:44,258,372...44,421,812 		JBrowse link
G Wwp1 WW domain containing E3 ubiquitin protein ligase 1 increases expression EXP fenvalerate results in increased expression of WWP1 mRNA CTD PMID:30307764 NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046 		JBrowse link
G Xiap X-linked inhibitor of apoptosis multiple interactions
increases expression		 ISO
EXP		 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of XIAP protein
fenvalerate results in increased expression of XIAP mRNA		 CTD PMID:28949029 PMID:30307764 NCBI chr  X:120,890,537...120,938,413
Ensembl chr  X:120,897,907...120,934,700 		JBrowse link
G Ybx2 Y box binding protein 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA CTD PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371 		JBrowse link
G Ydjc YdjC chitooligosaccharide deacetylase homolog increases expression EXP fenvalerate results in increased expression of YDJC mRNA CTD PMID:30307764 NCBI chr11:83,832,177...83,844,691
Ensembl chr11:83,841,306...83,846,336 		JBrowse link
G Yipf3 Yip1 domain family, member 3 decreases expression EXP fenvalerate results in decreased expression of YIPF3 mRNA CTD PMID:30307764 NCBI chr 9:14,730,289...14,735,644
Ensembl chr 9:14,730,284...14,735,641 		JBrowse link
G Ypel1 yippee-like 1 increases expression EXP fenvalerate results in increased expression of YPEL1 mRNA CTD PMID:30307764 NCBI chr11:83,921,799...83,936,409 JBrowse link
G Zbtb10 zinc finger and BTB domain containing 10 increases expression EXP fenvalerate results in increased expression of ZBTB10 mRNA CTD PMID:30307764 NCBI chr 2:92,475,254...92,509,892
Ensembl chr 2:92,479,014...92,512,515 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011 		JBrowse link
G Zbtb20 zinc finger and BTB domain containing 20 increases expression EXP fenvalerate results in increased expression of ZBTB20 mRNA CTD PMID:30307764 NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210 		JBrowse link
G Zc3hav1l zinc finger CCCH-type containing, antiviral 1 like increases expression EXP fenvalerate results in increased expression of ZC3HAV1L mRNA CTD PMID:30307764 NCBI chr 4:66,994,192...67,003,207
Ensembl chr 4:66,994,199...67,001,620 		JBrowse link
G Zcchc12 zinc finger CCHC-type containing 12 increases expression EXP fenvalerate results in increased expression of ZCCHC12 mRNA CTD PMID:30307764 NCBI chr  X:115,433,444...115,436,691
Ensembl chr  X:115,433,259...115,436,692 		JBrowse link
G Zfhx2 zinc finger homeobox 2 increases expression EXP fenvalerate results in increased expression of ZFHX2 mRNA CTD PMID:30307764 NCBI chr15:28,533,155...28,565,667
Ensembl chr15:28,533,156...28,565,128 		JBrowse link
G Zfp148 zinc finger protein 148 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF148 protein CTD PMID:34896426 NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772 		JBrowse link
G Zfp292 zinc finger protein 292 increases expression EXP fenvalerate results in increased expression of ZFP292 mRNA CTD PMID:30307764 NCBI chr 5:49,384,177...49,468,177
Ensembl chr 5:49,387,893...49,468,265 		JBrowse link
G Zfp316 zinc finger protein 316 increases expression EXP fenvalerate results in increased expression of ZFP316 mRNA CTD PMID:30307764 NCBI chr12:11,294,445...11,313,841
Ensembl chr12:11,293,980...11,312,177 		JBrowse link
G Zfp322a zinc finger protein 322a decreases expression EXP fenvalerate results in decreased expression of ZFP322A mRNA CTD PMID:30307764 NCBI chr17:41,773,789...41,789,654
Ensembl chr17:41,773,782...41,790,078 		JBrowse link
G Zfp335 zinc finger protein 335 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF335 protein CTD PMID:34896426 NCBI chr 3:153,618,587...153,648,213
Ensembl chr 3:153,627,467...153,647,054 		JBrowse link
G Zfp41 zinc finger protein 41 increases expression EXP fenvalerate results in increased expression of ZFP41 mRNA CTD PMID:30307764 NCBI chr 7:107,307,303...107,320,164
Ensembl chr 7:107,306,867...107,320,270 		JBrowse link
G Zfp474 zinc finger protein 474 increases expression EXP fenvalerate results in increased expression of ZFP474 mRNA CTD PMID:30307764 NCBI chr18:46,041,224...46,071,502
Ensembl chr18:46,041,218...46,100,751 		JBrowse link
G Zfp488 zinc finger protein 488 increases expression EXP fenvalerate results in increased expression of ZFP488 mRNA CTD PMID:30307764 NCBI chr16:9,283,039...9,293,681
Ensembl chr16:9,283,043...9,293,671 		JBrowse link
G Zfp536 zinc finger protein 536 increases expression EXP fenvalerate results in increased expression of ZFP536 mRNA CTD PMID:30307764 NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990 		JBrowse link
G Zfp592 zinc finger protein 592 increases expression EXP fenvalerate results in increased expression of ZFP592 mRNA CTD PMID:30307764 NCBI chr 1:134,951,286...135,002,443
Ensembl chr 1:134,967,783...135,002,443 		JBrowse link
G Zfp668 zinc finger protein 668 increases expression EXP fenvalerate results in increased expression of ZFP668 mRNA CTD PMID:30307764 NCBI chr 1:182,474,633...182,484,957
Ensembl chr 1:182,474,633...182,492,878 		JBrowse link
G Zfp771 zinc finger protein 771 increases expression EXP fenvalerate results in increased expression of ZFP771 mRNA CTD PMID:30307764 NCBI chr 1:181,864,035...181,875,136
Ensembl chr 1:181,864,219...181,875,141 		JBrowse link
G Zfp846 zinc finger protein 846 increases expression EXP fenvalerate results in increased expression of ZFP846 mRNA CTD PMID:30307764 NCBI chr 8:19,119,788...19,137,120
Ensembl chr 8:19,119,945...19,137,281 		JBrowse link
G Zfpm1 zinc finger protein, multitype 1 increases expression EXP fenvalerate results in increased expression of ZFPM1 mRNA CTD PMID:30307764 NCBI chr19:50,334,352...50,391,029
Ensembl chr19:50,334,682...50,390,591 		JBrowse link
G Zfpm2 zinc finger protein, multitype 2 increases expression EXP fenvalerate results in increased expression of ZFPM2 mRNA CTD PMID:30307764 NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205 		JBrowse link
G Zfyve28 zinc finger FYVE-type containing 28 increases expression EXP fenvalerate results in increased expression of ZFYVE28 mRNA CTD PMID:30307764 NCBI chr14:76,468,424...76,554,039
Ensembl chr14:76,468,424...76,554,039 		JBrowse link
G Zic1 Zic family member 1 increases expression EXP fenvalerate results in increased expression of ZIC1 mRNA CTD PMID:30307764 NCBI chr 8:91,908,548...91,918,020
Ensembl chr 8:91,908,576...91,912,731 		JBrowse link
G Zic2 Zic family member 2 decreases expression EXP fenvalerate results in decreased expression of ZIC2 mRNA CTD PMID:30307764 NCBI chr15:99,576,697...99,581,522
Ensembl chr15:99,576,697...99,581,522 		JBrowse link
G Zmym3 zinc finger MYM-type containing 3 increases expression EXP fenvalerate results in increased expression of ZMYM3 mRNA CTD PMID:30307764 NCBI chr  X:66,528,585...66,544,234
Ensembl chr  X:66,528,585...66,544,782 		JBrowse link
G Zpr1 ZPR1 zinc finger increases expression EXP fenvalerate results in increased expression of ZPR1 mRNA CTD PMID:30307764 NCBI chr 8:46,564,898...46,574,719
Ensembl chr 8:46,565,146...46,574,719 		JBrowse link
G Zzef1 zinc finger ZZ-type and EF-hand domain containing 1 increases expression EXP fenvalerate results in increased expression of ZZEF1 mRNA CTD PMID:30307764 NCBI chr10:57,413,265...57,550,888
Ensembl chr10:57,411,149...57,549,568 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19841
    role 19817
      application 19661
        pesticide 17927
          acaricide 13713
            pyrethroid ester acaricide 3354
              fenvalerate 1709
                esfenvalerate 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19841
    subatomic particle 19839
      composite particle 19839
        hadron 19839
          baryon 19839
            nucleon 19839
              atomic nucleus 19839
                atom 19839
                  main group element atom 19789
                    p-block element atom 19789
                      carbon group element atom 19737
                        carbon atom 19733
                          organic molecular entity 19733
                            heteroorganic entity 19492
                              organochalcogen compound 19255
                                organooxygen compound 19172
                                  carbon oxoacid 18641
                                    carboxylic acid 18638
                                      monocarboxylic acid 18008
                                        fatty acid 16809
                                          short-chain fatty acid 15919
                                            fatty acid 4:0 8222
                                              butyric acid 6719
                                                methylbutyric acid 2478
                                                  isovaleric acid 1715
                                                    2-(4-chlorophenyl)-3-methylbutyric acid 1709
                                                      fenvalerate 1709
                                                        esfenvalerate 0
paths to the root